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1 INTRODUCTION 
 
Man has always utilized natural products for different purposes, of which medical application 
is the most common. Indeed, the first documents of traditional medicine trace back to the 
ancient ages.1 Besides healing agents, natural products have been used as poisons, narcotics 
(1), hallucinogens, stimulants (2), perfumes (3), spices (4), dyes and so on.2 
More precisely, the term ’natural products’ stands for secondary metabolites; compounds 
produced often species specific by microorganisms, fungi, plants or animals that are not 
essential for the survival of the organism. The biosynthesis and degradation of secondary and 
primary metabolites (sugars, polysaccharides, amino acids, proteins, common fatty acids,  
lipids, nucleotides, RNA, and DNA) are interrelated.2 
The relevance of natural product research in drug discovery is a subject of discussions in the 
pharmaceutical industry today. Nevertheless, according to a study in the 1990’s more than 
50% of the most often prescribed drugs in the US contained a natural product or a structurally 
related derivative.1 Hence there is hardly any doubt about the importance of natural products. 
In fact, natural product research is much more than searching for compounds that are 
potentially beneficial to men (as medicines, fragrances, insecticides). Who knows what kind 
of role antibiotics from microorganisms play in nature other than defense or which additional 
physiological functions pheromones may have?3 Investigating natural products requires joint 
work of organic chemists, biochemists, biologists and medical scientists. It offers at the same 
time challenging problems to solve: ultra-trace analysis in complex matrices, synthesis of 
complicated structures, revealing biosynthetic mechanisms, also on the level of genetics 
(combinatorial biosynthesis), and exploration of substrate-receptor interactions.3 
 
Early milestones of the history of natural products are records about plants and extracts used 
for medical purposes in the ancient world. The use of different plant oils (from Cedrus, 
Cupressus species, and Papaver somniferum) were documented in Mesopotamia as early as in 
about 2600 BC. Several hundred drugs, some also of animal origin were recorded in Egyptian 
1000 years later, although observations began long before. From about 1100-1000 BC stem 
the first documents from Asia (China, India). It were the Greeks that added new facts to the 
field of herbal drugs in the last hundred years of the ancient western culture. This medical 
knowledge was used in the early centuries of the mediaeval western world. However, Arabic 
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and Persian scholars completed their own experience with the Greco-Roman and Asian 
heritage and became real experts at the same time.1 
Personal documents about the use of natural products for healing purposes in the mediaeval 
ages are recipes of plant extracts from medical researchers in the 16th and 17th century. 
Nevertheless, the next stage of development, the isolation of active substances, such as 
morphine (1), strychnine, quinine, caffeine (2), nicotine, codeine, camphor, and cocaine was 
reported first in the 19th century.2 It was a great challenge for chemists to work out total 
synthetic routes and structure elucidation techniques. These efforts lead in the 20th century to 
the development of research methods to explore biosynthetic pathways. Due to the results of 
natural product research in the last decades we know more about the ecological function of 
theses substances, how they contribute to the competitiveness of the parent organisms.2 
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Scheme 1.1  Structures of some natural products being used traditionally: morphine (1) from Papaver 
Somniferum, caffeine (2), diallyl disulfide (3) in garlic, and geraniol (4) in rose oil.2 
 
Modern pharmaceutical research based on screening of natural products began with the 
exploration of antibiotics. The trigger of the research work directed to antibiotics was the 
isolation of penicillin in 1929, followed by intense screening of bacteria and fungi after the 
World War II. Interest in natural product research rose again after the thalidomide scandal in 
the 1960’s. As a consequence, secondary metabolites were applied in other pharmaceutical 
research fields, for instance in the development of anti-cancer drugs. One of the success 
stories was the discovery of the diterpene Paclitaxel (5), isolated from the bark of the yew 
tree, Taxus brevifolia, used under the trade name Taxol for the treatment of ovarian and breast 
cancer4, and being tested against other cancer types. 
In spite of the good results of natural product research combinatorial chemistry has been a 
major competitor in the pharmaceutical industry. Isolation and structure elucidation of the 
compound responsible for the desired biological activity from the natural extract found by 
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screening are highly time- and cost-intensive steps. In contrast, it is cheaper and faster to 
achieve the first clinical phase once a compound generated by combinatorial methods is 
proved to be active, since its structure is already known.4 Nevertheless, combinatorial 
chemistry produces structures without known function in the environment. 
A further problem in natural product research is the difficulty of supply of source organism or 
the uncertainty of future supplies, for example of  marine organisms. This is especially crucial 
in case of complicated natural products, where synthetic production is not possible. For this 
reason, microorganisms that easily grow in cell culture are still preferred. Some firms 
(Phytopharmaceuticals, Phytera) work with plant cell cultures to avoid the problem.4 
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Scheme 1.2  Structure of the anti-cancer drug Paclitaxel (5) and the anti-leukemic marine natural 
product Bryostatin-1 (6). 
 
As a new trend, natural product research is integrated, even though to a small percent (5-
20%), in the drug discovery program of large pharmaceutical companies (Merck, Novartis). It 
is not the principal goal any more to find ready-to-use natural drugs, but to perform a large 
scale biological screening and find as many interesting substances as possible with high 
structural diversity. These compounds are applied as lead molecules for further investigation: 
combinatorial development, or chemical modification to simplify the structure or improve 
pharmacological properties.1,4 In addition, smaller companies have been established to devote 
their efforts fully to natural product research. They usually specialize in a particular task. As a 
unique example, Shaman Pharmaceuticals Inc. in San Francisco organizes sample collections 
based solely on ethno-biological information (traditional medicine).4  
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Though investments are fluctuating, the role of natural products in drug discovery remains 
important. It is still nature that provides the highest structural diversity. 
 
Oceans cover 71% of the world’s surface5, and the marine biosphere has been seen lately as a 
newly detected source for natural products and drugs.6,7,8 Screening for marine natural 
substances has been supported only since the 1970’s. Development of underwater technology 
and ecologically relevant bioassays in the 1980’s was substantial for the research. One of the 
first discoveries in the early 1980’s was the isolation of the macrolide bryostatin-1 (6), an 
antileukemic acting substance, which is in clinical trials now. Since then, numerous secondary 
metabolites have been isolated and identified from all substance classes known hitherto from 
terrestrial organisms.9,6 
Why should some of the marine natural products be different from terrestrial ones? The 
answer lies probably in the special living conditions of marine organisms. High salt 
concentration (30-35 g/l9) in an aqueous medium, absence of light, high pressure and low 
levels of oxygen in deep sea are the distinctive characteristics of marine environment.10,8 As a 
consequence, exocrine substances are most probably water-soluble and highly active (to 
counteract dilution). Due to the high salinity halogenated compounds are frequently isolated 
from marine organisms.8 The terpene halomon (7)10  was isolated from the red alga Portieria 
hornemannii. In fact, bromophenol derivatives, the antibacterial and cytotoxic compound 8 
for instance from the sponge Aplysine cavernicola9, are unique to marine organisms.11a 
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Scheme 1.3  Halogenated marine natural products: halomon (7) and bromochloroverongiaquinol (8). 
 
The high chemical diversity of marine natural products is also a consequence of special 
functions of polyketide synthases (PKSs) and fatty acid synthases (FASs). These enzymes 
utilize catabolic products of amino acids (Val, Leu, Ile) as starter units, and propionate and 
butyrate as building blocks. 
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The high biological diversity in the marine biosphere is represented by the distribution of  the 
36 global Phyla: 34 are found in the oceans, and only 17 in terrestrial environment.12 
In fact, around 51% of the earth’s surface is covered with sea water deeper than 3000 meters;5 
and it is noteworthy that light diminishes at 200-400 m deep. Although it has been thought 
that deep seas merely contribute to the marine biological diversity, new diving and sampling 
techniques10 made discovery of new species, the picoplankton fraction and benthic species for 
example, possible.   
A revolutionary finding was made by the research group of one of the most devoted deep-sea 
scientist, William Fenical published in 2003.13 They isolated a highly potent compound, 
Salinosporin A (9) with anti-cancer cytotoxic activity produced by a marine actinomycete 
strain. These bacteria species live in tropical/subtropical waters and at depths of –1100 
meters. Several thousand strains of the new genus (called “Salinospora”) isolated so far need 
ionic sodium for growth representing the high level of adaptation to marine environment of 
these species. They can be considered “real marine bacteria”.  
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 Scheme 1.4  Structure of Salinosporin A (9) and omuralide (10), a marine 
 and a terrestrial natural product with similar biological activities. 
 
Although the bicyclic core of Salinosporin A is identical to that of omuralide (10) isolated 
from a terrestrial Streptomyces strain, the functional groups are more elaborate. This is just 
one example for the conviction that terrestrial and marine natural products have comparable 
carbon backbones but the latter are often uniquely functionalized.10 While bacteria are gaining 
more attention, sponges are the most frequently cited marine organisms in literature.8 While 
nearly 40% of the biologically active marine compounds were isolated from sponge species in 
the last years, only about 2-4% was of bacterial origin excluding cyanobacteria.6 
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Nevertheless, not all bacteria are free-living, they inhabit sediments and the surface or internal 
spaces of other organisms, sponges for example. The relationship to the host organism can be 
symbiotic or pathogenic.9 Indeed, often the symbiotic microorganism is the producer of 
natural products isolated from invertebrates.6 
The development of marine natural product research is probably slower than expected due to 
particular difficulties. It takes more effort and is more expensive to collect samples. There are 
no examples among traditional medicine records for the use of substances of marine origin to 
help to find potent organisms. The concentration of interesting substances is often very low, 
which makes isolation and structure elucidation more complicated.10  
Another barrier is that culturing marine bacteria is troublesome. Due to the “great plate count 
anomaly”, i.e. only a tiny part of the microscopic organisms build colonies on plates,14 the 
estimated fraction of already studied microorganisms is less than 0.1%15. Considering that the 
number of microorganisms is about 105-106/ml in sea water, there is a lot to do.  
 
The chemical ecology of spiders is a significantly narrower research field compared to 
studying marine natural products; and it has been by now thoroughly investigated. However, 
owing to new analytical techniques, for instance high performance liquid chromatography 
coupled with diode array detector and tandem mass spectrometry (HPLC-DAD-MSn) further 
substances can be identified from already known species.16,17  In addition to more sensitive 
analytical methods, novel milking techniques providing larger quantities and better quality of 
spider venom contribute to this trend. Indicating ’the steady-state’ of the research only a small 
number of pharmacological firms are interested in terrestrial invertebrates.4 
 
Although the majority of the substances will find probably no practical application in human 
therapy,11b screening natural products for cytotoxicity are the most granted research 
programs.8 This may distract attention from the ecological role of natural products other than 
defense. 
Secondary metabolites have diverse functions in nature, which are still to be discovered. This 
is especially true for marine natural products and marine bacteria. More specifically, the 
investigation of lipophilic compounds of marine origin is rather negligible compared to other 
substance classes.6 An interesting environment to investigate is the deep sea, since non-costal 
regions are probably free of pollution9,5 and the influence of terrestrial life11. 
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Exploration of the high complexity of natural products requires constant technical 
development, which again, results in discovery of novel structures. This automatism is the key 
of the future success of natural product research. 
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2 OBJECTIVE 
 
The aim of this Ph.D. work was to develop an analytical tool for the investigation of several 
100 marine extracts obtained from Prof. Laatsch, from the University of Göttingen, Germany, 
and to examine several low molecular weight (LMW) fractions of spider venom by capillary 
electrophoresis (CE) in cooperation with Prof. Kuhn-Nentwig from the University of Bern, 
Switzerland. 
Focus of the first part of the work was on the high-throughput analysis of gas 
chromatographic (GC) data of lipophilic marine fractions, usually discarded by chemists. A 
conversion program was to be written in order to enable the use of the statistical program 
package SPSS for the clustering of the samples based on their GC patterns. Different modes 
of cluster analysis were to be examined concerning hierarchical cluster analysis, principal 
component analysis, as well as various distance measures and linkage rules. Isolation and 
structure elucidation of novel substances found by the new method and the presentation of 
other interesting compounds should prove the successfulness of the whole process. The 
influence of fermentation conditions was also to be studied. The lipophilic fermentation 
extracts were investigated within a research program in Lower-Saxony, Germany. 
Crucial point in the second part of the work was the application of CE for the analysis of 
some LMW fractions of the venom of Cupiennius salei. Samples were to be examined first by 
derivatization and gas chromatography mass spectrometry (GC-MS). Furthermore, the 
usefulness of CE and indirect UV detection for the analysis of LMW venom components was 
to be investigated. Results were to be compared to literature data concerning spider venom in 
general. 
Marine bacteria 
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3 MARINE BACTERIA 
 
3.1 Research project 
 
Introduction 
The analysis of lipophilic extracts from marine bacteria was started within the Marine 
Biotechnology Research Project of Lower-Saxony, 1998-2002. The aim of the project was to 
investigate bacterial natural products in the North Sea and the Wadden Sea, in Germany. 
Several groups from different universities and institutes from Lower-Saxony worked together 
in this basic research program. The combined efforts of scientists from the field of biology, 
molecular biology, natural product research, organic chemistry, pharmacology and 
biotechnology focused on the identification of biologically active substances. 
The research activities were divided into five big subject areas. In the first one, chitosan and 
chitosan oligomers (I), enzymatic pathways were investigated for the environment friendly 
production of chitosan. The second and third subject areas, competition on surfaces (II) and 
secondary metabolites of microorganisms from the North Sea (III), were interrelated to a high 
degree. Several macroorganisms (tunicates, bryozoa) and the associated bacteria were isolated 
and characterized according to phylogenetical and physiological properties. Biological 
activity of the secondary metabolites were tested. Interesting compounds were synthesized for 
testing purposes by the research groups in the forth subject area, synthesis of marine natural 
products (IV). The aim of the fifth subject area (V) was the biological testing of samples and 
the development of new test methods. Antibiotic, anticancer and antiviral activities of newly 
found substances were analyzed and a voltage-dependent ion-channel test system was 
established. 
 
Contribution of our research group to the project in the first time period 1998-2000 
Our group participated in the work of two subject areas of the project: Synthesis of Marine 
Natural Products (IV) and Secondary Metabolites of Lately Discovered Microorganisms from 
the North Sea (III). 
Dr. Markus Müller was involved in subject area IV with his work on the egg-hatching-factor 
of barnacles.18 The compounds 11 and 12, also called trioxilin A3 and A4, are the two active 
Marine bacteria 
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constituents of the egg-hatching-factor of the barnacle, Balanus balanoides. (Scheme 3.1) 
However, the stereochemistry of the hydroxyl groups had not been elucidated. Trioxilin A3 
and A4 were found in the extract of the test organism, Elminius modestus. Saturated 
derivatives of the acids with all the four pairs of diastereoisomers were synthesized in order to 
find out which stereoisomer is produced in nature. 
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  Scheme 3.1  Trioxilin A3 (11) and Trioxilin A4 (12). 
 
The four diastereomers and seven of the eight enantiomers were separated on achiral and 
chiral GC phases. The natural product contains three or four isomers with an anti-(11,12) 
stereochemistry and the main isomer has a (8R,11RS,12RS) configuration.  
 
Another task was to investigate the lipophilic fraction of the fermentation extracts of marine 
bacteria by collaborating with groups from subject areas II and III. In the first period extracts 
of marine Streptomyces strains were analyzed after derivatization by GC-MS by Dr. Katja 
Stritzke.19 Beside ω-1 and ω-2 branched fatty acids, a new natural product, 3-hydroxy-12-
methyltetradecanoic acid was found in a sample from a strain. Other constituents, mostly 
already known from Streptomyces strains, were aromatic acids (benzoic and antranilic acid), 
hydrocarbons and diketopiperazines, for example. Further compounds were identified by 
synthesis and structure elucidation, summarized in Scheme 3.2. 
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Scheme 3.2  Natural products identified from marine strains of Streptomyces. 
 
The caprolactones 13 and 14 have a growth inhibitory effect on tumor cells.20 The compound 
x is a known stereo isomer of Albonoursin, and has antibacterial and cytotoxic activities.21 
Furthermore, different N-phenylethyl-alkylamides, 16, and N-substituted tyramine 
derivatives, 17, were identified by GC-MS. The tyramine 17d, for example, is known from a 
corynebacterium and has an inhibitory effect on aldose reductase.22 
 
The second time period of the project, 2000-2003   
The investigation of lipophilic marine extracts proceeded further in the second period of the 
project. After preliminary experiments several hundred marine strains were isolated and 
fermented. Our group received lipophilic fractions of fermentation mixtures produced mostly 
in the research group of  Dr. Laatsch in Göttingen. Isolation of the strains was carried out by 
the group of Dr. I. Wagner-Döbler from a biotechnological institute, ’Gesellschaft für 
Biotechnologische Forschung’, in Braunschweig. 
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Marine strains were isolated from the North Sea in different ways. 
 
1. Seawater was taken 10 m deep near Helgoland and single colonies were cultivated 
    after a series of dilution steps (samples Hel1 to Hel85). 
2. 100 liters of water sample were filtered (5 µm) and the filtrate was kept in the 
    dark at 4 oC for enrichment of bacteria. The picoplancton fraction, obtained 
    by a further filtration step (0.2 µm), was also investigated (samples Picx). 
3. Sterile plates of glass were kept 0.5 m deep in the seawater, 1 km from Helgoland; 
    the biofilm was scratched off and the bacteria were isolated. 
 
Isolated bacteria were first cultivated, than fermented to study the production of secondary 
metabolites. It is extremely difficult to cultivate marine bacteria. As a result, several types of 
medium had to be investigated and used throughout the whole project. Due to the diversity of 
medium constituents (sugars, proteins, dextrin, fish-meal, algae extract, metals, vitamins, 
calcium, for example) the extracts contained a lot of compounds that led to a high background 
in the chemical screening. The extraction yields were also rather low at the beginning, which 
resulted in very low amount of sample available for chemical analysis. 
Fermentation products were usually separated between methanol and cyclohexane, and the 
latter fraction was investigated in our laboratory by GC and GC-MS. Selected strains and 
control samples without bacteria were fermented in parallel experiments. These fermentation 
mixtures were extracted with ethyl acetate, only.  
In addition to marine samples, extracts of terrestrial Streptomyces strains (with a label 
GWx/x) were also obtained from Mr. Laatsch, from Göttingen.  
Due to the high number of extracts to analyze a selection tool had to be developed using data 
analysis based on clustering of the GC patterns. 
Marine bacteria 
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3.2 Multivariate data analysis 
 
In the following chapter I am going to discuss the theoretical background of data analysis of 
samples based on their chromatographic properties. 
Handling large data sets has become routine work for chemists as for other scientists. The 
number of the samples in a study is often a few hundred, or even more. The dimension of 
measurement data has also increased over the years with the development of chromatographic 
and spectrometric techniques. To find relationship between multiple measurement data and 
not directly measurable sample properties is impossible without computer assisted 
multivariate analysis. 
Data mining and pattern recognition procedures use a collection of multivariate data analysis 
methods. A pattern is a set of features that describe certain properties of an object. Pattern 
recognition means identifying a pattern as a member of the class to which it belongs.23 
Samples are usually the objects and measurements the features in chemical applications 
(section 3.2.2). 
Two approaches for data analysis are unsupervised and supervised learning. The first is 
distinguished from the second by the fact that there is no outcome measure, the goal is to 
describe the associations and patterns among a set of input measures. Supervised learning is a 
technique for predicting the value of an outcome measure based on a number of input 
measures.24 
As a rule, each sample of a raw data set is considered as a point in an n-dimensional 
measurement space. The samples, i = 1 to m,  are represented by the data vectors, xi  =  (xi1, 
xi2, …, xij, …, xin), where xij is the j-th measurement of the i-th sample, the area of the j-th peak 
in the i-th chromatogram, for example. The distance of two objects in the measurement space 
can be calculated (section 3.2.1.1). The smaller the distance, the more similar the samples. 
The method of choice for data analysis depends on what we are interested in: the natural 
grouping of samples (cluster analysis) or reduction of dimensionality (principal component 
analysis). 
Marine bacteria 
14
 
3.2.1 Unsupervised data analysis 
 
Since we had no a priori knowledge about our data set unsupervised analysis techniques were 
applied to extract information. The major methods: cluster analysis (CA) and principal 
component analysis (PCA) are presented below.  
 
3.2.1.1 Clustering 
 
Cluster analysis is a collection of methods to organize data by uncovering the natural 
grouping of samples or variables in a data set. Similar objects are grouped together and thus 
form a cluster. Most widely used is the so called hierarchical cluster analysis (HCA) of 
samples, particularly the agglomerative form of it. At the beginning samples are considered as 
one-member-clusters and the distance between each pair is calculated. Then the two nearest 
clusters are merged into a new cluster. The distances are calculated again with the new 
cluster, and the clustering proceeds, till all of the samples are assigned to a cluster.  
 
 
 
 
 
 
 
 
 
Fig. 3.1  A dendogram made by Euclidean distance and average linkage between groups. Hel73 C and 
Pic006 C are the two most similar objects. 
 
The clustering is visualized by a tree-like diagram, called dendogram. The position of the 
junction points are representing the level of similarity. In Fig. 3.1, for example, the samples 
Hel73 C and Pic006 C are the most similar ones. The clustering process is time intensive and 
is suitable for a few hundred samples only. 
                                Rescaled Distance Cluster Combine 
 
     C A S E        0         5        10        15        20        25 
 Label         Num  +---------+---------+---------+---------+---------+ 
 
 Hel73 C         4   òûòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòø 
Pic006 C        6   ò÷                                               ó 
 Ihg,3 C         3   òòòòòòòòòòòòòûòòòòòòòø                           ó 
 IHg,4 C         5   òòòòòòòòòòòòò÷       ó                           ó 
 Hel59 C         7   òòòòòòòòòòòòòòòòòòòòòôòòòòòòòòòø                 ó 
K- C            2   òòòòòòòòòòòòòòòòòòòòò÷         ùòòòòòòòòòòòòòòòòò÷ 
 Pic009 C        1   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ 
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Other clustering methods are two-way joining and K-means clustering. The first one is useful 
for discovering grouping within objects and variables simultaneously. The second is for 
organizing objects into a given number of clusters. 
 
Distance measures 
The metric used for the calculation of the distance between two points in the measurement 
space, called distance measure, depends on the data type. Binary data have only two values (1 
or 0, or yes or no), discrete data are represented by a finite number of values (taste of apple: 
very good, good, moderate, unsatisfactory). Chemical data are mostly continuous, and the 
number of values is infinite. Data scale is also important; the area of chromatographic peaks, 
for example, is a ratio scale continuous data type, since the scale has an absolute zero and 
ratios are meaningful. Possible distance measures for this type of data are:25a 
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where xi and yi are the i-th coordinates of samples x and y. The Euclidean distance provides 
the smallest distance between two points in an n-dimensional space. It is suitable for raw data, 
nevertheless, variables differently scaled are to avoid.26 Larger distances are weighted by 
choosing the squared Euclidean metric. City-block distance is more suitable for discrete 
distances. In order to save computational time Chebychev distance is used. Minkowski is 
identical to city-block at p = 1, Euclidean at p = 2, and approaches Chebychev as p 
increases.25a 
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Linkage rules 
The way the distance between clusters (with more than one members) computed, called 
linkage method, has an effect on the final structure of the clustering. The different linkage 
methods are presented in Fig. 3.2. For single, complete, and average linkage the distances 
between all pairs of points are calculated, taking points from different clusters.  
By single linkage the smallest distance, by complete linkage the largest distance is considered 
as distance between two clusters. The first one results in chain-like clusters and is sensitive to 
outliers, the second one is more suitable for distinct, compact clusters.24b,25b 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
Fig. 3.2  Linkage methods (for the Ward method see text). 
 
 
The average linkage joins clusters according to the arithmetical average of the distances and is 
generally good in most cases.24b,25b Weighted average linkage fits better, when the size of the 
clusters varies in a large scale. The centroid is a point in the measurement space with 
coordinates that are the weighted or unweighted arithmetic average of the coordinates of all 
points in the cluster. For centroid methods the centroid of the clusters is calculated; the 
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distance between two clusters is the distance between the centroids.  The Ward method is a 
different one (not presented in Fig. 3.2); those clusters are fused that cause the smallest 
increase in the sum of the squared Euclidean distances of the points to the centroid of the 
cluster. It tends to produce small clusters.26 Centroid and Ward clustering methods are used 
together with the squared Euclidean distance. 
 
Interpretation of the results of the hierarchical cluster analysis 
The limit of cluster analysis is the definition of the threshold value of similarity.27 It depends 
on the aim of the experiment, how many clusters we recognize on the dendogram. It is 
difficult to tell how well the outcome of the hierarchical clustering reflects the real grouping 
in the data set. In Fig. 3.1, for example, only two clusters are seen at the distance level 17, but 
five at the distance level 8. 
An indication for well separated clusters in a data set is that each linkage method gives the 
same distribution of clusters. In case of overlapping clusters the clustering should be 
performed with several linkage methods simultaneously. 
 
3.2.1.2 Principal component analysis 
 
In cases when variables are correlated to some extent in a raw data set it makes sense to find a 
smaller number of independent variables that contain almost all the information than the 
original ones. As a result, grouping of the objects or the original variables can be detected. 
Nevertheless, the main purpose is to reduce the dimensionality of the data. The collection of 
these methods is called data reduction. 
The most widely used method is the principle component analysis. The original n-
dimensional measurement space is transformed to another n-dimensional one, where the first 
few dimensions (components) hold most of the information (variance). The components are 
calculated by finding the eigenvectors (and eigenvalues) of the correlation matrix of the 
original variables. The first component represents the highest variance in the data and has the 
largest eigenvalue. The second one has the second largest eigenvalue, and so on. Ideally the 
first few components, the so called principal components, contain a high percentage of the 
total variance and the rest of the components contain noise. Thus the principal components 
can be extracted without major loss of information and they form the new axes in the 
measurement space. The coordinates of the objects are called scores, and that of the variables 
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loadings. Rotation of the axes gives the final solution, where the correlation of the 
components is minimized.      
The number of components to extract can be determined differently. A minimum eigenvalue 
the components should have can be fixed. The number of components to extract can also be 
selected before the process, nevertheless, it is better to perform preliminary analysis to 
estimate it (with the first criteria, for example). It is also useful to draw a so called scree 
diagram, the eigenvalue versus component number (Fig. 3.3). The elbow of the plot shows the 
number of components that are necessary to describe the data set. A more exact criterion is 
the minimum portion of the total variance the principal components should represent. 
Extracting 75 % of the variance leads usually to satisfactory results. The parallel use of the 
last two mentioned methods is advisable.28 
 
 
 
 
 
 
 
 
 
 
 
 
      Fig. 3.3  A scree diagram. The estimated number of principle 
      components in this case is two. 
 
Interpretation of the results requires caution. Grouping of the variables can be visualized by 
drawing 2D score plots with selected pairs of principal components as the two axes. Then, the 
meaning of the grouping of the variables is examined. It is not always possible to assign a 
property to each group. To discover the grouping of objects with PCA is more productive, if 
some structure in the data set is already known. Classification methods involve PCA steps to 
reduce dimensionality and both CA and PCA for discovering data structure, as presented in 
the next section.    
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3.2.2 Applications in chemistry 
 
’Computer pattern recognition methods extend the ability of human pattern recognition, but, 
in the end, it is the chemist who must do the chemistry.’ wrote Kowalski in 1975.29 
He was one of the pioneers who applied pattern recognition for chemical purposes. The 
development of these methods was very fast in  the ’70s owing to the big interest in predicting 
molecular structure from spectral (mainly MS) data. Since 1974 Chemometrics has been the 
name of this special field of chemistry.23  
The application of clustering and/or PCA for the classification of chromatographic data is 
remarkably widespread: for quality control purposes in the pharmaceutical and 
biotechnological industry, for diagnosis in medicine, for sensory evaluation and quality 
control in the food industry, for identifying oil source in the petrol industry, for environmental 
studies, and to determine the origin of objects according to some chemical properties, just to 
mention a few.30 
A few applications are presented to highlight some factors that influence the successfulness of 
classification of chromatographic data and to demonstrate the development of the methods. 
The way chromatographic peaks are integrated can affect the results, for example. 
Nonenzymatic posttranslational modification of collagen was followed by capillary zone 
electrophoresis in a study.31 Samples from groups of differently treated genetically 
hypertriglyceridemic animals and a control group were investigated. Due to the lack of 
baseline separation and the poor reproducibility of migration times not the single peaks but 
segments of the electropherogram served as variables. Four of the seven segments were 
enough to discriminate the different groups of animals. The results of the PCA was dependent 
on the peak integration method: valley-to-valley or common baseline. The second method 
gave no meaningful results.  
The standardization of raw data and the selection of the linkage method used for hierarchical 
cluster analysis is also relevant. In a research work from 1984 urine samples from patients 
with different renal disorders were clustered according to the HPLC analysis of the urinary 
proteins.32 Hierarchical cluster analysis using single linkage was not successful owing to the 
overlapping of the clusters. The dendograms obtained by Ward’s method, once with 
standardized data, once with the raw data, were different. Nevertheless, the interpretation was 
possible and the grouping was clinically meaningful in both cases. 
The use of CA and PCA to reveal taxonomic relationships from chemical data should be taken 
with caution. An Australian research group examined the gas chromatograms of some 
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essential leaf oils gained by a vacuum distillation technique.33 Although the three Eucalyptus 
series are clearly differentiated using morphological observations, no meaningful grouping  
was achieved by CA or PCA based on chromatographic data. The variation in the leaf oil 
composition of species was so large between and within series that the three series could be 
differentiated only by supervised learning using linear discriminant analysis. 
A recent publication describe the classification of samples using 2D measurement data. Jet 
fuels were investigated by a 2D gas chromatographic technique in the United States.34 The 2D 
separation, called comprehensive GC x GC, is achieved by transferring little gas plugs from 
the first column onto the second one. PCA and K-means clustering was performed on the data 
set after selecting the relevant features. Not only the jet fuel types were successfully 
differentiated (independent from geographical origin), but also the fuel mixtures with 
different composition. 
Kowalski was right, interpretation of the results is impossible without human sense. However, 
there exists the danger of overfitting parameters to obtain results that fit better the 
expectations.  
 
3.2.3 Introduction to SPSS 
 
SPSS Inc. exists since 1975 as a company, but its history started more than 35 years ago.35  
Three young men, a social scientist, an expert in operational research and a business 
administrator developed a software system to quickly analyze volumes of social science data, 
in 1968. It was then called Statistical Package for the Social Sciences. Having their office at 
the University of Chicago, they worked continuously on the development of the software and 
sold it mostly to universities. After incorporating in 1975, the circle of the customers became 
larger. The first statistical package for PCs appeared on the market in the mid-1980s. In 1992, 
SPSS Inc. provided the first statistical product for Microsoft Windows systems. 
The term SPSS covers Statistical Product and Service Solutions now. The company  has a 
large market penetration with its data mining products and concentrates on predictive analytic 
applications in the future. 
The software SPSS is an all-round statistical tool for different sciences.36 It offers data 
transformation, descriptive and explorative data analysis, data tests, variance analysis, 
correlation and distance calculation, linear regression analysis, cluster analysis, discriminant 
analysis, factor analysis and multidimensional scaling, for example. 
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Input data can be edited or undertaken from other programs. SPSS accepts Excel worksheets 
and also data in ASCII format. After selecting a procedure from the menu, the variables are 
chosen and the parameters are set by the user. The results are presented on a new sheet, which 
can be saved as a separate file. It is also possible to proceed further with the analysis of the 
results. 
 
 
3.3 Development of a high throughput process for the gas 
chromatographic investigation of several hundred 
marine extracts 
 
It was our task to explore the lipophilic compound diversity of marine bacteria from the North 
Sea and the Wadden Sea within the marine research project in Lower-Saxony (section 3.1). 
Hundreds of samples containing hundreds of components with concentrations from trace to 
high level had to be analyzed. The chemical screening of the samples required a high 
efficiency separation method coupled with universal detection for the identification of the 
components. The method of choice to separate and identify substances in marine extracts was 
gas chromatography-mass spectrometry. A large scale of polarity of the analytes was to be 
expected, partly due to the constituents of the cultivation media. Hence, it was necessary to 
derivatize the extracts. Since the number of samples was too high to analyze all of them by 
GC-MS, a data selection tool was developed based on GC data. The tool implies a self-made 
program, ChromConv to convert GC data and a clustering step.  
The combination of GC and GC-MS has advantages over HPLC-MS for the fast chemical 
screening of hundreds of unknown samples for LMW compounds, under 1000 amu. (Table 
3.1). The development of a separation method is easier, since a single BPX-5 capillary 
provides the separation of unpolar to mid-polar substances with high theoretical plates. Only a 
temperature program has to be created before analysis, instead of searching for the proper 
mobile phase mixture and gradient. The electron impact (EI) ionization in GC-MS is universal 
for analytes with a molecular weight below 1000 amu, whereas it is time consuming to find 
the optimal ionization parameters for the typical HPLC interfaces (ESI and APCI). Successful 
trace component analysis by GC-MS is due to the good overall sensitivity and the possibility 
of single ion monitoring (SIM). Tandem HPLC-MS techniques make analysis in trace level 
possible, but again, the method development is time consuming. In addition, the problem of 
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analyzing more polar substances by GC-MS can be solved with a proper derivatization 
method (section 3.3.2.1). Considering the small amount of extracts obtained in the project, 
often less than 1 mg, GC-MS remained the technique of choice for the chemical screening.  
 
    Table 3.1  Comparison of GC-MS and HPLC-MS techniques for the analysis of 
    unknown mixtures containing low molecular weight compounds (<1000 amu). 
 GC-MS HPLC-MS 
Costs inexpensive expensive 
Analytes volatile, thermally stable,  
but derivatization helps! 
nearly without limitation, 
but no universal ionization 
Speed of separation fast slow to fast 
Theoretical plates 105-106 104-105 
Resolution unique good  
Enhanced sensitivity by selected ion monitoring tandem MS 
Method development fast slow 
 
 
Since the number of samples to analyze reached quickly several hundred, the complete 
characterization of all of them by GC-MS was unthinkable. Traditional GC-MS analysis 
requires up to 5 different runs including different derivatization experiments. Still, we wanted 
to get an overall picture about the lipophilic compounds produced by marine bacteria. 
Moreover, it was our intention to isolate and characterize novel marine substances from 
selected strains. 
Therefore a data handling tool was developed to find grouping in our data set based merely on 
the results of gas chromatographic measurements. In order to be able to compare the results, 
all extracts were trimethylsilylated under standardized conditions before GC analysis. Without 
any knowledge about the data structure unsupervised data analysis was performed on the GC 
data. A GC analysis is inexpensive and fast. It was possible to derivatize and measure all the 
samples by GC. Raw GC data was converted by the self-made program, ChromConv. 
Clustering of the samples based on the converted GC data was performed by HCA and 
PCA/HCA, thus grouping of similar samples was revealed.  
For the identification of substances by GC-MS samples were selected with the help of our 
data selection tool. It was then possible to avoid the GC-MS analysis of very similar samples 
(dereplication). The other aspect was selecting interesting extracts that probably contain new 
metabolites. 
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3.3.1 The program ChromConv 
 
ChromConv is a data conversion program. It takes raw GC data as input and creates a so 
called measurement matrix in form of a text file. The output file contains a table with samples 
in rows and variables in columns and can be used for clustering.  
Perl was the language of choice for writing ChromConv. 
   
3.3.1.1 Compensation for retention time changes 
 
It was important to take into consideration how the retention time of a given compound 
changes during the years of the experiment. Retention time fluctuation was followed by 
regular analysis of a standard mixture of alkanes from C11H24 to C44H90.  
 
iicorri RTRTRT ∆+=,         Eq 3.1 
 
The retention time deviation from the first value measured at the beginning of the experiment 
was plotted against the actual retention time. Polynomial fit of the second order was applied 
to the points. (Fig. 3.4) As a result, the retention time values were corrected in the whole 
measurement time interval according to the parameters of the fitting curve (see Eq. 3.1). 
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       Fig. 3.4  Retention time changes of the standard  
       alkanes versus retention time (compared to the values 
       at the beginning of the experiment). 
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3.3.1.2 Conversion of gas chromatographic data 
 
The output of the conversion program had to be a two dimensional matrix with samples in 
rows and variables in columns. It was quite obvious that each marine extract or rather the GC 
chromatogram of it represents a case. The question was, which chromatographic feature holds 
the information for the classification of the samples. 
Since we had unknown samples and the GC analysis did not provide identification it was 
obviously impossible to compare samples according to the existence of given substances. To 
find the feature for the differentiation of the chromatograms, the format of the measurement 
results was examined. GC data are stored in two different ways by the measurement software 
(ChromCard) supplied from the manufacturer of the GC system. (Fig. 3.5) One form is a list 
of intensity values and the points in time it was measured, the raw GC data. The points in time 
are the same for each chromatogram by a given data rate. The other form is the measurement 
report. It contains the retention time and the integrated area of the peaks listed in pairs. 
Data alignment, that is peak matching with a given deviation or time window, is quite 
common.32,37,38 However, significant shifts of retention time, nearly 0.5 min, could be 
observed due to the lack of any carrier flow controlling system in the GC. The shift was not 
constant in the measurement time interval due to the splitless injection mode used in the 
experiment. In addition, the deviation was comparable to the retention time difference of two 
adjacent peaks.  
Another approach is the conversion of raw GC data.37 Clustering of samples occurs then 
according to the intensity value measured at a certain point in time. Disadvantage of this 
method is the loss of chemical information, since the chromatograms are considered as 
graphic lines. 
Finally, a modification of the first mentioned strategy, retention time-peak area concept, was 
used. The measurement time axis of the chromatograms, 6-110 min, was partitioned into 
equally large time segments. This way the dimensionality of the data is controlled.39 
The length of a segment was typically 0.5 or 1 minute. It was large enough to compensate the 
high retention time deviation (see text above), but not too large to lose too much from 
chemical information. The integrated peak area values were summed up within each time 
segment (Eq 3.2a and 3.2b) and normalized optionally to the maximum segment value (Eq. 
3.3) or to the sum of all peak area values (Eq. 3.3b) for each chromatogram. Peaks in the first 
section of the chromatogram (6 minutes) were ignored, since only the solvent and some 
derivatization by-products eluted so early from the column. 
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Fig. 3.5  Two GC data formats available by ChromCard. To the left: part of a list of raw GC data from 
a measurement; data rate is 60 / min. The peak is marked at 47.9667 min. To the right: measurement 
report of the same sample; retention time and area of the same peak (as to the left) are marked. 
  
 
 
∑= RTiij aA , ,  jRTj 5.065.05.5 +<≤+ ,  j = 1 to 208  Eq 3.2.a, 
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  Ascii chromatogram data 
  Time(Min) Datapoint(µV) 
 
   . 
   . 
   . 
   47.75  1722. 
   47.7667 1723. 
   47.7833 1724. 
   47.8  1733. 
   47.8167 1752. 
   47.8333 1764. 
   47.85  1772. 
   47.8667 1781. 
   47.8833 1817. 
   47.9  1904. 
   47.9167 2063. 
   47.9333 2365. 
   47.95  2830. 
   47.9667 3220. 
   47.9833 3167. 
   48.  2724. 
   48.0167 2207. 
   48.0333 1886. 
   48.05  1758. 
   48.0667 1719. 
   48.0833 1708. 
   48.1  1707. 
   48.1167 1703. 
   48.1333 1708. 
   48.15  1709. 
   . 
   . 
   . 
  
 
                                           Chrom-Card Report 
 
  Operator ID      : User 7  Company  Name  : AK Schulz        
  Method Name   : Katalin D           Method File         : KATADNAT.MTH 
  Analysed           : 06-06-01  22:01 Printed                 : 05.09.2001  11:27 
  GC Method       : 0                        Sampler Method : 1    Vial #  3  
 
  Sample ID       : 1/IHg,4 (# 102)       Channel              : Channel D              
  Analysis Type : UnkNown (Area)    Calc.  Method    : Area % 
  Chromatogram: C:\BENUTZER\KATALIN\DATA\kbnat102.DAT 
 
  Retention Time  Area             
  (Min)           (æV/Sec*10)      
  --------------- ---------------  
  47.97           62969            
  51.35           207724           
  67.18           31529            
  67.60           105240           
  67.84           131490           
  68.07           184831           
  68.30           234201           
  68.46           772874           
  68.86           29095040         
  68.89           4155142          
  73.51           377798           
  77.98           122723           
  79.02           66852            
  83.16           2141683          
  83.26           88274            
  87.17           4419515          
  90.87           2999515          
  94.57           726995           
                  ________                                                        
                  45924400                                                        
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where i and j are indexes for the chromatograms and the time segments, respectively; RT 
means corrected retention time (section 3.3.1.1); ai,RT  is the integrated peak area by retention 
time RT in the i-th chromatogram; Aij is the sum of peak area values in the j-th time segment 
of the i-th chromatogram; Ai,max is the maximum segment area in the i-th chromatogram; Ai,sum 
is the sum of peak area in the i-th chromatogram; Mij is the normalized value in the i-th row 
and the j-th column in the measurement matrix. 
Conversion results in a matrix containing the samples in rows and the variables in columns, 
208 or 104 segment values without additional data extraction. 
 
3.3.1.3 Data extraction 
 
It is important to discard samples and variables from the data set that hold no information for 
clustering. These were empty rows and columns of the measurement matrix and also columns 
that contained an artifact in almost all samples.  
Blank samples, that is derivatizated solvent samples, were measured regularly. These system 
blanks contained ideally just the solvent peak, thus, together with ’empty’ extracts, they were 
always sorted out automatically during the conversion procedure. 
Two strategies were used for the exclusion of redundant variables, called later HCA and 
PCA/HCA, respectively. As a feature of the program ChromConv, selected columns can be 
optionally deleted from the measurement matrix during data conversion; then HCA is 
performed with the remaining data (HCA method). The other process includes feature 
selection by PCA from the original matrix combined with HCA (PCA/HCA method). 
Selection of time segments or variables that do not differentiate the samples is quite 
challenging. Fermentation blanks, extracts of fermentation mixtures without bacteria, 
contained many substances in the whole time interval of the GC measurement. Most of the 
compounds were also present in the bacterial extracts, often in higher concentration than the 
compounds of interest. Including related time segments in the clustering process results in a 
clustering according to medium additives instead of substances produced by bacteria. 
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    Scheme 3.3  Artifacts often found in marine extracts: dioctyl phthalate (18a), bis-(2-ethylhexyl)- 
    phthalate (18b), tris-(2,4-di-tertbutylphenyl)-phosphate (19a) and tris-(2,4-di-tertbutylphenyl)- 
    phosphite (19b).  
  
 
The number of substances found in almost every sample grew dramatically, as more and more 
extracts from control experiments without bacteria were analyzed. Several known artifacts 
were identified quite early in the experiment. (Scheme 3.3) Peaks of artifacts, such as dioctyl 
phthalate (18a), bis-(2-ethylhexyl)-phthalate (19b), tris-(2,4-di-tertbutylphenyl)-phosphate 
(19a) and tris-(2,4-di-tertbutylphenyl)-phosphite (19b), can be optionally left out from the 
clustering process by deleting the related time segment values during data conversion. 
Other substances, such as sugars, were already in the fermentation medium as additives. 
Furthermore, a large group of compounds were often produced during fermentation without 
the presence of any bacteria. These were diketopiperazines (cyclization products of two amino 
acids), several fatty acids and aromatic acids, for example. (Scheme 3.4) Since these 
substances cover altogether a large percentage of the measurement time interval, it was 
impossible to ignore all the time segments related to them. Nevertheless, segments that 
involve the peaks of cyc(Ile-Pro) (20), cyc(Leu-Pro), and cyc(Phe-Pro) can be optionally 
discarded during data conversion with ChromConv. 
Time segments that contained zero values in more than 95% were deleted from the output file 
of ChromConv. 
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   Scheme 3.4  Typical components found both in marine extracts and control samples: cyc-(Ile-Pro) 
   (20), palmitic acid (21), phenylacetic acid (22). 
 
 
3.3.1.4 Overview of the program ChromConv 
 
ChromConv converts GC reports in ASCII format into a two dimensional measurement 
matrix. Retention time values are corrected and area values are summed up within time 
segments. Summed area values are organized in a table, where each row represents a sample 
and each column stands for a time segment of the measurement time interval. The 
functionality of the program is presented below. 
 
ChromConv 
• reads in parameters from a text file and saves them in a hash type of variable; 
• modifies certain parameters; 
• reads in a text file containing the list of measurements with file names and sample 
names, and saves this information in a string and a hash, respectively; 
• reads the content of the GC directory, opens the GC report files one-by-one, and 
saves retention time and peak area values in matrixes; 
• corrects retention time values and saves them separately in an other matrix; 
• sums up peak area values in each time segment for each sample and saves these 
values in a new matrix; 
• changes the segment value to zero for each sample, if the segment contains a peak of 
an undesired compound (section 3.3.1.3); 
• sums up the values in each row of the measurement matrix and saves it in a string 
type of variable (sum of peak area for each chromatogram); 
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• finds the maximum segment value for each chromatogram and saves it in a string; 
• the relative number of zero values in each segment is saved in a string; 
• prints out the final values of the measurement matrix in a text file. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.6   Part of a text file containing a measurement matrix made by ChromConv. It starts with a list 
of parameters followed by the matrix itself. The first row of the table, for example, contains the 
number of a GC file (139), the name of the sample (1/ACF,8-3) and the normalized segment area 
values. 
 
Output of the program is a table in ASCII format, which contains samples having at least one 
peak in the chromatogram (beside the solvent peak). Columns that contain more than 95% 
zero values are not printed out. A part of a typical matrix is presented in Fig. 3.6. Values in 
the table are normalized within each row according to the related parameter in the parameter 
file: either to the maximum segment area or to the sum of all areas. Each row starts with a 
sample identifier, derived from the name of the GC file, followed by the segment values 
separated by tabs. Rows are terminated by enter. 
  start = 6 
  end = 110 
  limit_1 = 315 
  limit_2 = 375 
  a_1 = 0.000607 
  a_2 = 0.000755 
  b_1 = 0.0982  
  b_2 = 0.1189 
  c_1 = 4.4954 
  c_2 = 5.7489 
  unwanted_1 = 68 
  unwanted_2 = 88 
  unwanted_3 = 91  
  norm = rel   
 
  139|1/ACF,8-3 0       0 0 0 0 0 0 0 3 . 
  140|1/Bio34          0 0 0 0 0 0 0 50 0 . 
  141|1/KCy,10 0         1 0 0 59 25 0 0 0 . 
  142|1/OM13,5      0 0 0 0 0 0 0 0 0 . 
  144|1/MCy,4        0 0 0 0 0 410 0 3 812 . 
  145|1//0001          0 2 0 0 0 0 1 77 0 . 
  146|HKI129-2      0    0 0 0 0 0 0 0 0 . 
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3.3.2 Gas chromatographic analysis of marine extracts 
 
3.3.2.1 Derivatization 
 
All the marine extracts were derivatized under standardized conditions before GC analysis. 
Using derivatives in chromatography increases the volatility of polar compounds and 
enhances sensitivity due to better peak shape. Compounds produced by bacteria, constituents 
of cultivation media and artifacts contain polar functional groups (-NH, -OH, -COOH) which 
otherwise interact with the injector wall and the silica surface of the GC capillary. 
The two most widespread micro-scale derivatization methods are trimethylsilylation and 
methylation. These derivatization reactions are convenient to carry out and the by-products 
are usually volatile. 
Silylation is the method of choice, when derivatization of all protic functional groups is 
needed in one experiment. It is usually performed in a polar solvent or completely without 
solvent. Since silylating agents are sensitive to moisture, reactions are carried out in excess of 
the reagent in sealed vials. Trimethylsilyl (TMS-) derivatives are most widely used and 
several libraries are available with reference spectra for the fast identification of the 
compounds. The intensive m/z 73, 75 and (M-15) fragments are characteristic for the electron 
impact ionization mass spectra of the most trimethylsilylated substances (Fig. 3.7). 
Marine samples were derivatized with N-methyl-N-trimethylsilyltrifluoracetamide (MSTFA) 
for the routine GC analysis. It is a very good silyl donor and its by-products are even more 
volatile, than that of N,O-bis(trimethylsilyl)trifluoracetamide (BSTFA).40 MSTFA was used 
in excess (section 5.3.1).  
Methylation is usually more selective; diazomethane derivatizes only carboxylic -OHs, and 
trimethylsulfonium hydroxide (TMSH) leaves aliphatic -OHs underivatized41. As an 
important property of TMSH, it is capable of transetherification of glycerine esters.42  
Although the MS fragmentation pattern of methyl esters are much more informative than that 
of the trimethylsilyl ones, substantial information can be lost via methylation, since marine 
bacteria produce fatty acid esters themselves. 
Although diazomethane and TMSH were used in a later stage for identification purposes, 
before clustering solely trimethylsilylation was applied.  
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           Fig. 3.7  MS spectrum of palmitic acid TMS ester. 
 
3.3.2.2 Gas chromatographic analysis 
 
A separate GC system with a flame ionization detector (FID) was used for the analysis of the 
marine extracts to avoid impurities of other origin. Moreover, all the measurements were 
carried out on the same unpolar capillary BPX-5. (section 5.2) Based on the regular analysis 
of the alkane standard (C11-C44) changes of retention time was followed. A slow GC ramp, 
3oC/min was chosen in order to get better separation of the extremely large number of 
components. Still, overlapping of certain chromatographic peaks could not be avoided owing 
especially to the tailing peaks of amines and amides, the diketopiperazines, for example. 
Injections were made in splitless mode to be able to detect trace components. 
Although concentration of the samples varied in a relatively large range depending on the 
scale and yield of fermentation, these differences were successfully omitted in most cases by 
proper dilution. 
Since no internal standard was used during fermentation, it did not make sense to introduce 
one at this point of the investigation.   
m / z50 100 200 250 300
100%
43 55
73
83 97
117
129
171185
201 269 285 299
313
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3.3.3 Cluster analysis of marine extracts 
 
Two methods were established: hierarchical cluster analysis of GC data after discarding 
segments of artifacts and diketopiperazines manually (HCA), and data reduction by principal 
component analysis of the original data set followed by HCA with extracted components as 
variables (PCA/HCA). 
For the PCA/HCA method conversion of GC data was performed with time segments of one 
minute in order to have less than hundred variables finally. (Eq. 3.2b) Feature selection was 
made by PCA. The number of components that describe a given percent of the variance in the 
data set was examined. Using selected factors as new variables HCA was performed with the 
score values. 
The output file of ChromConv is easy to process by SPSS. Once imported, it is saved in a 
special format. Each row represents a case, a marine extract, and each column stands for a 
variable, a time segment in the GC chromatogram. That is, samples are clustered according to 
their segment area values. 
The summed area value in a time segment represents a continuous variable, thus the 
Euclidean and squared Euclidean distances were used to measure similarity between cases. 
Since concentration or peak area value of the different compounds was in the same scale, no 
extra scaling of variables was necessary. Normalization to the sum of peak area values within 
samples allowed to compensate differences in concentration and hence was preferred. 
Average linkage was usually applied for merging clusters. Nevertheless, clustering of data 
sets was also examined with single and complete linkage. 
Hierarchical cluster analysis was performed on a specified part of the measurement time 
interval, when samples containing a given compound had to be found. For this purpose only 
the related part of the GC data was converted by ChromConv. A particular section of a 
chromatogram was selected by changing the values ’start’ and ’end’ in the parameter file for 
ChromConv. 
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3.4 Results 
 
3.4.1 Clusterification 
 
Since objects are always found to be similar to some extent by clustering, it is advisable to 
declare a similarity level. Similarity was defined by observation of the GC chromatograms. 
Three marine extracts were found to have very similar GC chromatograms: 1/IHg,3 and 
1/IHg,4 were almost identical, whereas 1/ACF,5 contained the same components but in 
smaller concentration. The chromatograms are presented in Fig. 3.8. These samples were 
included in every data set and used as ’similarity standards’ due to their unique GC pattern. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Fig. 3.8  GC chromatogram of the ’similarity standards’ a) 1/ACF,5, b) 1/IHg,4, and 
  c) 1/IHg,3. 
  
Samples with the same clustering pattern as seen in the dendogram for 1/IHg,3 and 1/IHg,4 
were declared to be very similar. The limit distance for similarity is mostly 4-8 % of the 
largest distance in the data set. 
Several samples were derivatized and analyzed or just analyzed repeatedly to control 
reproducibility of the method. In case these samples were not together in a cluster, it was 
more likely due to a changed GC pattern, some impurities in the chromatogram, than some 
failure in the clustering process. 
a
b
c
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Squared Euclidean distance measure was preferred over the Euclidean one to calculate 
distances between objects, since the latter is more sensitive for small differences and our 
samples were in general very different. 
Three linking methods were examined in parallel use of the squared Euclidean distance: 
single, complete and average linkage. Since the results were independent from the linkage 
method applied, average linkage between groups was the method of choice. 
Principal component analysis was used only for feature selection followed by hierarchical 
cluster analysis with the score values (PCA/HCA). Clustering of the samples merely by PCA 
was not successful, the first three principal components represented usually less than 30% of 
the whole variance. 
 
3.4.1.1 Clustering of lipophilic fractions 
 
The dendogram made by clustering all the extracts was difficult to interpret. Although at the 
beginning was helpful to find interesting extracts (section 3.4.3), the number of samples 
reached nearly 500 at the end, which resulted in distorted clusters. Too many samples were 
found to be similar. Nevertheless, some groups are recognizable. (Dendogram 8.11 in 
Appendix) It is also interesting to see how different samples from the same bacterial strain 
were placed in the dendogram; they are mostly ’far’ from each other due to different 
background substances from different fermentation media.  
Meaningful clustering was achieved by dividing the whole data set into several subsets, which 
were analyzed by HCA and PCA/HCA separately. It was based on the experience that 
conditions have a big influence on the outcome of the fermentation of bacteria. Due to lack of 
information about composition of fermentation media samples were put into a set by the date 
of posting from Göttingen, where fermentation was performed. These subsets are called 
STM2, STM3, STM4, and STM5. A batch of samples called parallel fermentation data set 
was investigated separately. Data analysis of the different data set is described in the 
following sections. 
 
Parallel fermentation data set  
Several strains, Hel38 (α-Proteobacterium), Hel59 (Marinomonas sp.), Hel73 (Brevibacter 
linens), IHg,3 (Cytophaga sp.), IHg,4 (Cytophaga sp.), Pic006 (Frigoribacter sp.) and Pic009 
(Cytophaga sp.), and control samples without bacteria were fermented in parallel experiments 
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in four different media: A, C, E, and F. (Table 3.2) Each medium contained half-concentrated 
artificial sea water. 
The fermentation mixture was filtered through celite, extracted with ethyl acetate and 
concentrated in vacuum. All the extracts were derivatized and analyzed by GC-MS. 
 
Table 3.2  Composition of the fermentation media A, C, E and F in the parallel experiments. 
 Concentration (g/l) 
 malt yeast flour fish-meal glucose peptone tryptone meat extract CaCl2 NaCl trace el. sol.* 
A 10 4 - - 4 - - - - - - 
C - 1 - - 10 2 - 1 - - - 
E - 5 - - 5 - 10 - - 10 - 
F - 10 10 5 21 - - - 0.5 - 0.01 
* trace element solution 
 
It was interesting to see whether clustering occurred according to strains or fermentation 
media, and how the control samples clustered. Each time segment of the chromatograms was 
included in the data analysis procedure to be able to compare control samples with real 
extracts. 
 
 
 
 
 
 
 
 
 
 
 
    
       Fig. 3.9  Scree plot resulting from the PCA of the parallel 
       fermentation data set. 
 
 
Application of PCA for feature selection was examined. By PCA the first 10-20 components 
covered 65-90 % of the variance. (See scree plot in Fig. 3.9.) Extracting, for example, the first 
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13 components, 75 % of the variance, and saving the score values in the SPSS table made it 
possible to perform HCA with these components as new variables. That is, the number of 
variables was reduced from 77 to 13 in this case. 
Results obtained by the methods HCA and PCA/HCA were compared. (Dendogram 8.1 and 
8.2 in Appendix.) The IHg,3 and IHg,4 samples in fermentation media A, C and E are 
clustered together in both cases, just like the samples Hel73 C and Pic006 C. The method 
PCA/HCA revealed more outliers in the data set, whereas by normal HCA a completely 
different sample, an alkane standard was also clustered together with a few marine extracts. 
These results showed that except the aforementioned examples no clustering of the samples 
was meaningful. Marine extracts in this data set were not significantly different from control 
samples. Moreover, the difference in the composition of the fermentation media (A, C, E, F) 
had a negligible influence on the GC pattern of the samples. 
Main components found in the bacterial extracts were fatty acids and sugars. Nevertheless, 
these compounds were background substances, also present in control samples. Table 3.3 
represents typical components identified by GC-MS in control samples. 
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            Table 3.3  Substances found in control samples from parallel fermentation. -: not detected, 
            +++: 50-100%, ++: 10-50 %, +: 0-10%, (+): below limit of calculation (% of the maximum 
            peak area). 
 Medium A Medium C Medium E Medium F 
2-phenylethyl alcohol + + (+) - 
2-(2-hydroxyphenyl)-ethylalcohol ++ ++ - ++ 
benzoic acid - - + + 
phenylacetic acid + - + - 
2-hydroxyphenylacetic acid - - + - 
3-phenylpropionic acid - - - ++ 
2-(3-indole)ethanol + + - + 
3-indoleacetic acid - - + - 
bis-(2-ethylhexyl) phthalate + + + + 
3ß-hydroxy-5ß-cholestane - - + - 
3ß-hydroxy-5-cholestene - - ++ ++ 
3ß-hydroxy-24-ethylcholest-5-ene - - - + 
cyc(Ile-Pro) (2 isomers) - + + + 
cyc(Leu-Pro) (2 isomers) - + + + 
cyc(Phe-Pro) (2 isomers) - + + (+) 
cyc(Pro-Tyr) (2 isomers) + + - - 
glycerin + + + + 
monomyristin - - - + 
glycerin monopentadecanoate - - - + 
monopalmitin + - + - 
glycerin monolinoleate - - + + 
glycerin monooleate - - + - 
monostearin - - + + 
2-keto-D-gluconic acid + ++ + ++ 
sorbose/fructose - + + + 
ß-D-galactofuranose - ++ + + 
α-D-glucopyranose ++ +++ +++ +++ 
mannose + +++ +++ +++ 
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            Table 3.3  Continued. 
 Medium A Medium C Medium E Medium F 
decenoic acid + + - - 
capric acid + + - - 
lauric acid + + - - 
12-methyltridecanoic acid + -   
11-methyltridecanoic acid + - + ++ 
13-methylmyristic acid + - - + 
12-methylmyristic acid + - + (+) 
pentadecanoic acid + - - + 
hexadecenoic acid + - + + 
14-methylpentadecanoic acid + - + + 
13-methylpentadecanoic acid - - ++ +++ 
palmitic acid ++ + - - 
heptadecenoic acid - - - + 
15-methylpalmitic acid + - - - 
14-methylpalmitic acid + - + - 
heptadecanoic acid - - + + 
Z,Z-9,12-octadecenoic acid +++ - ++ +++ 
Z-11-octedecenoic acid + - ++ +++ 
stearic acid + - + + 
arachidic acid - - - + 
hexadecyl alcohol - + - - 
octadecyl alcohol - + - - 
 
 
Subset STM2 
This was the first batch of samples obtained in 2000 containing 98 extracts. Composition of 
fermentation medium (or media) was unknown. HCA was performed after deleting undesired 
segments by ChromConv (Dendogram 8.3 in Appendix). By the other method 25 components 
were extracted from 75 by PCA, which represented 79 % of the variance, and HCA was made 
with the score values. (Dendogram 8.4 in Appendix.) The two dendograms were compared. 
Several groups of similar samples were found with both methods. 
A few samples were further analyzed by GC-MS. Some extracts in one of the clusters 
contained two isomers of oleic amide as main components. The cluster of 1/IHg,3, 1/IHg,4, 
and 1/ACF,5 (probably Cytophaga sp.) (Fig. 3.10) was further investigated by HR-MS and 
other methods, described in section 3.4.3.1. In fact, by the combination of PCA and HCA 
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another sample, 1/OM13,5 (Halomonas sp.) was found to contain the same series of 
compounds. 
 
 
 
 
 
 
 
 
 
 
Fig. 3.10  Part of the dendogram of sub data set STM2 made a) by HCA b) PCA/HCA. A forth 
extract, 1/OM13,5 was found by method b to contain the same substances as the other marked 
samples. These samples have a very typical GC pattern. 
 
Novel terpenes 26 and 27 and isomers of a lactone (discussed in section 3.4.3.4) were found 
in the extract of the strain 1/AMP,3 (Cytophaga sp.). Isolation and structure elucidation of the 
terpenes is presented in section 3.4.2. 
The sample 1/Hel26 (Roseobacter sp.) contained amides of palmitic and oleic acids, and the 
iso-propyl ester of palmitic acid. 
 
Subset STM3 
This batch, obtained in 2000, contained 91 samples. Composition of fermentation medium (or 
media) was unknown. Dendograms were made again by both methods: HCA (Dendogram 8.5 
in Appendix) and PCA/HCA . By the second method 20 components were extracted from the 
original 70 variables by PCA (74 % of variance) and HCA was performed with the score 
values. (Dendogram 8.6 in Appendix.) The scree plot from PCA did not have a sharp elbow 
(see Fig. 3.11), which means the variables were already uncorrelated, or there was a high 
noise in the data set. 
Selected samples from subset STM3 were analyzed by GC-MS. Methylene-1,1’-bis-
piperidine was found in a large number of extracts. In sample ANT253(RE) a series of N-
acetyl amides was identified by GC-MS. (see Scheme 3.5)  Two extracts, ANT323 and 
ANT46 were found to have almost the same GC pattern as the ’similarity standards’ 
a       b 
 
 102|1/IHg,4       òûòø      
 129|1/IHg,3       ò÷ ùòòòø   102|1/IHg,4       òø 
 90|1/ACF,5        òòò÷   ó   129|1/IHg,3       òôòòòòòòòòòòòø 
 98|HKI 129-1      òûòø   ùòòòòòø  90|1/ACF,5        ò÷           ùòòòø 
 146|HKI129-2      ò÷ ùòòòú     ó  142|1/OM13,5      òòòòòòòòòòòòò÷   ó 
 93|1/AM13,1       òòò÷   ó     ó 
 89|1/ACF,8-1      òòòòòòò÷     ó 
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(introduction to section 3.4.1), but the substances identified by GC-MS turned out to be esters 
of long-chain fatty acids and long-chain alcohols. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.11  Scree plot made by PCA of the samples in subset STM3; 
no sharp elbow can be observed. 
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Scheme 3.5  N-acetyl amides from ANT253(RE). The amides 16a and 17a were also 
identified in marine Streptomyces strains in the first period of the project (section 3.1). 
 
The sample VH Hel10 (Roseobacter sp.) contained alkanes, long-chain alcohols, fatty acids, 
and 2-(indo-3-yl)-ethanol. 
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Subset STM4 
This batch of 76 samples was obtained in April 2001. The composition of the fermentation 
medium (or media) was unknown. HCA was made after deleting undesired segments with 
ChromConv. (See Dendogram 8.7 in Appendix.) By the subsequent use of PCA and HCA all 
segments were included and 20 components (from 88) were extracted, which represented 74% 
of the variance. HCA was made with the score values, as usual. (See Dendogram 8.8 in 
Appendix.) Samples from control derivatization and injection were clustered mostly together. 
Certain extracts from the data set were selected to be analyzed by GC-MS. A group of strains 
were found to be producers of N-(phenylethyl)-acetamide (16a) in larger amounts. A long-
chain derivative 24 was identified by GC-MS in Pic006 (Scheme 3.6). In fact, N-acetyl 
derivatives of other amines were also common in the data set. 
The strains Pic006 (Frigoribacter sp.), Hel38 (α-proteobacterium), Bio137 (Cytophaga sp.) 
and Bio138 (probably Cytophaga sp.) inhibit the growth of specific tumor cells, such as 
gastric, liver, and breast cancer. Long-chain ketones with (n-1)/(n-2) methyl branching were 
identified by GC-MS and other techniques in Pic009 and Pic006, presented in section 3.4.3.2. 
In the extracts Bio137 and Bio138 sulphur heterocycles were found, summarized in section 
3.4.3.3. Hel38 contained squalene and the C35 terpenes 26 and 27 (section 3.4.2) beside 
aromatic acides, amines, and long-chain amides. 
 
N C17
O
N C15
O
2524
 
 
          Scheme 3.6  Long-chain N-acyl derivative 24 from Pic006 (subset STM4) 
          and a long-chain N-acyl derivative of piperidine, 25, from Hel45 and 
          Hel73 (subset STM5). 
 
The cyclohexane extract of Hel45 (Roseobacter sp.) contained antranilic acid, antranylamide, 
indole and its derivatives, fatty acid methyl esters, and ß-hydroxy-capric acid. 
 
Subset STM5 
This batch of 67 samples was obtained in July 2001. The composition of the fermentation 
medium (or media) was unknown. HCA was performed after deleting undesired segments 
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with ChromConv. (See Dendogram 8.9 in Appendix.) By PCA 20 components were extracted 
from 80 variables, which was 76 % of the variance, then HCA was made with the score 
values. (See Dendogram 8.10 in Appendix.) Repeatedly injected samples were clustered 
together more or less by both methods. 
A cluster of extracts was revealed containing the C35 terpenes 26 and 27, described in section 
3.4.2, and it was more clearly separated by PCA/HCA. (Fig. 3.12) Closer examination of the 
results of the GC and GC-MS analysis led to the discovery that all these samples contained 
diketopiperazines in a high concentration, which was the reason for the clear clustering by 
PCA/HCA. 
The strains Hel10, Hel26 and Hel45 (all Roseobacter sp.) were fermented for the second time 
(see samples VH Hel10, 1/Hel26 and Hel45 above). New substances were the C35 terpenes 
26 and 27 identified in Hel10 and Hel45 and the amide 25 from Hel45 and Hel73 
(Brevibacter linens). (Scheme 3.6) 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.12  Cluster of the C35 terpenes in the sub data set STM5 made by HCA (a), and PCA/HCA (b). 
 
Hel73 turned out to be another producer of the long-chain ketones with (n-1)/(n-2) methyl 
branching (see section 3.4.3.2). 
a 
  256|Pic022           òòòòòûòòòòòòòòòú   
  295|Hel73            òòòòò÷         ùòø 
  270|AM13,1 weiß      òûòø           ó ó 
  286|Hel10            ò÷ ùòòòòòø     ó ó 
  273|Bio001           òòò÷     ùòø   ó ó 
  265|Pic019           òûòòòø   ó ó   ó ó 
  283|Pic016           ò÷   ùòòò÷ ó   ó ó 
  258|Bio017           òòòûò÷     ó   ó ó 
  298|Hel45            òòò÷       ùòø ó ó 
  306|Bio007           òòòòòòòòòòòú ó ó ó 
  262|Hel11            òòòòòòòòòòò÷ ó ó ó 
 
b 
  295|Hel73           òûòø   ó ó 
  302|Hel12           ò÷ ó   ó ó 
  273|Bio001          òø ó   ó ó 
  286|Hel10           òú ó   ùò÷ 
  258|Bio017          òú ùòòòú   
  293|Hel26           òôòú   ó   
  306|Bio007          òú ó   ó   
  256|Pic022          ò÷ ó   ó   
  262|Hel11           òòòú   ó   
  270|AM13,1 weiß     òòòú   ó   
  298|Hel45           òûòú   ó   
  303|Bio008          ò÷ ó   ó   
  301|MPep,2          òòò÷   ó 
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3.4.2 Isolation and structure elucidation of two novel C35 terpenes 
 
A pair of late eluting peaks was observed in the chromatogram of AMP,3 (Cytophaga sp.) 
with a molar mass of  474 and 476, and a retention index RI = 3363 and 3368, respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.13  MS spectra of the two terpenes 26 and 27 with HRMS data.   
 
The MS spectra of the substances were terpene-like and similar to that of  ar- and β-
curcumene.43 The m/z 69 fragment is typical for oligoprenyl chains. (Fig.3.13) The main 
fragment of the terpene 26 (M474), the m/z 119 derives from the cleavage of the single bond 
at the methyl branching nearest to the aromatic ring. (Fig.3.13) GC-HRMS analysis revealed 
the molecular formula of the substances 26 and 27: C35H54 and C35H56 with 9 and 8 double 
bond equivalents, respectively. 
Cluster analysis with segments from the particular part of the GC chromatograms, where the 
peaks eluted, led to the discovery of other samples that contained the two terpenes. 
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(Dendogram 8.12 in Appendix) In order to obtain more structural information, the substances 
were isolated. 
 
3.4.2.1 Liquid chromatographic isolation 
 
Samples that contained the terpenes in a higher concentration were chosen for the isolation 
based on the results of the cluster analysis. More material was obtained by additional 
fermentation of AMP,3 and Hel59 in a larger scale (5 L). The lipophilic fraction of the 
samples was dissolved in n-pentane, loaded onto a silica column and eluted with n-pentane. 
The terpenes were separated from more polar compounds, but not from squalene. Several 
fractions contained both terpenes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
         Fig. 3.14  UV scan from the HPLC peak of 26 at 15.78 min 
 
The fractions of interest were united and further purified by NP-HPLC. The best separation of 
the three compounds was obtained on a Supersphere Si60 column with n-hexane as a mobile 
phase (see section 5.2 for details). The UV detection was at 215 nm in the absorption range of 
polyenes. Small maxima at 266, 260 and 273 nm could be observed in the UV spectrum of 26, 
which was a hint for the aromatic character of the substance. This way 1-1.5 mg of 26 and 
approx. 0.5 mg of 27 were isolated. 
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3.4.2.2 Determination of the number of double bonds by catalytic 
hydrogenation 
 
The fraction containing the terpene 27 was hydrogenated with Pd/C to determine the number 
of  aliphatic double bonds. The terpene M476 was already partly isomerized to M474, which 
could be observed from the GC-MS analysis made directly before hydrogenation. As a result, 
a mixture of partially saturated compounds was obtained with a molar mass of 480, 482, 484 
and 486. All these products contained the aromatic ring except for the M486. Consequently, 
both terpenes possess five aliphatic double bonds and a ring, which is aromatic in 26. That 
correlated again with the structure of the curcumenes. 
Substance 27 was analyzed by nuclear magnetic resonance spectroscopy (NMR) before 
hydrogenation and partly aromatized during these experiments. 
  
3.4.2.3 Structure elucidation by NMR spectroscopic experiments 
 
The isolated terpenes 26 and 27 were analyzed by NMR (400 MHz) in different solvents. Due 
to the small amount of the samples, it was not possible to carry out 13C-NMR experiments. 
However, the chemical shift values of the carbon atoms of compound 26 could be observed 
by H,C-correlation measurements (HSQC, HMBC). 
1H-NMR and HSQC spectra from 26 and 1H-NMR spectrum from 27 were recorded first in 
deutero-dichloromethane. The large peak at 1.52 ppm in both of the 1H-NMR spectra revealed 
the presence of a water peak, which was overlapping a signal of methyl protons (16.1 ppm). 
  
26
27
*
*
 
Scheme 3.8  Structure of the C35 terpenes 26 and 27. 
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The attempt to remove water from the sample containing 27 in vacuum was only partly 
successful; although the water peak became smaller, other impurities (ether) were detected in 
the sample. 
The proton signal of water in deutero-benzene does not disturb the methyl signals, since it lies 
at 0.40 ppm. Therefore, deutero-benzene was chosen as a solvent for further experiments: 1H-
NMR of terpene 27, and HSQC and HMBC of terpene 26. 
 
 
 
 
 
 
 Scheme 3.7  Numbering of the atoms corresponding to NMR data in  
 Table 3.4, 3.5, and 3.6. 
 
 
      Table 3.4  Comparison of the 1H-NMR data of the terpene 26 and that of  
       ar-curcumene.  
Position of the protones 1H-NMR chemical shifts in ppm 
ar-
curcumene 
26 ar-curcumene in 
CDCl344 
26 in CD2Cl2 
8’ 8’ 1.19 (d, 3H) 1.20 (d, 3H) 
12’ 12’ 16’ 20’ 24’ 28’ 1.50 (s, 3H) 1.52 (s, 3H), 1.59 (s, 12H) 
8 8 12 16 20 24 1.51-1.65 (m, 2H) 1.82-2.00 (m, 10H) 
12 28 1.65 (s, 3H) 1.67 (s, 3H) 
9 9 13 17 21 25 1.81-1.89 (m, 2H) 2.02-2.10 (m, 10H) 
7’ 7’ 2.30 (s, 3H) 2.29 (s, 3H) 
7 7 2.60-2.67 (m, 1H) 2.60-2.70 (m, 1H) 
10 10 14 18 22 26 5.04-5.10 (m, 1H) 5.07-5.14 (m, 5H) 
1 2 4 5 1 2 4 5 7.04 (s, 4H) 7.07 (dd, 4H) 
 
The 1H-NMR spectra and the 13C signals obtained by HSQC and HMBC for 26 match the 
corresponding signals of ar-curcumene43 (presented in Table 3.4 and 3.6). H,C-correlations 
are presented in Scheme 3.9 and 3.10. 
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Table 3.5  Comparison of the 1H-NMR data of the terpene 27 and that of β-curcumene.  
Position of the protones 1H-NMR chemical shifts in ppm 
β-curcumene 27 β-curcumene in CDCl343 27 in CD2Cl2 
8’ 8’ 0.99 (d, 3H) 0.98 (d, 3H) 
12’ 
8 
12’ 16’ 20’ 24’ 28’ 
8 12 16 20 24 
1.20-1.60 (m, 5H) 1.58 (s, 3H), 1.60 (s, 12H) 
1.87-2.02 (m, 10H) 
7’ 12 7’ 28 1.67 (br.s, 6H) 1.65 (s. 3H), 1.67 (s, 3H) 
9 7 9 13 17 21 25 7 1.90 (m, 2H), 2.09 (m, 1H) 2.02-2.13 (m, 11H) 
2 5 2 5 2.58 (m, 4H) 2.56 (br.s, 4H) 
10 10 14 18 22 26 5.09 (m, 1H) 5.06-5.15 (m, 5H) 
1 4 1 4 5.42 (s, 2H) 5.42 (m, 2H) 
 
 
Table 3.6  Comparison of the 13C-NMR data of the terpene 26 and that of ar-curcu- 
  mene. (afrom HMBC). 
Position of the carbon atoms 13C-NMR chemical shifts in C6D6 in ppm 
ar-curcumene M474 ar-curcumene45 26a 
12’ 12’ 16’ 20’ 24’ 28’ 17.7 (q) 16.1, 16.2 (3C), 17.8  
7’ 7’ 21.0 (q) 21.1 
8’ 8’ 22.9 (q) 23.1 
12 28 25.8 (q) 25.8 
9 9 13 17 21 25 26.6 (t) 27.2 (5C) 
8 8 16 20 24 12 38.8 (t) 38.9, 40.2 (3C), 40.3 
7 7 39.4 (d) 39.5 
10 26 14 18 22 10 125.1 (d) 125.0, 124.7-124.9 (3C), 125.2 
1 5 1 5 127.3 (d, 2C) no (H,C) corr. observed 
2 4 2 4 129.3 (d, 2C) 129.4 (2C) 
11 27 11 15 19 23 131.1 (s) 131.2, 135.0-135.1 (4C) 
3 3 135.3 (s) 135.3 
6 6 144.7 (s) 144.9 
 
 
The difference in the number of methyl groups between 1.5-1.6 ppm (5 instead of 1), the 
number of methylene groups (10 instead of 2), and the number of tertiary protons between 
5.0-5.2 ppm (5 instead of 1) demonstrates that 26 contains four more prenyl units than ar-
curcumene. 
Likewise, the similarities (and differences) of the 1H-NMR spectrum of 27 and that of β-
curcumene (Table 3.5) showed that this terpene had the same ring structure as β-curcumene, 
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but again, its chain is four prenyl unit longer. With only eight double bond equivalents, it 
contains a hexadiene ring. 
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  Scheme 3.9  H,C-correlation in the molecule of 26 from the HSQC 
  experiment. 
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  Scheme 3.10  H,C-correlation in the molecule of 26 from the HMBC 
  experiment, black are the 2J(C,H) and gray are the 3J(C,H) couplings. 
 
Based on the results of the NMR experiments and spectral analogy to the curcumenes the 
structure of the two terpenes was elucidated (Scheme 3.8). We propose for the new terpenes 
26 and 27 the names tetraprenyl-ar-curcumene and tetraprenyl-β-curcumene, respectively. 
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3.4.2.4 Determination of the absolute configuration of 26 
 
Both terpenes contain a chirality center at the position seven. (scheme 3.8) Regarding the 
extreme small amount of substance available, only chiral gas chromatographic methods were 
suitable for the determination of the absolute configuration. 
Since the low volatility of the terpenes and the long chain makes a direct chiral GC analysis 
impossible center, the molecule had to be chemically degraded. The aromatic ring was 
cleaved to obtain the smallest degradation product that still contains the asymmetric carbon. 
Several oxidative degradation methods that cleave a double bond are suitable for opening an 
aromatic ring. As final stage by these methods a carboxylic acid is generated at the position of 
the cleavage. This degradation offers some advantages; the product is stable and easy to 
derivatize to the more volatile methyl ester for the chiral GC analysis.  
 
Oxidative degradation of the aromatic ring with ruthenium tetroxide 
Cleavage of a resonance stabilized aromatic ring is difficult. The bacterial enzymatic cleavage 
of an aromatic ring can be oxidative under aerobe conditions or reductive without the 
presence of oxygen.46 The chemical methods developed in the lab are oxidative: degradation 
with trifluoroperacetic acid47, ozone48,49 or ruthenium tetroxide50. The first mentioned method 
did not become wide-spread because of the difficulty with handling excess amounts of the 
reagent.51,47 Although ozonolysis could be successful with ozone concentrations more than 
15%,48 the reaction itself and the work-up methods are not really suitable for micromolar 
levels. 
Alternatively, an oxidation method using ruthenium tetroxide, generated continuously in the 
reaction mixture with a stoichiometric oxidant (mostly sodium periodate) in a biphasic 
system, proved to be extreme useful in the natural product research.52,53 Alkyl-substituated 
benzenes are first oxidized to an α-keto-aldehyde and four molecules of formic acid, which is 
further oxidized to carbon dioxide.54 The reaction of the keto-aldehyde with ruthenic(VIII) 
acid (or the aldehyde-hydrate with ruthenium(VIII)-tetroxide) results in the formation of a 
diester of ruthenic(VIII) acid. Finally, the shift of three valence electron pairs leads to the 
generation of an alkyl-substituated acid and carbon dioxide. 
The mechanism of the attack of ruthenium tetroxide on the olefinic double bond is discussed 
in detail elsewhere.55 
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The first attempts date back in the early 1950s, when ruthenium tetroxide was used as a 
substitute oxidizing agent for the strongly toxic osmium tetroxide.56 Since it is good soluble in 
carbon tetrachloride, the reaction had been carried out in a two-phase mixture with water.57 
The most cited publication in this topic is from 1981, from Sharpless et al.50. They managed 
to optimize the reaction conditions and found out that adding acetonitril to the mixture helps 
to maintain the activity of the Ru(VIII) catalyst. A systematic study appeared in 199058 
revealed the usefulness of periodic acid instead of periodate, especially with small amounts of 
starting material. The authors also reported about the temperature dependence of the reaction. 
The volatility of ruthenium tetroxide and the danger of over-heating set an upper limit of 
approx. 40oC, whereas under 20oC the reaction would be too slow. The catalyst can be 
deactivated with an excess of dichloromethane50 or diethyl ether57,58, which are also suitable 
solvents for work-up. Electron-donating substituents on the aromatic ring have an activating 
effect.57 
 
 
  Fig. 3.11  Degradation of citronellene (28) and the natural product (26) to 2-methylglutaric acid (29); 
   a) 35 equiv. H5IO6 and 2 mol% RuCl3.(H2O)n in CH3CN/CCl4/H2O 2/2/3, b) diazomethane; c) 8.1 
   equiv. NaIO4 and 2 mol% RuCl3.(H2O)n in CH3CN/CCl4/H2O 2/2/3, d) Amberlyst 15 in methanol.59 
 
The natural product 26 was degraded with periodic acid as stoichiometric oxidant and 
ruthenium tetroxide as catalyst. The micro-scale work-up with dichloromethane was followed 
by derivatization with diazomethane (see section 5.3 for details). (Scheme 3.11.) As synthetic 
references, both enantiomers of citronellene were oxidized to 2-methylglutaric acid. 
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Chiral separation 
The R and S enantiomers of dimethyl 2-methylglutarate (29a and 29b) could be separated on a 
Hydrodex-6-TBDMS (15m, 0.25mm) column by 60oC isotherm and a linear velocity of 67 
cm/s (hydrogen as carrier). The peak resolution was 0.7. 
The absolute configuration of the degradation product, dimethyl 2-methylglutarate (29), was 
determined by analyzing both synthetic enantiomers and the 1:1 mixture of them by GC-MS 
on the capillary used for the GC separation. The results were compared to that of the natural 
product. (See Fig. 3.15.) Identification by MS compensated for the unsatisfactory separation 
on the same column installed in the GC-MS instrument. Thus the absolute configuration of 
the original natural 26 product was proved to be (R). 
 
 
                          
 
 
 
 
 
 
 
 
 
 
Fig. 3.15  GS-MS separation of  the enantiomers of  
dimethyl 2-methylglutarate. a) ion trace m/z 114 of  
the degradation product of the isolated natural product, 
b) ion trace m/z 114 of the coinjection with 1:1 mixture 
of the synthetic enantiomers, c) synthetic enantiomer (R), 
d) synthetic enantiomer (S), e) 1:1 mixture of the syn- 
thetic enantiomers. 
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3.4.3 Selected substances from marine extracts 
3.4.3.1 Hexanetriol esters from IHg,3, IHg,4, and ACF,5 
 
A significant cluster of three samples (Fig. 3.10), IHg,3, IHg,4, and ACF,5 (all Cytophaga), 
were examined. The strains were isolated from cultures enriched from filtered water sample  
(5 µm pore size) taken from the North Sea. 
The GC-MS analysis of the MSTFA derivatized samples revealed a series of structurally 
related  esters ,30, 31, 32, 33, 34, and 35, containing fragment ions m/z 127 and m/z 155. The 
MS spectra of the earlier eluting two compounds contained the fragment m/z 73 but not m/z 
147, which meant that only one functional group was trimethylsilylated. Related (M-15)+ 
fragments were m/z 471 and m/z 499 for the silylated 30 and 31. The molecular ion of the 
underivatized compounds was not observable.  
 
      Table 3.7  Results of the GC-HRMS analysis. 
 Exact mass/ amu Fragment Formula Post. Mol. 
Form. 
m/z 127 127.113 α (acyl) C8H15O+ - 
m/z 155 155.144 α (acyl) C10H19O+ - 
30-TMS 471.350 (M-CH3)+ C26H51O5Si+ C27H54O5Si 
31-TMS 499.382 (M-CH3)+ C28H55O5Si+ C29H58O5Si 
32 369.301 (M-OC(O)C7H15)+ C22H41O4+ C30H56O6 
33 397.329 (M-OC(O)C7H15)+ C24H45O4+ C32H60O6 
34 397.329 (M-OC(O)C9H19)+ C24H45O4+ C34H64O6 
35 425.364 (M-OC(O)C9H19)+ C26H49O4+ C36H68O6 
 
 
IHg,3 was further analyzed by a gas chromatograph-high resolution mass spectrometer (GC-
HRMS) system. (Table 3.7.) Knowing the exact mass of the fragments of the derivatized and 
underivatized compounds a general structure was postulated (see Scheme 3.12). These 
compounds are probably esters of a hexanetriol, acylated with octanoic and/or decanoic acid. 
The intensity ratio of the acyl fragments, m/z 127 and m/z 155 in the MS spectrum revealed 
the acylation pattern (see for example for 33 and 34 in Fig. 3.16). 
 
 
Marine bacteria 
53
 
 
 
                 
OR
OR''
OR'
 
 
Scheme 3.12  The general structural formula postulated for the hexantriols and the 
    R groups of the particular substances. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.16  MS spectra of  33 (M540), above, and 34 (M568), below. The intensity ratio of  
the acyl fragments reveals the acylation pattern of the triols (MS spectra of the other 
hexanetriols are in Appendix).  
 
 
 R R’ R’’ 
30 
C(O)C7H15 C(O)C9H19 H 
31 
C(O)C9H19 C(O)C9H19 H 
32 
C(O)C7H15 C(O)C7H15 C(O)C7H15 
33 
C(O)C7H15 C(O)C7H15 C(O)C9H19 
34 
C(O)C7H15 C(O)C9H19 C(O)C9H19 
35 
C(O)C9H19 C(O)C9H19 C(O)C9H19 
 
C7H15
O
C9H19
O
2
1
C7H15
O
C9H19
O
1
2
(M-OC(O)C7H15)+
(M-OC(O)C9H19)+
50 100 150 200 250 300 350 400
100%
43
57
71 98
127
155
212
243
285 325
369
415 438
397
m / z
100%
43
57
71
127
155
213
243
271
285 312
397
456
8598 425
50 100 150 200 250 300 350 400 m / z
 
Marine bacteria 
54
 
The esters in the sample IHg,4 were transesterified with TMSH and derivatized with MSTFA 
to find out which hexanetriol isomers were in the sample. The MS spectrum of the 
derivatization product was compared to the MS spectra of trimethylsilylated derivatives of 
1,2,3-, 1,2,6- and 1,3,4-hexanetriol. None of them was the natural product. 
 
Although the fermentation of the strains IHg,3 and IHg,4 was repeated in a large scale (5 liter) 
and also in different fermentation media, the production of the hexanetriol esters was not 
repeatable. 
 
 
3.4.3.2 Long-chain alkenes and ketones from Pic009 and Bio1 
 
Two samples, Pic009 and Bio1 (both Cytophaga sp.) were found to contain several isomers of 
long-chain ketones and related alkenes. The strains Hel73 (Brevibacter linens) and Pic006 
(Frigoribacter sp.) turned out to produce one of the alkenes. The substances were identified 
by GC-IR, GC-MS and HRMS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.17  MS spectrum of 2,24-dimethyl-14-hexacosanone (39b) found in Bio1. 
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Two or three isomers were found for each ketone with a molar mass of 366 (36), 380 (37), 
394 (38), 408 (39) and 422 (40) and a molecular formula of C25H50O, C26H52O, C27H54O, 
C28H56O and C29H58O, respectively. Characteristic ions in the MS spectra of the ketones are 
the α fragments (or acyl fragments) m/z 169, 197, 211 and 225 ([C10H21CO]+, [C12H25CO]+, 
[C13H27CO]+ and [C14H29CO]+) together with the corresponding fragments from the cleavage 
of the Cα-Cβ bond accompanied by the rearrangement of two protons (m/z 185, 213, 227 and 
241). These fragments were indicating the position of the oxo group in the chain. (Fig. 3.17) 
The pattern of the alkyl fragments in the low-mass area was a sign of a longer saturated 
hydrocarbon chain. Nevertheless, the intensity of the alkenyl fragments, formed by proton 
rearrangement, indicated a branched chain. In addition, the relative high intensity of the 
fragments (M-15)+, (M-29)+ and (M-43)+ showed that the branching was at the end of the 
chain. (Fig. 3.16) 
To find out which isomers were found the retention indexes were calculated and compared to 
the measured ones. The retention index of a substance can be estimated according to a simple 
equation (Eq. 3.4):60 
 
RIcalc = N + FG + ΣMei – ΣS   Eq. 3.4, 
 
where N is 100 times the length of the main chain, FG is a functional group increment, Mei is 
an increment dependent on the position of the methyl branching relative to the end of the 
chain (Table 3.8), and ΣS is a special steric increment (5 for each 1,5 position of two methyl 
groups). ΣS was zero in our case. 
 
     Table 3.8  Mei values.60 
Position of the Me group Mei 
2/(n-1) 60 
3/(n-2) 73 
4/(n-3) 56 
5/(n-4) 46 
 
 
The unbranched isomer, 15-nonacosanone (41) was isolated from cabbage by liquid 
extraction with hexane and the retention index was determined by GC-MS (RI = 3088). The 
FG value for the oxo group in 15-nonacosanone was calculated from Eq.3.4 to be 188. 
Marine bacteria 
56
 
The retention indexes of all the isomers of the nonacosanone were smaller than that of the 
unbranched 15-nonacosanone. The values measured in the sample Bio1 match very good the 
calculated ones for 2/(n-1), 2/(n-2) and 3/(n-2) methyl-branched 14-heptacosanones, 40a, 40b, 
and 40c. (see Table 3.9) 
 
Table 3.9  Measured (RImeas) and calculated (RIcalc) retention indexes 
of the nonacosanone isomers found in Bio1  
 RIcalc RImeas 
15-nonacosanone (41) - 3088 
3,25-dimethyl-14-heptacosanone (40c) 3034 3031 
2,25-dimethyl-14-heptacosanone (40b) 3021 3019 
2,26-dimethyl-14-heptacosanone (40a) 3008 3008 
 
 
The same branching pattern was found for the other ketones. Although the position of the oxo 
group differs slightly for different ketones (11-15), the FG values are still almost the same in 
this range, thus the retention index difference between two ketones with the same methyl 
branching, relative to the end of the chain, is 100 times the difference in the main chain 
length. 
 
 
 
 
 
 
 
 
 
         Fig. 3.17  MS spectrum of 3,23-dimethyl-12-pentacosene (43c: RI 2607) from Bio1 with the 
         characteristic m/z 70 and  (M-30)⋅+ fragments (other spectra are in Appendix). 
 
The substances in the other isomeric series from extracts Bio1 and Pic009 had a molar mass 
of 364 (42), 378 (43), 392 (44), and 406 (45). Moreover, isomers of M406 were found also in 
the extracts of Pic006 (45c: RI 2803) and Hel73 (45b: RI 2795, 45c: 2809). The GC-IR 
analysis of Pic006 (Fig. 8.28 in Appendix) showed that these substances were hydrocarbons. 
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The molecular weight matched the molecular formulas of an alkene series: C26H52, C27H54, 
C28H56 and C29H58. 
Characteristic fragments in the spectra were (M-28/30)+., (M-44)+., (M-56/58)+. and (M-
70/72)+. and the m/z 70 fragment with different intensities (Fig. 3.18, 3.19). Intensity of the 
fragments relative to the molecular ion was examined within a group of isomers with the same 
molecular mass. The relative intensity of the (M-30)+. and (M-72)+. ions increased while that 
of the (M-44)+. and (M-56/58)+. fragments decreased with increasing RI within a group. The 
relative intensity of the m/z 70 fragment increased with increasing RI of isomers with the 
same molar mass.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.19  Radical ion fragments by neutral loss from the molecular ion of the isomers of  
dimethyl-12-pentacosaene (43); a: 2,24-dimethyl-, b: 2,23-dimethyl-, c: 3,23-dimethyl-. 
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The HRMS analysis confirmed the postulated molecular formulas and also revealed the 
branching pattern of the alkenes. The higher intensity of the m/z 70 ([C5H10]+.) fragment 
together with the (M-30)+. and (M-72)+. ions indicated (n-2) methyl groups. The slightly 
higher intensity of the (M-44)+. and (M-56/58)+. fragments was a sign for (n-1) methyl groups. 
(See Fig. 3.19). 
The position of the double bond (DB) in 3,25-dimethylheptacosene (45c) was determined by a 
micro-reaction of sample Hel73 A with iodine and dimethyldisulfide (DMDS). The generated 
vicinal methylthio groups were in the middle of the chain indicating position 13.  
The same branching pattern and the same position of the oxo and DB functionalities were 
hints for a common biosynthetic origin of the ketones and the alkenes, which is discussed in 
more detail in chapter 3.5. 
 
 
3.4.3.3 Cyclic polysulfides from Bio137 and Bio138 
 
The extracts Bio137 and Bio138 (Cytophaga sp.) were found to contain cyclic polysulfides 
with a molar mass of 152, 208 and 240. M208 and M240 had two isomers. The molecular 
formula was determined by GC-HRMS analysis: C4H8S3 (46), C8H16S3 (47a, 47b) and 
C8H16S4,  (48a, 48b) each with one double bond equivalent (DBE). 
The elemental composition of the fragments and the relative intensities are summarized in 
Table 3.10. The formula of a few fragments in parenthesis was postulated without exact mass 
according to literature data.61,62 The peaks of the polysulfides were overlapping other peaks 
which made it difficult to get a clear MS spectrum. As a result, the relative intensity values of 
the fragments were averaged between the two samples. Both values are shown in the table if 
averaging led to high standard deviation. 
The MS spectra of the polysulfides were compared to literature data since nuclear magnetic 
resonance spectroscopy experiments were not possible to carry out due to the small 
concentration of the substances and the small amount of sample available. The MS spectra of 
the two isomers of M208 (C8H16S3) were very similar to that of 4,4,6,6-tetramethyl-1,2,5-
trithiepane (47a) and 3,3,7,7-tetramethyl-1,2,5-trithiepane (47b) described by Mieloszynski61. 
The first isomer of M240 (C8H16S4) had a similar MS spectrum to that of 3,3,8,8-tetramethyl-
tetrathiocan (48a).61 Based on the MS data and assuming that the polysulfides found in the 
marine extracts are biosynthetically related a structural formula was postulated for each 
isomer, presented in Scheme 3.13. 
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Several structures were ruled out based on numerous publications containing MS data of 
cyclic polysulfides.61-71 
 
 
   Table 3.10  Elemental composition and relative intensitya of the fragments in the EI+ MS spectra 
   of the polysulfides found in Bio137 and Bio138; the related numbered structures (Scheme 3.13) are 
   postulated. 
  M152 M208 M240 
Formula m/z 46: RI  1175 47a: RI  1472 47b: RI  1516 48a: RI  1727 48b: RI  1748 
C8H16S4+
⋅
 
240 - - - 39 62 
C8H16S3+⋅ 208 - 100 82 - - 
C4H8S3+⋅ 152 100 71/59 100 100 100 
C8H15S+ 143 - 13 - - - 
C4H8S2+⋅ 120 - 28 26 24 59 
(C3H6S2+⋅)2 106 2 12 42 1 - 
S3+⋅ 96 4 1 1 - - 
C4H8S+⋅ 88 27 53 41 24 26 
C4H7S+ 87 52 94 87 56 55 
C3H5S+ 73 10 10 8 2 19 
S2+⋅ 64 13 4 3 4 4 
C2H3S+ 59 21 27 32 11 15 
C4H7+ 55 38 95 76 54 82 
(CHS+)2 45 17 19 18 9 10 
C3H5+ 41 19 27 29 17 23 
(C3H3+)2 39 18 21 20 13 16 
       a
 Intensity values are the average of the two measurements (Bio137 and Bio138); both values are shown if 
      the difference is too large, for compound 48b only data from Bio137 is shown. 
       b
 Formulas that were postulated without exact mass. 
 
 
S
S
S S
SS
S
SS
S S
SS
S S
SS
46 47a 47b 48a 48b
 
Scheme 3.13  Postulated structural formulas for the polysulfides found in extracts Bio137 and Bio138. 
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Possible 1,2,4-trithiolanes with the molar mass of 152 do not match the spectra of 46, since 
the fragment (M-CnH2n-1S)+⋅ is missing: m/z 92 from the spectrum of 3,5-dimethyl-1,2,4-
trithiolane65 and m/z 78 from that of 3-ethyl-1,2,4-trithiolane.68 As a consequence, and also 
due to the S3+⋅ fragment directly formed from M+, three adjacent sulphur atoms were 
postulated in the molecule of 37. No MS data was found for the six- and seven-ring isomers 
(2+1) and for 4-ethyl-1,2,3-trithiolane. The vicinal five-ring isomer (3,4-dimethyl-1,2,3-
trithiolane) should have two (cis/trans) isomers and thus seems less likely. 
In the MS spectrum of 47a and 47b m/z 55 is the longest CnH2n-1+⋅ and m/z 87 the longest  
CnH2n-1S+⋅ fragment which means that no more than four carbons are adjacent. Considering 
the number of carbons (eight) in the molecule, it is only possible with two C4 units. The 
symmetrical 3,5-dipropyl-1,2,4-trithiolane67,68 and the diisopropyl one71 do not produce such 
a strong (M-C4H8)+⋅ fragment, m/z 152, but a more intensive (M-S2H)+⋅ fragment, m/z 143. For 
the six-ring isomers no literature data were found. Nevertheless, the complete lack of (M-
CnH2n+1)+ fragments near M+ indicates aliphatic alkyl side-chain no longer than n=1, which 
makes the postulated seven-rings for 47a and 47b (Scheme 3.13) more convincing. The 
intensity difference of the fragment m/z 106 in the two isomers (Table 3.10) is also in 
agreement with literature data.61 As an alternative, 3,3,6,6-tetramethyl-1,2,5-trithiepane (not 
presented in Scheme 3.13) can not be ruled out completely for the compound 47a or 47b. 
The MS spectra of the polysulfides 48a and 48b contain the same fragments as that of  47a 
and 47b (except m/z 106), which is a hint for a similar structure. Since the spectrum of 48a 
matches the literature data of 3,3,8,8-tetramethyl-tetrathiocan,61 3,3,7,7-tetramethyl-
tetrathiocan is a realistic suggestion for 48b.  
 
3.4.3.4 Isomeric lactones from AMP,3 and Hel59 
 
Two isomeric substances 49a and 49b (RI 1454 and 1468) were found with a molar mass of 
209  and almost identical MS spectrum in the extracts of the strains AMP,3 (Cytophaga sp.) 
and in Hel59 (Marinomonas sp.).  
An intensive carbonyl band was detected for 49a and 49b by GC-IR at 1801 cm-1 and 1804 
cm-1, respectively, which probably indicates an unsaturated γ-lactone structure.72 (Fig. 8.29 
and 8.30 in Appendix) 
The molecular formula and the elemental composition of the fragments (see Table 3.11) was 
determined by GC-HRMS analysis: the M+ is C12H19NO2 with four or five DBE. 
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The concentration of the compounds was higher in the polar fraction of the extracts. Besides, 
two additional isomers 50a and 50b (RI 1442, 1462) were detected in Hel59, the MS spectra 
were similar to that of 49a and 49b. (The related MS spectra are in Appendix.) 
 
 
Table 3.11  Elemental composition and relative intensity 
of the fragments in the EI+ MS spectra of the substances 
49a and 49b in AMP,3 analyzed by HRMS. -: no HRMS 
data available. 
Relative intensities 
Formula m/z 
49a 49b 
C12H19NO2+⋅ 209 7.7 10.3 
C11H16NO2+ 194 0.8 0.6 
C11H19NO+⋅ 181 3.6 5.7 
C9H12NO2+ 166 60.0 45.3 
C8H10NO2+ 152 4.0 6.0 
C8H12NO+ 138 12.8 9.0 
C6H6NO2+ 124 67.8 52.8 
- 110 3.9 3.6 
C6H10O+⋅ 98 31.8 47.7 
C5H7O+ 83 11.6 13.0 
C4H5O+ 69 24.9 31.2 
C3H3O+ 55 100 100 
- 43 24.9 22.5 
- 41 30.8 27.5 
 
 
 
3.5 Discussion 
 
3.5.1 Data analysis tool 
 
Hundreds of lipophilic bacterial extracts were derivatized and analyzed by GC under 
standardized conditions. The program ChromConv converted the GC data in report format 
into a measurement matrix. The converted GC data were processed by SPSS and the 
similarity of the GC patterns was visualized by dendograms created by HCA and PCA/HCA 
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methods (section 3.4.1). No a priori knowledge was at hand about the nature of the data set. 
Not even the fermentation conditions were given, since marine bacteria are extremely difficult 
to culture and thus many different media were used. The problem presented in this work was 
therefore more elaborate than other described chromatographic applications of clustering 
(section 3.2.2). It belongs to the field of exploratory data analysis, and interpretation of the 
results should be taken with caution. 
 
Data selection 
Identification of as many components as possible was carried out by GC-MS analysis of 
selected samples in order to obtain information about the metabolism of marine bacteria. 
Several extracts were chosen for further investigation based on properties, like unusual smell, 
such as Pic009, or biological activity, for example Bio137. Other samples were picked out 
according to their position in the dendogram and analyzed by GC-MS in order to seek novel 
substances. The extract of the strain ANT17 (subset STM3), for example, contained mostly 
alkanes, alkenes and fatty acids. On the other hand, Bio1 (subset STM3) was found to 
produce the same methyl-branched long-chain alkenes and ketones as Pic009 (presented in 
section 4.3.2.2) 
Once an extract was found to contain novel substances, similar ones were sought by 
clustering. Nevertheless, the same interesting compounds (or series of compounds) were often 
found in extracts with different overall GC patterns. Thus clustering a particular part of the 
GC chromatograms was necessary to find other samples containing the given compounds, as 
in case of the two C35-terpenes 26 and 27 (Dendogram 8.12 made by analyzing the 84-89 min 
segment of the chromatograms). 
 
Interpretation of the results 
It is difficult to measure validity by using unsupervised clustering techniques. The methods 
measure rather the goodness of the clustering,24b,25b that is how good the results reveal the 
natural grouping in the data set, which was in our case secondary. Since none of the 
components of the marine extracts were preferred (most of them were unknown), it was not 
possible to prepare model mixtures and perform cluster analysis on a model data set. Several 
strains were repeatedly fermented, some extracts were repeatedly derivatized, and a few were 
repeatedly injected, which helped to evaluate our data selection tool.   
Marine bacteria 
63
 
Similar but somewhat irregular GC patterns, as in case of the extracts IHg,3, IHg,4 and ACF,5 
(see Fig. 3.10), were found to be similar by the method, just like most of the repeatedly 
derivatized and injected samples. Yet, not all of the derivatization and injection control 
samples were clustered together (see Bio210 control samples in Dendogram 8.7 and 8.8), 
which means the method is relatively sensitive to concentration differences and impurities 
from the vials and the GC system (see Fig.3.20).  
 
 
 
 
 
 
 
 
 
 
      Fig.  3.20  GC patterns of Bio210 (a), Bio210 der.I (b), Bio210 der.IIa/1 (c), Bio210 der.IIa/2 
      (d), Bio210 der.IIb/1 (e), Bio210 der.IIb/2 (f). Spikes from detector are marked by *. Bio210  
      was derivatized repeatedly (a, b, c, e); c injected once more is: d; e injected once more is: f.  
      It can be seen that early peaks are not reproducible and by the injection of e impurities could  
      be observed. 
 
The GC pattern of the strains fermented repeatedly in the project was rarely reproducible (see 
Fig.3.21 and sample names in bold in Dendogram 8.11 in Appendix). It is well-known that 
some bacteria do not produce identical compounds under identical culture conditions for 
unknown reasons.  
 
 
 
 
 
 
 
 
 
         Fig. 3.21  GC patterns of the repeatedly fermented strain Hel45 (Roseobacter sp.). 
20 40 60 80 t / min
*
20 40 60 80 t / min 20 40 60 80 t / min
*
a
b
c
d
e
f
 
20 40 60 80 t / min 20 40 60 80 t / min
 
Marine bacteria 
64
 
High background in the GC analysis 
Limitations of the clustering tool arise mainly from the nature of the fermentation 
experiments. The culturing conditions, the composition of the medium and the solvent used 
for extracting the fermentation mixture play an important role in the reproducibility of the 
experiment and the successfulness of data selection by cluster analysis. 
The origin of the problems was the high background in GC analysis. Large number of 
components unspecific to the strains were evenly distributed in the middle part of the GC 
chromatograms, roughly in the 30-80 min segment of the total interval. Typical substance 
classes were fatty acid derivates, diketopiperazines, sugar derivates (less in the lipophilic 
fractions), and aromatic substances (presented in table 3.3 in section 3.4.1.1). 
Diketopiperazines are well-known natural products biosynthesized generally from 
proteinogenic L-α-amino acids by cyclization of the corresponding L,L-dipeptide.73 As 
exceptions to the rule, cyc(L-Xxx-D-Pro) diketopiperazines have been also isolated (see 
Scheme 3.14), but the origin of them is still unclear. Since proline racemases are rarely found, 
a non-enzymatic pathway is more plausible. 
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Scheme 3.14  Unusual cyc(L-Xxx-D-Pro) diketopiperazines as natural products: 51, cyc(L-Phe-D-
Pro), isolated from the fungus Aspergillus flavipes, and 52, cyc(L-Arg-D-Pro), produced by the 
bacteria Pseudomonas sp. IZ208.73 
 
Moreover, formation of the thermodynamically more stable cyc(L-Xxx-D-Pro) from the cyc-
L,L-epimer under mild acidic or basic conditions was confirmed.74-77 
The diketopiperazines found also in control samples without bacteria in our experiment (see 
Table 3.x in section 3.4.1.1) gave always two peaks in the GC analysis. By GC-MS analysis 
of reference compounds the occurrence of the epimers cyc(L-Leu-L-Pro) and cyc(L-Leu-D-
Pro) was demonstrated, with lower concentration of the second. Hence, it is most unlikely, 
although not impossible that the diketopiperazines identified in the marine extracts were of 
bacterial origin. These substances are more polar and thus give a broad chromatographic peak 
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(with leading). They were the most disturbing components due to overlapping other, probably 
more interesting peaks. 
In order to minimize the influence of the background substances on the results the time 
segments containing peaks of diketopiperazines and artifacts (phthalates and aromatic 
phosphates) were excluded from the data mining process by ChromConv for HCA. 
Nevertheless, omitting all the segments with disturbing substances would have resulted in 
loosing substantial chemical information. The effect of the diketopiperazine peaks on the 
clustering is demonstrated in the dendograms of subset STM3 and STM5 (Dendogram 8.6 and 
8.10 in Appendix) obtained by the PCA/HCA method: extracts with high diketopiperazine 
concentration were clustered together, since here the whole time interval was included in the 
clustering process. 
 
 
3.5.2 Conclusion 
 
The lipophilic bacterial extracts investigated in the marine research project in Lower-Saxony 
contained various novel substances and a high background originated from fermentation 
media. To apply unsupervised learning techniques for the exploratory analysis of such a 
complex data set a better experiment design is necessary. 
It is very important to control the repeatability of the fermentation process, of the 
derivatization method and the GC analysis. The most critical point is to which extent a strain 
produces the same substances under identical conditions. Parallel experiments should be 
carried out with a few strains under the same conditions and also over a period of time (day-
to-day reproducibility) and the results should be evaluated by the data mining tool. 
The GC pattern was often dominated by the substances from the fermentation medium. 
Therefore it is advisable to note the fermentation parameters and perform cluster analysis with 
extracts obtained from fermentation experiments with the same medium composition. It is 
also required to make fermentation blanks (without bacteria) to each medium on a regular 
basis to obtain information about the background. Cluster analysis should be carried out 
including these blank extracts. 
Adding a proper internal standard to the mixture at the beginning of the fermentation 
experiment helps to control the yield. It provides then an internal standard for sample 
preparation as well. Deuterated alkanes or fatty acids would be suitable, for example. 
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Selecting a short- and a long-chain isomer would cover the range of volatility and the GC 
peaks would not interfere with others. 
 
3.5.3 Interesting substance classes from marine bacteria 
 
Several interesting compounds were found and identified during the marine research project 
(described in sections 3.1 and 3.4.3). By analyzing the lipophilic fractions of the fermentation 
mixture in the second period of the project two terpenes, 26 and 27, were isolated and their 
structure was elucidated. Other compounds are not yet fully investigated, still it is interesting 
to discuss their possible origin and biosynthesis. 
 
C35 terpenes 
Well-known short-chain homologues of 26 and 27 are the monoterpenes γ-terpinene (53) and 
p-cymene (54) from essential oils of Citrus, Origanum, and Thymus species,78,79 the 
sesquiterpenes β-curcumene (55)80 and ar-curcumene (56)80,81 found in various essential oils 
of Curcuma and Salvia species,43 and the diterpene 57 isolated from Salvia dorisiana 
(Scheme 3.15).82 
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  Scheme 3.15  Homologues of  the C35 Terpenes 26 and 27 : γ-terpinene (53), p-cymene (54), β- 
  curcumene (55), ar-curcumene (56), (E)-1-methyl-4-(1,5,9-trimethyl)-deca-4,8-dienylbenzene (57). 
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Long-chain isoprenoids are often found in marine sediments, they probably regulate 
membrane fluidity of the cell.83 The so called highly-branched isoprenoids (HBI) with 
different chain-length (C-20, -25, -30) and saturation are biomarkers characteristic to the 
source organism and the different environmental conditions.84-86 An example is the compound 
58 isolated from the marine diatom Rzizosolenia setigera (Scheme 3.16).87 Isoprenoid wax 
esters, such as compound 59, are known from Acinetobacter, Pseudomonas and Marinobacter 
species (Scheme 3.16).88 
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Scheme 3.16 An isoprenoid wax ester, 59, from Marinobacter squalenivorans, and a C-30 HBI, 58, 
from the marine diatom Rzizosolenia setigera. 
 
The biosynthesis of longer (>C-20) isoprenes is quite versatile. Aliphatic C35 isoprene 
hydrocarbons are biosynthesized by head-to-head coupling of farnesyl pyrophosphate (FPP) 
and geranylgeranyl pyrophosphate (GGPP) by the deep see methanogen  Methanococcus 
jannaschii under anaerobic conditions.83 It was also observed that a C-30 carotenoid synthase 
accepts longer substrates, GGPP for example, and is thus able to produce a C35 backbone. 
Nevertheless, aliphatic head-to-tail all-trans-C-30 and C35 isoprene chains are produced by 
elongation of FPP with (three or four) isopentenyl pyrophosphate (IPP) units. The reaction is 
catalyzed by prenyl-transferase type II enzymes (consisting of two components) discovered in 
Bacillus subtilis.89a 
Moreover we assume that the final cyclization and aromatization steps of the biosynthesis of 
26 and 27 are mechanistically similar to the biosynthesis of γ-terpinene and p-cymol from 
geranyl pyrophosphate (GPP).89b 
According to the literature data a biosynthetic pathway for 26 and 27 was postulated. (Scheme 
3.17) From FPP (59) (generated by an FPP-synthase) an all-trans heptaprenyl chain is 
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produced by stepwise elongation with IPP mediated by an extra prenyl-transferase (a). A 
terpene cyclase regulates the conformation of the chain and mediates the following reactions: 
isomerization of the carbocation 60 (b), nucleophilic attack of the double-bond and 
production of carbocation 61 (c), generation of carbocation 62 from 61 by 1,2-hydrid shift (d), 
and formation of the product 27 by deprotonation (e). The hexadiene 27 is eventually 
aromatized to 26 by a desaturase (f). 
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Scheme 3.17  Postulated biosynthetic Pathway to 26 and 27. Step a: FPP (59) is elongated by four IPP 
units by prenyl transferase II. Steps b-e are catalyzed probably by a terpene cyclase; b: isomerization 
of the carbocation and regulating the conformation of the chain, c: cyclization, d: 1,2-hydride shift, 
and e: deprotonation. Step f: the terpene 27 is aromatized to 26 by a desaturase or non-enzymaticaly 
by oxygen. 
 
According to our observation the concentration of the terpene 27 was higher than that of the 
aromatic derivative 26 in freshly fermented samples, but the relation has turned to the 
opposite over time. For this reason it is still uncertain whether 26 is a natural product or a 
more stable oxidation product of 27. 
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Long-chain ketones and alkanes 
The occurrence of the structurally related long-chain ketones and alkenes in the extract of the 
strain Bio1 (summarized in Table 3.12.) reflects their biosynthetic origin (Scheme 3.18). It is 
well-known that (n-1)- and (n-2)-methyl-branched fatty acids (FAs) are synthesized from 
special starter units generated from isobutyryl-CoA, 2-methylbutyryl-CoA and 3-
methylbutyryl-CoA, which are catabolic products of the amino acids L-Val, L-Ile and L-Leu 
respectively.90 As a consequence of the nature of the chain-elongation (always by a C-2 unit), 
the (n-2)-methyl-FAs have an even-numbered backbone starting from 2-methylbutyryl-CoA. 
The (n-1)-methyl-branching occurs both by even- and odd-numbered backbones due to the 
corresponding even and odd starting units (3-methylbutyryl-CoA and isobutyryl-CoA). As a 
result, a few isomers are not produced by the bacteria. 
 
Table 3.12  Summary of the ketones and alkenes found in Bio1 (Cytophaga sp.) with the measured RI 
values; -: not detected. 
Position of 
the Me 
groups 
Chain- 
length 
Ketones RImeas Alkenes RImeas 
3, (n-2) 27 3,25-dimethyl-14-heptacosanone 40c 3031 3,25-dimethyl-13-heptacosaene 45c 2807 
2, (n-2)  2,25-dimethyl-14-heptacosanone 40b 3019 2,25-dimethyl-13-heptacosaene 45b 2795 
2, (n-1)  2,26-dimethyl-14-heptacosanone 40a 3008 2,26-dimethyl-13-heptacosaene 45a 2784 
3, (n-2) 26 3,24-dimethyl-13-hexacosanonec - 3,24-dimethyl-13-hexacosaened  - 
2, (n-2)a  2,24-dimethyl-13-hexacosanone 39b 2920 2,24-dimethyl-13-hexacosaened 44b 2696 
2, (n-1)  2,25-dimethyl-13-hexacosanone 39a 2908 2,25-dimethyl-13-hexacosaened 44a 2686 
3, (n-2) 25 3,23-dimethyl-12-pentacosanone 38c 2828 3,23-dimethyl-12-pentacosaened 45c 2607 
2/3, (n-2/1)b  2,23-dimethyl-12-pentacosanone 38b 2817 2,23-dimethyl-12-pentacosaened 43b 2595 
2, (n-1)  2,24-dimethyl-13-pentacosanone 38a 2807 2,24-dimethyl-12-pentacosaened 43a 2585 
3, (n-2) 24 3,22-dimethyl-12-tetracosanonec - 3,22-dimethyl-12-tetracosaened - 
3, (n-1)a  3,23-dimethyl-12-tetracosanone 37b 2717 3,23-dimethyl-12-tetracosaened 42b 2495 
2, (n-1)  2,23-dimethyl-12-tetracosanone 37a 2707 2,23-dimethyl-12-tetracosaened 42a 2485 
3, (n-2) 23 3,21-dimethyl-10-tricosanone 36c 2625 - - 
2/3, (n-2/1)b  2,21-dimethyl-10-tricosanone 36b 2615 - - 
2, (n-1)  2,22-dimethyl-10-tricosanone - - - 
a
 only one isomer is possible 
b 
 both dimethyl isomers, 2,(n-2) and 3,(n-1), are possible  
c
 isomer probably not produced 
d
 postulated double-bond position 
 
The postulated mechanism of the biosynthesis of 2,25-dimethyl-14-heptacosanone (40b) and 
2,25-dimethyl-13-heptacosaene (45b) is shown below (Scheme 3.18). Both building blocks 
are derived from FAs commonly found in bacteria. In essence, two long-chain FAs are 
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condensed head-to-head in a fashion similar to Claisen-condensation. This reaction has so far 
not reported from nature. 13-Methylmyristic acid is activated by addition of a carboxylic acid 
group to form an alkylmalonate, as known for acetyl-CoA in normal FA biosynthesis.90 This 
compound (64), bound to an acyl-carrier protein (ACP), is then condensed with 12-
methylmyristyl-thioester to form the keto ester 65. Via decarbonylation the ketone 40b is 
released. By reduction and dehydration of 65, well-known reactions from fatty acid synthases 
(FASs), the α,β-unsaturated 66 is produced and the alkene 45b is released by 
decarbonylation. 
The mechanism is being currently investigated vie feeding experiments, due to the fact that 
one of the strains, Hel73, produces 3,25-dimethyl-13-heptacosaene (45c) reproducibly. 
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Scheme 3.18  Postulated biosynthetic route to the ketone 40b and the alkene 45b. (a) Condensation 
reaction of 12-methylmyristyl-thioester (63) and  activated 13-methylmyristyl-SACP (64), the β-keto-
adduct 65 is generated. (b) Decarbonylation of 65 to the ketone 40b. (c) Reduction and dehydration of 
65, the α,β-unsaturated 66 is produced. The alkene 45b is released by decarbonylation (b’) of 66. 
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3.6 Summary 
 
More than 500 bacterial extracts were analyzed by means of unsupervised learning techniques 
based on their gas chromatographic pattern. Raw GC data was arranged into a measurement 
matrix by a self-made program ChromConv. Hierarchical cluster analysis was successfully 
applied on converted GC data for selecting interesting samples for further analysis (GC-MS, 
GC-IR, NMR) and finding similar ones to save measurement labor and time. 
Although a few clusters of samples were revealed during clustering (the hexanetriols in Fig. 
3.10), it was not the clusters we were looking for. Hierarchical cluster analysis was rather 
used as a presentation method of the similarity degree between bacterial fermentation extracts 
according to their GC pattern.  
Two methods were used. Variables were extracted manually by ChromConv or by PCA of the 
original variables (by using SPSS). Hierarchical cluster analysis was performed by SPSS on 
the whole data set as well as on smaller subsets with samples fermented more or less at the 
same time (see dendograms in Appendix). Despite the high background in the GC 
measurements originating from the fermentation medium several interesting substance classes 
were discovered.  
Two C35 terpenes, (R)-tetraprenyl-β-curcumene ((R)-27) and (R)-tetraprenyl-ar-curcumene 
((R)-26) (Scheme 3.19) were isolated by liquid chromatographic methods and their structure 
was elucidated by GC-MS and NMR analysis.  
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Scheme 3.19  (R)-tetraprenyl-β-curcumene ((R)-27) and (R)-tetraprenyl-ar-curcumene ((R)-26). 
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According to the cluster analysis results on the relevant segment of the GC chromatograms 
several extracts were found to contain these substances (Dendogram 8.12 in Appendix), 
which helped the isolation. The absolute configuration was determined by chiral GC analysis 
of the degradation product of 27, we assume that 26 has the same configuration: R. 
Monocyclic hydrocarbon terpenes with this chain-length have been hitherto unknown. The 
strains producing these substances  possess probably a unique terpene cyclase enzyme. 
 
A series of long-chain ketones and biosynthetically related alkenes with (n-1) and/or (n-2) 
methyl branching at both chain-ends were identified (Table 3.12 in Discussion). A special 
condensing enzyme and a FAS supposedly mediate the unusual biosynthetic pathway. 
(Scheme 3.18) Although the production of these substances by the strains Bio1 and Pic009 do 
not seem to be reproducible, other strains are found to synthesize the alkene 45c. The 
postulated mechanism is being currently studied. 
 
Other substance classes have not been yet fully investigated. The tentative structures of the 
hexanetriols (Scheme 3.12 in section 3.4.3.1) and the cyclic polysulfides (Scheme 3.13 in 
section 3.4.3.3) must be synthetically confirmed, since isolation was not possible due to the 
low amount of extract available and the lack of reproducible production of these compounds. 
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4 LOW MOLECULAR WEIGHT COMPONENTS IN 
THE VENOM OF THE SPIDER CUPIENNIUS SALEI 
 
4.1 Spider venom 
 
Introduction 
Spiders, species from the order Aranea, are one of the most widespread living creatures on 
Earth; they are carnivores and produce offensive material, venom, to capture their prey.91 
Although from the more than 30 000 species described so far just about 180 bite man and 
only the minority is truly venomous,91,92 they are treated with respect by humans (from 
caution to arachnophobia). Dangerous is the bite of widow spiders (genus Latrodectus), 
Australian funnel-web spiders (genus Atrax), banana spiders (genus Phonentria) and members 
of the genus Loxosceles.91,92 Since spiders do not attack primarily men and due to the good 
supply of antiserum, severe injuries are more frequent from stings of honey-bees in Australia, 
the habitat of the majority of these threatening species.  
Meanwhile, scientists are interested in finding the basis of the success of these animals in 
evolution. Although investigations have started already in the middle of the 20th century, the 
examination of spider toxins gained considerable attention in the last decades.91 It is very 
tedious to obtain suitable amount of venom for analysis (the yield is sometimes less than 1 µl 
pro animal) due to the small size of spiders and their glands. Nevertheless, as a result of the 
fast improvement of analytical techniques, and the development of modern, nondestructive 
milking methods,93,94 substantial knowledge has been gained about the composition and 
biological role of spider venom since the 1980’s. 
Neuroactive compounds of different substance classes (proteins, polyacylamines) have been 
found in the venom of several spider species. These substances have reversible or irreversible 
paralyzing effect on prey animals, thus they are good candidates for insecticides. Moreover, a 
bite of the most dangerous species may cause death to humans when not properly treated. 
Still, purpose of the research is not solely to seek for antivenomous compounds, to generate 
novel insecticides or to understand the behavior of spiders but to find useful tools to 
investigate neural diseases, such as stroke, Alzheimer’s disease, and epilepsy.16 
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Composition of spider venom 
The amount of venom available from one animal varies from a few hundred nanoliters  to 
several microliters. It is common that females produce more venom than males, also when 
body size is taken into consideration.95 Venom composition is highly variable. Interspecific, 
intersex and interpopulational differences can be significant not only due to different venom 
constituents but also to different concentration ratios.95 
Spider venom contains generally proteins with or without enzymatic activity, polypeptides, 
low molecular weight compounds (<1000 Da) (such as purine bases, nucleotides, amino 
acids, citric acid) and inorganic salts.16,91,96 
The peptide content of the venom has been more thoroughly investigated, compared to the 
group of low molecular weight (LMW) compounds. Among the well investigated neurotoxic 
acting proteins some are selective blockers of presynaptic ion channels, others form divalent 
cation channels. 
Several examples are mentioned here to illustrate different modes of action. Both the agatoxin 
ω-Aga-IA (7.5 kDa, 66aa) from the funnel web spider Agenelopsis aperta and the peptide 
SNX-325 (49 aa) from Segestria florentina block N-type Ca ion channels, and the former one 
inhibits also L-type Ca channels.91 Proteins from Latrodectus and Steatoda species bind to 
presynaptic membranes and form transmembrane  ion channels, which leads to liberation of 
neurotransmitters.97 Two toxins from the black widow spider Latrodectus mactans act 
similarly but with different prey selectivity: α-latrotoxin (130 kDa) is active on vertebrates, 
α-latroinsectotoxin (120 kDa) on insects.91 Other peptides, such as µ-Aga-I (4.2 kDa) (A. 
aperta) and two peptides (PhTx2-5, PhTx2-6, 6-8 kDa) from the American banana spider 
Phonentria nigriventer act on voltage-sensitive Na ion channels and cause repetitive release 
of transmitters from nerve cells. 91,97 
In addition to neuroactive peptides a few enzymatic active proteins have been found, such as 
hyaluronidases,98 phosphplipases, proteases, peptide isomerases, and collagenases.91 
Typical LMW substance classes found in spider venom are amines, polyamines and free 
amino acids. Some of the LMW compounds contribute to synergistic effects. Histamine, for 
example, increases the permeability of capillary walls and allows toxin transport, whereas 
taurine inhibits neurotransmitters in the prey animal, decreasing the chance of escape.98,99 
Citric acid is also a known constituent of spider venom, it prevents self-intoxication by 
inhibition of phospholipases.91 
A relatively new group of LMW compounds, the acylpolyamines were discovered in the 
beginning of the 1980s. Acylpolyamines have been isolated mostly from the venom of spiders 
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in the family of Araneidae and Agelenidae.97 The two main structural constituents of these 
compounds are a lipophilic aromatic acyl head group and a polyamine chain. Additional parts 
are optional: an amino acid linker between the head group and the chain, and a basic amino 
acid or positively charged amino group at the other end of the chain, such as in compound 67. 
(Scheme 4.1).93 Acylpolyamines are neurotoxic and bind selectively to neural receptors or ion 
channels.97 Most of them block glutamate receptors and thus inhibit Ca ion channels.91  
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Scheme 4.1  The acylpolyamide Argiotoxin 636 (67) found in the poison gland of Argiope lobata.97 
 
In 1993, an unusual neuroactive compound, HF-7 (68), was isolated from the venom of a 
funnel-web spider, Hololena curta. This compound is a glyconucleoside disulfate, namely the 
3’-O-(4’’-O-acetyl-α-L-fucopyranosyl)-guanosine-2’,5’-disulfate (Scheme 4.2), which also 
blocks glutamate-sensitive Ca channels.100,101 
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Sheme 4.2  HF-7 (68) from Hololena Curta. 
 
Certain neural disorders (Alzheimer’s disease, for example) are connected to the misbehavior 
of glutamate receptors, therefore these neuroactive components of spider venom might be 
useful for further investigation of such diseases.97 
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Analysis of low-molecular weight components of spider venom 
For the isolation and analysis of LMW venom constituents a mixture of chromatographic and 
spectroscopic methods is used. The peptide content is usually separated from the rest by gel 
filtration, for example, and several steps of purification, such as cation exchange 
chromatography, RP-HPLC, TLC, CE are applied to isolate the compounds.98 
Identification of LMW compounds in venom fractions is possible by HPLC-MS or by 
derivatization and GC-MS, although the latter is not suitable for analyzing thermally labile 
compounds, acylpolyamines for instance. For structure determination tandem mass 
spectrometry (MS-MS) is required, since the soft ionization techniques used in HPLC-MS do 
not result in substantial fragmentation. As an example, in case of the acylpolyamines isolated 
by RP-HPLC, the position of nitrogen atoms in the chain was resolved by continuous-flow 
fast atom bombardment MS-MS (FAB MS-MS) analysis.91,93 
The exact structure is determined usually by NMR analysis of the natural compound, and it is 
eventually confirmed by synthesis. 
It is important to avoid loosing venom during isolation due to the low amount available. 
Using micro-HPLC for the isolation of venom constituents or analyzing the crude venom 
directly can be a solution to the problem. The molecular mass can be measured by matrix 
assisted laser desorption ionisation mass spectrometry (MALDI-MS)(SP011), and structural 
information can be obtained by low- and/or high energy collision induced dissociation (CID) 
even without HPLC separation.93 Recent coupled techniques allow to obtain amazing amount 
of structural information from one injection. Online HPLC-UV(DAD)-API-MS/MS systems 
are good alternatives to the ’old’ FAB techniques.16,17 
Snake venom and venom proteins from spiders have been investigated by HPLC,102,103 also by 
CE.104,105 However, the use of CE for the examination of LMW components of spider toxins 
has not been reported so far. This technique is especially promising, since it is suitable for 
analyzing polar metabolites in low amounts mostly without time consuming sample 
preparation. 
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4.2 Introduction in capillary electrophoresis 
Basics 
High-performance capillary electrophoresis (HPCE) has been probably the most rapidly 
developing analytical separation technique in the last two decades. It covers a group of 
methods based on different migration velocities of charged particles. The movement of the 
different entities is driven by the electric field applied between the two ends of a capillary, 
which is filled with a buffer solution, also called the background electrolite. 
Separation occurs nowadays in an uncoated or chemically modified fused silica capillary with 
typical internal diameters of 50-100 µm. A basic case of introducing electric force (0-30 kV) 
in such a narrow tube filled with a BGE and  analytes are demonstrated in Fig. 4.1. 
The inner capillary wall is usually negatively charged because of dissociated silanol groups on 
the inner surface with the exception of very acidic conditions or due to additives. It attracts 
positive ions from the solution and an electric double-layer forms. When applying voltage the 
diffusion layer start to move to the negative electrode, the cathode. Then, owing to viscosity, 
the whole bulk solution moves in the same direction, to the cathode, with a constant velocity 
after reaching a stable voltage in a few seconds. It is called the electroosmotic flow (EOF) and 
its mobility (and velocity) has a positive sign in the case described above. It is also possible to 
eliminate or reverse the electroosmotic flow by changing the capillary wall: by lowering the 
pH of the BGE, adding additives (dynamic coating) or by chemical modification of the silica 
surface.106a,107a  
Neutral molecules are taken by the electroosmotic flow, whereas charged analytes migrate in 
the electrical field to the anode or the cathode according to their ionic mobility and the EOF. 
The mobility  of cations is positive, of anions negative. The net electrophoretic velocity of a 
charged analyte in the EOF is the sum of the individual electrophoretic velocity and the 
velocity of the electroosmotic flow. 
Analytes are separated according to their charge and size under given conditions such as 
capillary type, composition of the BGE, applied voltage and temperature. 
A special feature of the electrically driven flow is its flow profile. Whereas liquid 
chromatographic techniques generate parabolic flow, the liquid current in CE is constant in 
the axial direction, except a rapid flow drop to zero at the capillary wall.107a Therefore very 
high theoretical plate numbers are possible to achieve in HPCE: in the order of 105–106. 
Nevertheless, extra heat is produced owing to molecular collisions in the high field strength 
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applied in the electrolite. This phenomenon is called the Joule heating. To support heat 
dissipation and thus eliminate the resulting peak broadening, the capillary has to be cooled. 
 
 
 
 
 
 
 
 
Fig. 4.1  Direction of the velocities of analytes A+, A- and the electroosmotic flow (EOF) in a bare 
fused silica capillary after applying positive voltage. 
 
High efficiency, easy quantitation and automation make HPCE superior to slab gel 
electrophoresis, although 2D protein separations still remain a challenge.106b 
HPCE has many advantages over HPLC, too. It is usually faster, more efficient, needs lower 
amounts of solvent and analyte. Analysis of biological samples is very convenient due to 
aqueous buffers mostly used as BGE. On the other hand, migration time of the analytes is not 
always reproducible  since it is sensitive to chemical changes of the capillary wall. In 
addition, scaling-up separations to preparative level is easier by HPLC.107b 
Although the concentration limit of detection of CE is worse (higher) than that of HPLC, CE 
is much more mass sensitive.107c Thus CE-MS is a very promising technique, although not yet 
routinely used. 
 
Instrumentation 
Current HPCE systems are fully automated. Samples and buffer vials are stored on large 
plates and the measurement-cycle (Fig. 4.2) is carried out by the autosampler. First the rest of 
BGE from previous measurement is removed and the capillary wall is conditioned by rinsing 
with basic or acidic solutions by applying pressure or vacuum. As next, the capillary is filled 
with the BGE followed by injection of the samples by applying low pressure (hydrodynamic 
injection) or electric field (electrokinetic injection). Then separation occurs by merging both 
ends of the capillary into the vials containing BGE solution filled to the same level. 
   
 
+
- - - - - - - - - - - - - - -
- - - - - - - - - - - - - - -
+ + ++ +++ +++
-
+ + ++ +++ +++
EOFA- A
+
A+A-
+
+ +-
-
-
-
-
Cupiennius Salei 
79
 
 
 
 
 
 
 
 
 
Fig. 4.2  A typical measurement cycle in HPCE. S: sample vial, BI and BO: buffer inlet and outlet 
vials, R: rinse vial, W: waste vial, V: high-voltage power supply, D: detector. The inlet end of the 
capillary is by the positive electrode, the anode. The steps are after washing the capillary: 1. filling the 
capillary with BGE from R to W with pressure, 2. injection of the analyte solution from S to W with 
pressure or vacuum, 3. separation from BI to BO by applying voltage (positive in this figure).  
 
 
The temperature of the capillary is maintained constant by air-cooling, or even better, a  
coolant fluid is circulated in the cartridge holding the capillary. In some instruments the 
samples can be cooled, too. A high-voltage supply provides the longitudinal electric field in 
the capillary for the separation. Ultraviolet absorbance, photo-diode-array, fluorescent, 
conductivity and mass spectrometry detectors are the commercial ones in capillary 
electrophoresis systems.107d The detection window is usually a few centimeters from the 
separation end, except for conductivity and MS detection. 
 
Different techniques and applications 
Capillary zone electrophoresis (CZE), micellar electrokinetic chromatography (MEKC), 
capillary gel electrophoresis (CGE), capillary isoelectric focusing (CIEF), capillary 
isotachophoresis (CITF) and capillary electrochromatography (CEC) are all capillary 
separation techniques, where the bulk flow is electrically driven.107b The main characteristics 
of these methods are presented in Table 4.1. They are also possible to perform in the same 
system in most cases. 
Due to its high efficiency and various modes of action, high-performance capillary 
electrophoresis competes already with high-performance liquid chromatography in several 
application fields, such as clinical analysis, peptide mapping, analysis of LMW compounds 
using detergents and by MEKC, chiral separations, carbohydrate analysis, and separation of 
inorganic ions.106b 
S BI BO WR
D+
-
V
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Table 4.1  Different modes of HPCE.107e 
 Principle Application 
CZE separation according to charge to size ratio of the 
analytes 
small molecules in general, peptides, 
proteins, carbohydrates, enantiomer 
separations107f  
MEKC uncharged analytes migrate in micelles owing to 
surfactant concentrations over cmc 
universal except DNA, enantiomer 
separations107g 
CGE macromolecular analytes are separated according to 
their size in the gel- or polymer network-filled capillary 
proteins, oligo- and polynucleotides, 
complex carbohydrates107h 
CIEF analytes separate according to their isoelectric point in a 
longitudinal pH gradient in the capillary 
peptides, proteins, smaller zwitterionic 
substances107i 
CITP analyte zones are moving between a leading and a 
terminating zone with the same velocity, dilute analytes 
are enriched 
mostly a trace enrichment technique 
during injection in CZE107j 
CEC uncharged molecules are separated on a stationary phase  universal except DNA, enantiomer 
separations107k 
 
 
 
4.3 Investigation of the venom of Cupiennius salei by 
different separation techniques 
 
Cupiennius salei 
One of the best investigated spiders today is the wandering spider Cupiennius salei 
(Araneae:Ctenidae) (Fig. 4.3) found originally in the tropical rainforest from Central Mexico 
to northern South America.94,98 It came to Europe with banana transports. 
The yield of electrical milking from adult females is 7-15 µl venom per animal. It has been 
shown that the spider is able to use its venom economically according to the size and mobility 
of its prey.94 
The concentration of the inorganic ions Na and Ca in the venom of C. salei is lower,  that of  
the K ion is higher than in the hemolymph of spiders in general. This reveals a possible 
change in the function of the toxins after being injected into the hemolymph of prey 
animals.98 
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Fig. 4.3  Cupiennius salei consuming its prey.108 
 
 
LMW compounds identified so far in the venom of C. salei are free amino acids (Gly, Asx, 
Ala, Arg, Leu, for example), amines, such as histamine and taurine, and the polyamines 
putrescine and cadaverine in very low amounts.98 
The neuroactive peptides isolated form the venom of C. salei can be divided into two groups: 
some peptides (6-8 kDa) act neurotoxic, others, the so called cupiennins (3-4 kDa), have an 
additional cytolitic activity.94 The most toxic component is CSTX-1 (8.4 kDa), a highly basic 
peptide (pI 9.26) containing 74 amino acids and four disulphide bridges.(SP015) It has an 
inhibitory effect on L-type Ca ion channels. The cupiennins are characterized by the lack of 
Cys, and most of them lack also Pro. These peptides are active against Gram + and Gram – 
bacteria and show cytolitic activity against human erythrocytes as well. They bind to the 
membrane with their polar C terminus and the insertion of the hydrophobic end (N-terminus) 
destroys the membrane structure.94 Although cupiennin1a is less neurotoxic than CSTX-1, the 
two peptides act probably synergistically. 
One larger protein (with a molecular mass 33-38 kDa) was found to have hyaluronidase 
activity in enzyme assay experiments.98 This protein is most likely a spreading factor in target 
tissue.  
 
Isolation of LMW fractions of C. salei by the group of Prof. Nentwig 
 
Venom composition of C. salei has been thoroughly investigated by the research group of 
Prof. Nentwig from the Institute of Zoology, Department of Synecology, University of Bern 
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(Switzerland).98,94 In order to examine the LMW content of the venom more closely, specific 
fractions and a crude venom sample were sent to our laboratory. 
The venom fractions containing LMW components were gained by several chromatographic 
separation steps from the crude venom of C. salei. (Scheme 4.3) Spider venom was dissolved 
in an ammonium acetate buffer and the components were separated according to their size on 
a Superdex 75 HR 10/30 (Pharmacia) column. Three middle fractions (3c, 4a, 4b) were 
chosen for further purification on a Nucleosil 300-5C4 column (4mm x 250mm, Macherey & 
Nagel). Molecular weight of the retained compounds were between 2-4 kDa. 
Since are aim was to identify LMW components, the early eluting two peaks were collected 
for our research purposes. The fractions were washed more times with distilled water and then 
lyophilized. In our experiments we refer to these samples as CSG-1 to CSG-6. Analysis of the 
fractions by GC-MS and CE-UV(DAD) was planned and samples were kept at –80oC until 
then. 
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   Scheme 4.3  Isolation of the low molecular weight fractions CSG-1 to CSG-6 from 
   the venom of the spider Cupiennius salei by the group of Prof. Nentwig. 
 
 
4.3.1 GC-MS experiments 
Venom fractions 
The samples CSG-1 to CSG-6 were derivatized with MSTFA without solvent and analyzed 
by GC-FID and GC-MS (Table 4.2). Two pairs of fractions were similar; CSG-1 and CSG-3 
contained citric acid, and CSG-4 and CSG-6 contained histamine as main component. In the 
samples CSG-2 and CSG-5 no substance was detected by GC-MS. 
In order to verify the identification of the compounds reference substances were used in 
control experiments; commercially available citric acid, isocitric acid and histamine were 
derivatized with MSTFA. 
Venom of the spider 
Cupiennius Salei 
D001 
Dissolved in NH4OAc 
buffer 
Gel chromatography; Superdex 75 HR 
(Pharmacia)  
D001 / 4aD001 / 3c D001 / 4b
Early peak 1 
CSG-1 
Early peak 2 
CSG-2 
Early peak 1 
CSG-3 
Early peak 1 
CSG-5 
Early peak 2 
CSG-4 
Early peak 2 
CSG-6 
HPLC; Nucleosil C4 (Macherey & Nagel)  
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       Table 4.2  Substances found in derivatized CSG-fractions and reference samples analyzed by  
       GC-MS. TMS: trimethylsilyl, TFA: trifluoracetyl derivative. For +/- signs see Table 3.3. 
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Phosphoric acid, tri-TMS-  ++ - + - - - ++ ++ ++ ++ 
3-Methylene-succinic anhydrid  + - - - - - + ++ + + 
Lactic acid, di-TMS-  + - + - - ++ - - - - 
Succinic acid, di-TMS-  - - + - - - - - - + 
2-Methylene-succinic acid, di-TMS-  ++ - + - - - +++ +++ +++ + 
Isocitric acid lactone, di-TMS-a  - - - - - - - - - +++ 
c/t-Aconitic acid, tri-TMS-  + - + - - - +++ +++ + ++ 
Unknown acid, x-TMS-  +++ - + - - - - - + - 
Citric acid, tetra-TMS-  +++ - +++ - - - - - +++ - 
Isocitric acid, tetra-TMS-  + - + - - - - - - +++ 
Histamine  - - - ++ - - - - - - 
Histamine, N-TFA-  - - - +++ - +++ - - - - 
Glycerine, tri-TMS-  - - + + - - - - - - 
Myristic acid, mono-TMS-  - - + - - - - - - - 
Pentadecanoic acid, mono-TMS-  - - + - - - - - - - 
Palmitic acid,  mono-TMS-  (+) - + - - - - - - ++ 
Heptadecanoic acid, mono-TMS-  - - (+) - - - - - - - 
Oleic acid, mono-TMS-  - - + - - - - - - ++ 
Stearic acid, mono-TMS-  - - (+) - - - - - - + 
         
a
 Two peaks of diastereomers.  
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Although citric acid in CSG-1 and CSG-3, and histamine in CSG-4 and CSG-6 were 
confirmed, the existence of other short chain acids in fractions CSG-1 and CSG-3 remained 
uncertain. The compounds 2-methylene-succinic acid, its anhydride, succinic acid, and 
aconitic acid were identified in CSG-1 and CSG-3, and also detected in the derivatized 
reference samples of citric and isocitric acid. Hence it was not obvious whether these 
compounds are really constituents of the venom of C. salei, or are formed during 
derivatization or chromatographic separation. 
The geometric isomers of aconitic acid were not separated on the BPX-5 phase. 
 
Crude venom 
The crude venom sample was analyzed by GC-MS. Three aliquots of about 2 µl from the 
sample were transferred into 1 ml vials and derivatized with MSTFA, diazomethane solution 
in dichloromethane, and TMSH solution in methanol. 
Derivatization with diazomethane was successful, nevertheless no other substance as citric 
acid was detected. The results of the other derivatization experiments were not significant. 
 
4.3.2 Capillary electrophoresis experiments 
 
The venom fractions CSG-1 to CSG-6 were further analyzed by capillary electrophoresis to 
confirm GC-MS results. Two separate methods were used: the one for negative inorganic ions 
and small organic acids, the other for positive inorganic ions and amines. Indirect UV 
detection was required to analyze compounds without a chromophore functionality. Samples 
were spiked with magnesium chloride in order to have an internal standard to follow 
fluctuations of migration time.  
 
4.3.2.1 Literature 
 
For the analysis of small organic acids and inorganic anions indirect detection is usually used. 
Typical chromophores with suitable electrophoretic mobility are aromatic acids, such as 
salycic acid,109 benzoic acid,110 phthalic acid,111 trimellitic acid,112 and pyromellitic acid.113,114 
The electroosmotic flow is lowered or reversed to the anode by adding modifiers to the BGE 
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solution; such additives are tetradecyltrimethylammonium bromide,109,112 
myristyltrimethylammonium bromide,111 and hexamethonium hydroxide.113,114 
Inorganic cations and amines are frequently analyzed together by CE with indirect UV 
detection. Chromophores in case of smaller amines are, for example, copper(II)-sulfate115 and 
imidazol,116 whereas the BGE for the indirect analysis of biogenic amines contains quinine 
sulfate.117,118 
 It is possible to analyze anionic and cationic analytes simultaneously if certain criteria are 
met; the absolute value of the mobility of the electroosmotic flow must be slightly smaller or 
larger than that of the anionic analytes, and two chromophores are required to provide indirect 
UV detection.119 
 
4.3.2.2 Conditions of the CE experiments 
 
Negative ions 
A commercially available buffer from Fluka was used to analyze samples in the negative ion 
mode at a pH value of 7.7. The content of the buffer was the following: 
 
- pyromellitic acid  2.25 mM, 
- hexamethonium hydroxide 0.75 mM, 
- triethanolamine  1.6 mM, 
- sodium hydroxide  6.5 mM. 
 
The electrophoretic mobility of the buffer (electroosmotic flow) was measured with methanol 
as neutral analyte. Once it was injected at the usual end of the capillary and 30kV was applied 
for separation, followed by injection at the short end, 10 cm from detector window, and 
separation at –30kV. The measured values were 28·10-5 cm2(Vs)-1 and 23·10-5 cm2(Vs)-1, 
respectively. Notwithstanding the difference between the two values, it showed an 
electroosmotic flow in the direction of the cathode. Since the cathode (negatively charged) 
was at the injection end, the negative analytes were measured in counter-flow by applying 
negative voltage.  
 
Positive ions 
To measure positive ions and amines we used an other commercially available buffer from 
Fluka. The pH value of the buffer was set to 3.0 with phosphate. Buffer constituents were: 
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- copper(II) sulfate 4.0 mM 
-18-crown-6-ether  3.0 mM, 
- formic acid  4.0 mM. 
 
Indirect detection at 217 nm made the analysis of both organic and inorganic cations possible. 
Electroosmotic flow was measured at –20 and 20 kV from the short and long end, and turned 
out to be 13·10-5 cm2/(Vs) and 16·10-5 cm2/(Vs), respectively. It was a low electroosmotic 
flow, again to the cathode, the bulk flow and the cationic analytes migrated in the same 
direction by applying positive voltage. 
 
4.3.2.3 Results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.4  Separation of the anion standard (a) and the venom fraction CSG-3, spiked with Cl- (b) in  
negative ion mode. Components: (1) Cl-, (2) t-aconitate, (3) c-aconitate, (4) isocitrate, (5) citrate, 
(6) phosphate, and (7) acetate. Injection: 0.5 psi, 5s; separation: Fluka anion buffer, -30kV; 
detection: UV indirect at 220 nm. 
 
 
Negative ions 
The separation of the four anions t-aconitate, c-aconitate, isocitrate, and citrate, identified in 
fractions CSG-1 and CSG-3 by GC-MS, was acceptable with the original Fluka buffer (Fig. 
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4.4a) Adding Ca2+ in a concentration of 0.1 mM to the buffer resulted in a better separation 
(Fig. 4.5b), but the decrease in reproducibility of the migration times of late eluting ions, 
citrate, phosphate, and acetate, became significant. None of the isomers aconitic acid was 
found in the venom fractions. Citrate was detected as the only acid anion in CSG-1 (Fig. 
4.5a,b), and in small amounts in CSG-3 (Fig. 4.4b). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.5  The venom fraction CSG-1, spiked with Cl-, separated in the commercial Fluka buffer (a), 
and with additional 0.1 mM of Ca2+ in the buffer (b), in negative ion mode. For conditions and 
components see Fig. 4.4. 
 
 
Positive ions 
The system was tested with a mixture of five inorganic cations: ammonium, sodium, 
potassium, calcium, and magnesium, which were properly separated.(Fig. 4.6a) Histamine 
gave a negative peak under the conditions listed above.(Fig. 4.6b) 
All the venom fractions contained ammonium and sodium. The histamine content of CSG-4 
and CSG-6 could be confirmed with the method.(Fig. 4.7a,b) 
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Fig. 4.6  Separation of the inorganic cation standard (a) and histamine spiked with Mg2+ (b) in 
positive ion mode. Components: (1) NH4+, (2) K+, (3) histamine, (4) Na+, (5) Ca2+, and (6) Mg2+. 
Injection: 0.5 psi, 5s; separation: Fluka cation buffer, 10 kV; detection: UV indirect at 217 nm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.7  The venom fractions CSG-4 (a) and CSG-6 (b) spiked with Mg2+, separated in positive ion 
mode. For conditions and components see Fig. 4.6. 
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4.4 Discussion 
 
The results of the CE experiments confirmed the findings of the GC-MS analysis; citric acid 
and histamine are LMW constituents of the venom of C. salei. Citric acid was found in 
fractions CSG-1 and CSG-3, which were the first early eluting peaks in the RP-HPLC 
chromatogram of the gel chromatography fractions D001/3c and D001/4a, respectively. 
(Scheme 4.1) The related fraction from D001/4b, CSG-5, was probably more diluted, since no 
peak was observed by the GC-MS analysis. Histamine was the main component in samples 
CSG-4 and CSG-6, the second early eluting fractions from D001/4a and D001/4b, 
respectively. Again, the same fraction of D001/3c, CSG-2, was probably not concentrated 
enough. 
No aconitic acids were detected in fractions CSG-1 and CSG-3 by CE-UV/DAD, although the 
corresponding GC peak was significant. Aconitic acid is produced probably in the GC injector 
by dehydration of citric acid, since its occurrence seems to correlate with that of citric acid in 
the samples (Table 4.2). 
Several substances were detected by CE-UV/DAD and declared unknown due to lack of 
identification and reference compounds. Nevertheless, all the fractions contained late eluting 
peaks, probably phosphate and acetate, the latter from sample preparation. Similarly, 
ammonium was detected in each fraction. The samples CSG-1, CSG-3, and CSG-5 contained 
most likely chloride as early eluting component, whereas sodium, potassium and calcium 
were also found in different concentrations in the fractions. 
Although volatility of analytes can be enhanced by derivatization of polar functional groups, 
gas chromatographic methods are not suitable for the analysis of thermally unstable 
compounds, for example the acylpolyamines from spider venom. In addition, derivatization 
may lead to by-products, the possibility to gain impurities during sample preparation is 
higher. 
It is more convenient to analyze a biological sample, without transferring it to an organic 
solvent, by HPCE methods. Nevertheless, identification of the components is only possible by 
offline or online MS detection. The direct coupling of CE with MS was first reported in 
1987120 and has been intensively investigated in the last years.121-124 Still, one condition has to 
be fulfilled: replacing non-volatile BGE constituents for volatile ones, which may be 
challenging to do without loss of separation efficiency. Ammonium formate-formic acid and 
ammonium acetate-acetic acid buffers are used in the acidic and neutral pH range, whereas 
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separation of basic compounds can be achieved with ammonium bicarbonate (basic 
conditions).125,126 In sheath liquid interfaces the capillary effluent is diluted with methanol or 
acetonitril. 
 
 
4.5 Summary 
 
Two known constituents of spider venom: citric acid and histamine have been identified by 
GC-MS and CE-UV/DAD in the LMW fractions of the venom of Cupiennius salei. Citric 
acid inhibits self-intoxication by building a complex with calcium, which is necessary for the 
activity of the phospholipases.91 Histamine is a spreading factor; it facilitates toxin transport 
into the tissue by damaging capillary walls.99  
Inorganic ions, as well as several unidentified compounds were also detected by CE-
UV/DAD. In order to complete the investigation of the venom of Cupiennius salei CE-MS 
analysis of the LMW fractions would be necessary. 
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5 EXPERIMENTAL 
 
5.1 Materials 
 
Chromatographic analysis 
Dichloromethane Suprasolv (MERCK), made for gas chromatographic trace analysis, was 
used for analytical experiments in non-aqueous media was. 
Derivatization of natural samples prior GC analysis was carried out with N-methyl-N-
trimethylsilyltrifluoracetamide (MSTFA) (CE Chromatography Service).  For methylation the 
methanolic solution of trimethyl sulfonium hydroxide 0.25M (TMSH) (Fluka) or a self-made 
solution of diazomethane in dichloromethane was used (see section 5.3). 
HPLC grade hexane (ACROS or ROTH) was applied as mobile phase for HPLC separations 
during isolation of the C35 terpenes. 
 
Capillary electrophoresis experiments 
Deionized water of CE grade (Fluka) was used to prepare standard solutions, as well as to 
dilute venom samples. Stock solutions of both organic and inorganic ions and solutions for 
rinsing the capillary were made from substances of analytical purity. The  concentration of the 
stock solutions was 100 mM. Commercially available running buffers from Fluka were 
applied for the separation in anionic and cationic mode (section 4.3.2.2). 
 
Synthesis 
Reagents were purchased from different firms: ruthenium trichloride from Aldrich, Amberlyst 
from ACROS, sodium periodate from JANNSEN CHIMICA, periodic acid from MERCK, 
and (-)/(+)-citronellene from Fluka. Solvents were only distilled before use. Distilled water 
was used as reaction solvent or solvent in work-up procedures. Reactions were followed with 
thin-layer chromatography (TLC) on Polygram SIL G/UV254 plates from Machrey&Nagel; 
substances were detected with a UV lamp at 254 nm by immersion into the charring reagent. 
Flash gel chromatography was made on silica M60 (0.04-0.063 mm, 230-400 mesh ASTM) 
from Machrey&Nagel under pressure. 
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5.2 Instrumentation and equipment 
 
Derivatization 
Sample concentration and derivatization was carried out in a heating block (Lab-Line 
Instruments Inc.). A gentle stream of nitrogen was applied to evaporate residual solvents and 
by-products. 
 
Gas chromatographic analysis 
Gas chromatographic measurements were performed on a GCTop 8000 gas chromatograph, 
connected to an AS800 autosampler from ThermoQuest, with hydrogen as carrier gas. Flame 
ionization detection was used with nitrogen as make-up gas.  The carrier flow was usually set 
to 1 ml/min at 100oC, or else see actual description in the text. Data acquisition and evaluation 
was carried out by the software ChromCard 1.19 from ThermoQuest. 
 
Derivatized marine extracts were analyzed on the same BPX-5 (25 m x 0.25 mm x 0.25 µm) 
capillary from SGE Inc. under identical conditions. The split/splitless inlet was in splitless 
mode at a temperature of 250oC (split ratio 1:20 with valve time set to 0.75 min) and the FID 
operated at 280oC. The initial oven temperature was 50oC for 2 minutes followed by a slow 
ramp of 3 oC/min to the final temperature of 320oC. Retention time shifts were followed by 
regular analysis of a hydrocarbon standard mixture containing C11-C44 alkanes. 
 
Routine measurements as well as the analysis of reaction mixtures were carried out on an 
other BPX-5 (25 m x 0.25 mm x 0.25 µm) capillary with the inlet in split mode (1:20) and a 
normal ramp of 10 oC/min. Other parameters were identical to that described before. 
 
GC-MS analysis 
A GC 6890 was coupled to an MSD 5973 from Hewlett Packard to identify substances 
separated on a BPX-5 (25 m x 0.25 mm x 0.25 µm) capillary from SGE Inc. with helium as 
carrier gas and a constant flow rate of 1 ml/min. The split/splitless inlet was operated either in 
split (1:20) or in splitless mode (1:20, 0.75 min valve time) at 250oC. Samples were injected 
by a HP G1513A autosampler or manually. The oven program was the same as for GC. 
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Heated zones in the MS were set at 320oC, 230oC and 150oC for the transfer line, ion source 
and the quadrupoles, respectively. The ion source was used in EI+ mode at 70 eV. Zone 
temperature and final oven temperature values were lower when using a chiral capillary Data 
was recorded by the HP software ChemStation v. A.03.00, whereas data evaluation was 
carried out with various programs, such as MassLib, ChemStation Enhanced Data Analysis 
(HP) and NIST98. 
 
GC-IR analysis 
Infrared spectra of selected compounds were obtained on a HP GC 6890 system coupled with 
a HP 5965A infrared detector. Helium was the carrier gas at a constant flow of 2 ml/min. The 
capillary HP5 (30 m x 0.32 mm x 0.25 µm) was used. Samples were injected splitless (1:20, 
valve time 1 min). Data acquisition was performed by the software GRAMS/32 v. 4.14. 
 
HPLC analysis 
High-performance liquid chromatographic experiments were made on a Spectra System from 
ThermoQuest containing a P4000 pump, an AS3000 autosampler and an SN4000 diode array 
detector. A Superspher Si60 column (250 x 4 mm, 4 µm) from MERCK was used to separate 
the compounds with hexane as the mobile phase. Flow rate was set to 1 ml/min. Fractions 
were collected manually. ChromQuest 2.1 was used for data acquisition and analysis. 
 
Capillary electrophoresis experiments 
Spider venom samples and standards were analyzed on a P/ACE MDQ system from Beckman 
Coulter. The UV detector had a deuterium lamp and four filters with a wavelength of 200, 
214, 254 and 280 nm. The photo-diode-array (PDA) detector contained a deuterium and a 
mercury lamp providing a wavelength range of 190-600 nm. Measurement data were recorded 
and analyzed by the software 32Karat 4.0 (Beckman). An uncoated fused silica capillary 60.2 
cm x 0.75 mm i.d. (Beckman) was used with self-burned optical window at 10 cm from the 
outlet end. The capillary was maintained at 20 or 25oC, the samples at 20oC during 
measurements. The coolant liquid was a mixture of perfluoro compounds (C5-C18) from 
Beckman. 
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Nuclear magnetic resonance spectroscopy 
NMR spectra of synthesis products were obtained on a AC-200F (1H 200 MHz, 13C 50 MHz), 
for natural products on a DRX-400 (1H 400 MHz, 13C 100 MHz) instrument from BRUKER. 
The internal standard was tetramethylsilane.  
 
 
5.3 Procedures  
 
5.3.1 Derivatization methods 
 
Trimethylsilylation of marine extracts 
Samples were dissolved in dichloromethane to get similarly concentrated solutions, and 
transferred into a 1.5 ml-vial (CE Chromatography Service). 50 µl of the solution was mixed 
with 100 µl of MSTFA in a micro-insertion vial, closed tightly and maintained at 50oC for an 
hour. The rest of MSTFA and the solvent was evaporated at 50oC under a gentle stream of 
nitrogen. Samples were redissolved in dichloromethane. 
 
Methylation A 
TMSH converts aromatic alcohols to the methyl ether and acids as well as esters to the methyl 
ester.  To 50 µl of a sample 100 µl of the TMSH solution was added. The vial was closed 
tightly and kept at room temperature for 15 minutes. The rest of TMSH and the solvent was 
evaporated at 50oC under a gentle stream of nitrogen. The sample was redissolved in 
dichloromethane. 
 
Methylation B 
A self-made diazomethane solution was applied to derivatize organic acids in natural samples. 
Solution A was prepared from 1.71 g (8 mmol) Diazald (N-methyl-N-nitroso-p-
toluolsulfonamide) dissolved in 5 ml of a 1:1 mixture of diethyleneglycol-dimethylether 
:diethyl ether. 10 g of KOH was dissolved in a 1:1 mixture of water and methanol to give 
solution B. A volume of 0.5 ml of both solutions was added to a GC vial. The gaseous 
Experimental 
96
 
diazomethane was led through a buffer vial into 1 ml of dichloromethane in a third vial, which 
was cooled with ice. The vials were connected with teflon tubing, and a canulla served as an 
opening in the collection vial. Yellow coloring of the diazomethane solution showed 
saturation. It was stored in a refrigerator at 4oC for a week. 
Samples were titrated with small portions of the diazomethane solution until it became 
colorless. In the case of colorful samples an excess of diazomethane was used. The rest of 
diazomethane and the solvent was evaporated at 50oC under a gentle stream of nitrogen. 
Samples were redissolved in dichloromethane. 
 
Determination of double bond position 
The sample was dissolved in dichloromethane. To 50 µl of the solution was added 50 µl of 
dimethyl disulfide and 5 µl of 5% etherous iodine solution. The closed vial was kept at 60oC 
for a day. The cold mixture was diluted with 200 µl of dichloromethane. Iodine in excess was 
reduced by shaking the mixture with 200 µl of aqueous sodium sulfite solution. After 
separation of the phases, the solvent in the organic phase was evaporated in a gentle stream of 
nitrogen. The residue was redissolved in dichloromethane.  
 
Catalytic hydrogenation of double bonds in micro-scale 
The lipophilic sample was dissolved in 0.5 ml of isooctane in a GC vial with screw cap and a 
small magnetic stirrer. The experiment was carried out at room temperature under continuous 
stirring. A tiny portion of Pd/C (10%) was added with a spatula edge and the mixture was 
stirred for 10 minutes. Hydrogen was introduced into the vial via stainless steel tubing with a 
valve and a canulla at the end. A second canulla provided gas purge through the septum. The 
pressure was maintained at 0.1 bar for 45 minutes before removing the extra canulla. The 
hydrogen valve was closed and the reaction was stirred for another 15 minutes under 
hydrogen atmosphere. The mixture was filtrated through silica in a Pasteur-pipette, and the 
filtrate was concentrated under a gentle stream of nitrogen at 50oC. The residue was dissolved 
in dichloromethane. 
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5.3.2 Oxidative cleavage 
 
(R)-2-methyl-glutaric acid dimethyl ester (29a)50,59 
A solution of 1.73 g (8.1 mmol) of sodium-periodate (NaIO4) in 3 ml of water was stirred at 
room temperature for 20 minutes, which was followed by the addition of 2 ml of acetonitrile, 
2 ml of carbon tetrachloride and 180 µl (140 mg, 1 mmol) of (-)-(R)-citronellene. By 
introducing 4 mg (0.02 mmol, 2 mol%) of ruthenium trichloride hydrate (RuCl3.(H2O)n), the 
temperature was kept between 20-80oC with a water bath and the mixture became soon 
orange-brown. The reaction was followed with TLC and GC after micro-derivatization with 
TMSH. After 4 hours of vigorous stirring 10 ml of diethyl ether was added which caused a 
rush darkening of the mixture. The aqueous phase was acidified with 2N HCl solution and 
extracted 3 times with diethyl ether. The combined organic phases were washed with brine, 
dried over magnesium sulfate (MgSO4) and concentrated at 50oC under normal pressure. The 
residue was filtrated through a celite pad in vacuum (water pump), and the solvent was 
removed in vacuum. The crude product was used without purification for the next reaction. 
Methylation: The crude product was dissolved in 8 ml of methanol and 0.32 g of Amberlyst 
15 was added. The mixture was stirred vigorously at room temperature for a day. The resin 
was filtrated off and washed with diethyl ether. The mixture was concentrated in vacuum. The 
crude product was purified with flash chromatography on silica to give 10 mg (yield 6%) 
product.  
Spectroscopic data (MS, NMR) was identical to that in the literature.127,128 
 
(S)-2-methyl-glutaric acid dimethyl ester (29b) 
The same procedure was used as for the (R)-enantiomer, but with 180 µl (1 mmol) of (+)-(S)-
citronellene. The crude product was purified with flash chromatography on silica to give 9 mg 
(yield 5%) product.  
Spectroscopic data (MS, NMR) was identical to that in the literature.127,128 
 
Oxidative degradation of the natural product 26 
A mixture containing 0.5 mg (1 µmol) of the isolated natural product  
26, 8 mg (35 µmol, 35 equiv.) of H5IO6, 20 µl of acetonitrile, 20 µl of carbon tetrachloride, 
and 30 µl of distilled water was stirred 5 minutes in a GC vial at room temperature. Then a 
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minute amount of RuCl3.(H2O)n was introduced and the whole mixture was stirred 5 hour 
long. After shaking with 200 µl of dichloromethane (Suprasolv, MERCK) and 200 µl of 
brine, the phases were separated. The organic phase was concentrated in a gentle stream of 
nitrogen at 30oC and derivatized with a solution of diazomethane. The solvent was evaporated 
and the residue was dissolved in dichloromethane. 
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6 ABBREVIATIONS 
 
 
2D two dimensional 
ACP acyl carrier protein 
APCI atmospheric pressure chemical ionization 
BGE background electrolite 
BSTFA N,O-bis(trimethylsilyl)trifluoracetamide 
CA cluster analysis 
CE capillary electrophoresis 
d doublet 
DB double bond 
DBE double bond equivalent 
DMDS dimethyldisulfide 
EI electron impact 
EOF electroosmotic flow 
ESI electrospray 
Et ethyl 
FA fatty acid 
FAS fatty acid synthase 
FID flame ionization detector 
FPP farnesyl pyrophosphate 
GC gas chromatography 
GC-HRMS gas chromatography high-resolution mass spectrometry 
GC-MS gas chromatography mass spectrometry 
GGPP geranylgeranyl pyrophosphate 
HBI highly-branched isoprenoid 
HCA hierarchical cluster analysis 
HMBC hetero multiple bond correlation 
HPCE high-performance capillary electrophoresis 
HPLC high-performance liquid chromatography 
HPLC-MS high-performance liquid chromatography mass spectrometry 
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HR-MS high-resolution mass spectrometry 
HSQC heteronuclear single quantum coherence 
i.d. internal diameter 
J coupling constant 
LMW low-molecular weight 
m multiplet 
M molecular ion 
Me methyl 
MSTFA N-methyl-N-trimethylsilyltrifluoroacetamide 
m/z mass per charge ratio 
NMR nuclear magnetic resonance 
PCA principle component analysis 
PDA photo diode-array 
Pd/C palladium on activated charcoal 
PKS polyketide synthase 
R alkyl chain 
RI retention index 
s singulet 
SIM single ion monitoring 
SPSS statistical software 
t tirplet 
TIC total ion chromatogram 
TMS trimethylsilyl 
TMSH trimethylsulfonium hydroxide 
UV ultraviolet 
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8 APPENDIX 
8.1 Mass spectra 
8.1.1 Artifacts 
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Fig. 8.1  Tris-(2,4-di-tertbutylphenyl)-phosphate (19a), M662, from 1/Hel39. 
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  Fig.8.2  Tris-(2,4-di-tertbutylphenyl)-phosphite (19b), M646, from 1/Hel12. 
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8.1.2 Diketopiperazines 
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  Fig. 8.3  cyc(Ile-Pro) (20), M210, from Hel26. 
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  Fig. 8.4  cyc(Leu-Pro), M210, from Hel26. 
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  Fig 8.5  cyc(Phe-Pro), M244, from Hel26. 
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8.1.3 Amides 
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  Fig. 8.6  N-acetyltryptamine (23), M202, from ANT253(RE). 
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  Fig. 8.7  N-palmitoyl-2-phenylethylamine (24), M359, from  Pic006. 
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  Fig. 8.8  N-stearoylpiperidine (25), M351, from Hel45. 
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8.1.4 Hexanetriols 
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  Fig. 8.9  Hexantriol (30), M414, RI 2801, from 1/IHg,3. 
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  Fig. 8.10  Hexantriol (31), M442, RI 2999, from 1/IHg,3. 
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  Fig. 8.11  Hexantriol (32), M512, RI 3149, from 1/IHg,3.  
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8.1.5 Long-chain ketones and alkenes 
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  Fig. 8.12  Hexantriol (35), M596, RI 3709, from 1/IHg,3. 
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  Fig. 8.13 15-nonacosanone (41), RI 3088, isolated from cabbage.  
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  Fig. 8.14  2,26-dimethyl-14-heptacosanone (40a), RI 3008, from the extract Bio1 
  (m/z  211 and 239 are probably from 2,26-dimethyl-13-heptacosanone). 
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  Fig. 8.15  2,25-dimethyl-14-heptacosanone (40b), RI 3019, from the extract Bio1. 
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  Fig. 8.16  3,25-dimethyl-14-heptacosanone (40c), RI 3031, from the extract Bio1. 
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  Fig. 8.17  2,24-dimethyl-12-pentacosene (43a), RI 2585, from the extract Bio1. 
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8.1.6 Cyclic polysulfides 
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  Fig. 8.19  Cyclic polysulfide (46), M152, RI 1175, from the extract Bio137. 
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  Fig. 8.20  Cyclic polysulfide (47a), M208, RI 1472, from the extract Bio137. 
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Fig. 8.18  2,23-dimethyl-12-pentacosene (43b), RI 2595, from the extract Bio1. 
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  Fig. 8.21  Cyclic polysulfide (47b), M208, RI 1516, from the extract Bio137. 
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  Fig. 8.22  Cyclic polysulfide (48a), M240, RI 1727, from the extract Bio137. 
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Fig. 8.23  Cyclic polysulfide (48b), M240, RI 1748, from the extract Bio137. 
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8.1.7 Isomeric lactones 
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  Fig. 8.24  Lactone (50a), M209, RI 1442, from the extract Hel59 5L. 
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  Fig. 8.25  Lactone (50b), M209, RI 1462, from the extract Hel59 5L. 
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  Fig. 8.26  Lactone (49a), M209, RI 1454, from the extract Hel59 5L. 
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  Fig. 8.27  Lactone (49b), M209, RI 1468, from the extract Hel59 5L. 
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8.2 GC-IR spectra 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8.28  Gas-phase IR spectrum of  3,25-dimethyl-13-heptacosene (45c), RI 2803, 
from  Pic006. 
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            Fig. 8.29  Gas-phase IR spectrum of  lactone 49a, RI 1454, from 1/AMP,3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                Fig. 8.30  Gas-phase IR spectrum of  lactone 49b, RI 1468, from 1/AMP,3. 
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Fig. 8.31  TIC of IHg,3 (Cytophaga sp.); (1) dibutylphthalate, (2) bis-(2-ethylhexyl)-phthalate,  (3) hexanetriol 30-
TMS, (4) hexanetriol 31-TMS, (5) hexanetriol 32, (6) hexanetriol 33, (7) hexanetriol 34, (8) hexanetriol 35. 
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Fig. 8.32  TIC of 1/AMP,3 (Cytophaga sp.); (1) 2-phenylacetic acid TMS ester, 22-TMS (2) lactone 49a, (3) lactone 
49b, (4) methyl 13-methylmyristate, (5) methyl 12-methylmyristate, (6) 13-methylmyristic acid TMS-ester, (7) 12-
methylmyristic acid TMS ester, (8) cyc(Pro-Pro), (9) 14-methylpalmitic acid TMS ester, (10) C35 terpene 26, (11) 
C35 terpene 27. 
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Fig. 8.33  TIC of Bio1 (Cytophaga sp.); (1) 2-phenylacetic acid TMS ester, 22-TMS, (2) cyc(Ala-Pro), ethyl myristate 
in trace, (3) cyc(Pro-Val) 1., ethyl pentadecanoate in trace, (4) cyc(Pro-Val) 2., (5) cyc(Ile-Pro) 1., (6) dibuthyl-
phthalate, cyc(Leu-Pro) 1., (7) cyc(Leu-Pro) 2., cyc(Ile-Pro) 2., (8) ethyl palmitate, (9) cyc(Phe-Pro) 1., 9-octadecen-
amide (2 isomers), bis-(2-ethylhexyl)-adipate, (10) cyc(Phe-Pro) 2., (11) alkenes 42a, b, (12) bis-(2-ethylhexyl)-
phthalate, (13) alkenes 43a, b, c, (14) ketones 36b, c, (15) alkenes 44a, b, (16) ketones 37a, b, (17) alkenes 45a, b, c, 
(18) ketones 38a, b, c, (19) ketones 39b, c, (20) ketones 40a, b, c, (21) glycerin esters. For compounds 36-40 and 42-
45 see Table 3.12. 
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Fig. 8.34  TIC of Bio137 (Cytophaga sp.); (1) 2-methylbutanoic acid TMS ester, (2) 3-methylbutanoic acid TMS ester, (3) 2-
methylbutenoic acid TMS ester, (4) 3-methylbutenoic acid TMS ester, (5) cyclic polysulfide 46, (6) (2-phenyl-ethyl)-amine, (7), 
cyclic polysulfide 47a, (8) N-(2-phenylethyl)-formamide, (9) cyclic polysulfide 47b, (10) N-acetyl-(2-phenylethyl)-amine, 16a, 
(11) 13-methyl-3-tetradecanone, (12) cyclic polysulfide 48a, (13) cyc(Ala-Pro), (14) cyclic polysulfide 48b, (15) 2-hexadecanone, 
(16) methyl 13-methylmyristate, (17) cyc(Pro-Val) 1., (18) ethyl 13-methylmyristate, (19) cyc(Pro-Val) 2., (20) ethyl 
pentadecanoate, (21) methyl palmitate, (22) cyc(Ile-Pro) 1., (23) cyc(Leu-Pro) 1., (24) cyc(Leu-Pro) 2., cyc(Ile-Pro) 2., ethyl 
hexadecenoate, (25) ethyl heptadecenoate, (26) methyl octadecenoate, (27) N-acetyltryptamine, 23, (28) cyc(Met-Pro) 1., (29) 
cyc(Met-Pro) 2., (30) cyc(Phe-Pro) 1., (31,32) 9-octadecenamide, (33) cyc(Phe-Pro) 2., (34) bis(2-ethylhexyl)-phthalate, (35) 
bis(2-ethylhexyl)-adipate. 
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8.4 Dendograms 
 
 
Marked sample names 
 
Dendogram 8.1-8.12: gray: group of similar samples or single outliers (alkane 
standard) that do not belong to the data set, 
 
Dendogram 8.3-8.12: underlined: sample analyzed by GC-MS, 
    italics:  injection and/or derivatization control sample, 
    *:  sample fermented more times, 
    Ros:  Roseobacter sp., 
 
Dendogram 8.11, 8.12: bold: sample contains the C35 terpenes 26 and 27. 
 
 
 
Substance codes 
 
Examples C16:0-(O)OH:  palmitic acid, 
3-OH-15-Me-C16:0-Me: methyl 3-hydroxy-15-methylpalmitate, 
9-C18:1-NH2:   9-octadecenamide, 
FA-Et:    fatty acid ethyl ester. 
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Dendogram 8.1  Parallel fermentation data set; HCA, average linkage, quadratic Euclidean distance.  
 
 
                                     Rescaled Distance Cluster Combine 
 
          C A S E            0         5        10        15        20        25 
  Label                 Num  +---------+---------+---------+---------+---------+ 
 
  102|1/IHg,4            32   òø 
  129|1/IHg,3            34   òôòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòø 
  90|1/ACF,5             33   ò÷                                         ó 
  563|Pic009 F            4   òòòòòø                                     ó 
  579|IHg,4 F            20   òòòòòôòòòòòòòòòø                           ó 
  586|Hel38 F            27   òòòòò÷         ó                           ó 
  564|K- A                5   òòòòòûòòòø     ó                           ó 
  571|Ihg,3 F            12   òòòòò÷   ùòòòø ùòø                         ó 
  584|Hel38 A            25   òòòòòòòûò÷   ó ó ó                         ó 
  585|Hel38 E            26   òòòòòòò÷     ó ó ó                         ó 
  583|Pic006 F           24   òòòòòòòø     ùò÷ ó                         ó 
  589|Hel59 A            30   òòòòòòòôòòòòòú   ó                         ó 
  569|Ihg,3 C            10   òòòòòòò÷     ó   ó                         ó 
  575|Hel73 F            16   òòòòòòòûòø   ó   ó                         ó 
  317|Alkane std.        37   òòòòòòò÷ ùòø ó   ó                         ó 
  582|Pic006 E           23   òòòòòòòòò÷ ó ó   ó                         ùòòòòòø 
  265|Pic019             35   òûòòòòòòòòòôò÷   ó                         ó     ó 
  283|Pic016             36   ò÷         ó     ó                         ó     ó 
  566|K- E                7   òòòòòûòòòòòú     ó                         ó     ó 
  587|Hel59 C            28   òòòòò÷     ó     ùòø                       ó     ó 
  565|K- C                6   òòòòòûòø   ó     ó ó                       ó     ó 
  588|Hel59 E            29   òòòòò÷ ó   ó     ó ó                       ó     ó 
  567|K- F                8   òòòòòòòôòø ó     ó ó                       ó     ó 
  572|Hel73 A            13   òòòòòòò÷ ó ó     ó ó                       ó     ó 
  574|Hel73 E            15   òòòòòûòø ó ó     ó ó                       ó     ó 
  578|IHg,4 E            19   òòòòò÷ ó ó ó     ó ó                       ó     ó 
  568|Ihg,3 A             9   òø     ùòú ó     ó ùòòòòòòòòòòòòòø         ó     ó 
  576|IHg,4 A            17   òôòø   ó ùò÷     ó ó             ó         ó     ó 
  577|IHg,4 C            18   ò÷ ùòø ó ó       ó ó             ó         ó     ó 
  570|Ihg,3 E            11   òòò÷ ùò÷ ó       ó ó             ó         ó     ó 
  580|Pic006 A           21   òòòòò÷   ó       ó ó             ùòòòòòòòòò÷     ó 
  559|Pic009 A            1   òòòòòòòòò÷       ó ó             ó               ó 
  590|Hel59 F            31   òòòòòòòòòòòòòòòòò÷ ó             ó               ó 
  561|Pic009 C            2   òòòòòòòòòòòòòòòòòòò÷             ó               ó 
  562|Pic009 E            3   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷               ó 
  573|Hel73 C            14   òûòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ 
  581|Pic006 C           22   ò÷ 
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Dendogram 8.2  Parallel fermentation data set; PCA/HCA, 75% of the variance extracted, average 
linkage, quadratic Euclidean distance. 
 
 
                                     Rescaled Distance Cluster Combine 
 
          C A S E            0         5        10        15        20        25 
  Label                 Num  +---------+---------+---------+---------+---------+ 
 
  102|1/IHg,4            32   òûòòòòòø 
  129|1/IHg,3            34   ò÷     ùòòòòòòòòòòòø 
  90|1/ACF,5             33   òòòòòòò÷           ó 
  564|K- A                5   òòòòòûòòòòòòòòòòòø ó 
  571|Ihg,3 F            12   òòòòò÷           ó ó 
  576|IHg,4 A            17   òø               ó ùòòòø 
  577|IHg,4 C            18   òú               ó ó   ó 
  568|Ihg,3 A             9   òôòòòòòòòø       ó ó   ó 
  570|Ihg,3 E            11   òú       ó       ó ó   ó 
  578|IHg,4 E            19   ò÷       ó       ó ó   ó 
  566|K- E                7   òûòòòø   ùòòòòòø ùò÷   ó 
  567|K- F                8   ò÷   ó   ó     ó ó     ó 
  563|Pic009 F            4   òòòø ó   ó     ó ó     ó 
  579|IHg,4 F            20   òòòôòú   ó     ó ó     ó 
  565|K- C                6   òòò÷ ùòòò÷     ó ó     ó 
  573|Hel73 C            14   òø   ó         ó ó     ó 
  581|Pic006 C           22   òôòòòú         ó ó     ó 
  583|Pic006 F           24   ò÷   ó         ó ó     ó 
  569|Ihg,3 C            10   òòòûò÷         ùò÷     ùòø 
  584|Hel38 A            25   òòò÷           ó       ó ó 
  580|Pic006 A           21   òòòòòòòòòòòòòòòú       ó ó 
  589|Hel59 A            30   òòòòòòòòòòòòòòò÷       ó ó 
  562|Pic009 E            3   òòòòòòòòòòòòòòòòòòòòòòòú ùòòòòòø 
  574|Hel73 E            15   òòòòòûòòòòòòòòòòòø     ó ó     ó 
  585|Hel38 E            26   òòòòò÷           ùòòòòò÷ ó     ó 
  575|Hel73 F            16   òòòòòòòòòòòòòòòòò÷       ó     ùòø 
  587|Hel59 C            28   òòòòòòòòòòòòòòòûòòòòòòòòò÷     ó ó 
  588|Hel59 E            29   òòòòòòòòòòòòòòò÷               ó ùòø 
  265|Pic019             35   òòòòòòòòòòòòòòòòòòòòòûòòòòòòòòò÷ ó ó 
  283|Pic016             36   òòòòòòòòòòòòòòòòòòòòò÷           ó ùòòòø 
  586|Hel38 F            27   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ó   ùòòòø 
  582|Pic006 E           23   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷   ó   ùòòòø 
  561|Pic009 C            2   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷   ó   ùòø 
  559|Pic009 A            1   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷   ó ó 
  317|Alkane std.        37   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ó 
  590|Hel59 F            31   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòú 
  572|Hel73 A            13   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ 
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Dendogram 8.3  Subset STM2; HCA, Average linkage, quadratic Euclidean distance 
 
 
                                     Rescaled Distance Cluster Combine 
 
          C A S E            0         5        10        15        20        25 
  Label                 Num  +---------+---------+---------+---------+---------+ 
 
  102|1/IHg,4            48   òûòø 
  129|1/IHg,3            74   ò÷ ùòòòø 
  90|1/ACF,5*            37   òòò÷   ó 
  98|HKI 129-1           45   òûòø   ùòòòòòø 
  146|HKI 129-2          90   ò÷ ùòòòú     ó 
  93|1/AM13,1            40   òòò÷   ó     ó 
  89|1/ACF,8-1           36   òòòòòòò÷     ó 
  78|1/Hel18             25   òòòûòòòòòø   ó 
  92|1/Hel19             39   òòò÷     ó   ó 
  12|1/115ba              3   òòòø     ó   ó 
  95|1//0025             42   òòòôòø   ó   ó 
  106|1/AMP3             52   òòò÷ ó   ó   ó 
  101|1/H135ba           47   òòòòòôòø ó   ó 
  118|B1616              63   òòòòò÷ ó ó   ó 
  103|1/HKI136L          49   òòòòòûòú ó   ó 
  115|HKI135L            60   òòòòò÷ ó ùòø ó 
  117|1/MPep,2           62   òòòûòòòôòú ó ó 
  135|1/ACP,4LB          80   òòò÷   ó ó ó ó 
  14|1/Hel30              5   òûòø   ó ó ó ó 
  5|1/Icy,2              12   ò÷ ó   ó ó ó ó 
  141|1/KCy,10           86   òòòôòø ó ó ó ó 
  131|1/Hel13            76   òòò÷ ùòú ó ó ó 
  96|1/GCy,1             43   òòòòòú ó ó ó ó 
  134|1/ACP,4            79   òòòòò÷ ó ó ó ó 
  7|1/Hel27              14   òòòòòòò÷ ó ó ó 
  119|1//0004            64   òòòø     ó ó ó 
  136|1/Hel24            81   òòòôòø   ó ó ó 
  13|1//0024              4   òòò÷ ó   ó ó ó 
  3|1/Hel36              10   òø   ó   ó ó ó 
  145|1//0001            89   òú   ùòø ó ùòú 
  87|1/Hel14             34   òú   ó ó ó ó ó 
  9|1//0005              16   òôòø ó ó ó ó ó 
  121|1/Bio32            66   ò÷ ùò÷ ó ó ó ó 
  114|3497-50l,Fetts.    59   òòò÷   ùò÷ ó ó 
  97|1/CCy,8 Hfl         44   òòòûòòòú   ó ó 
  116|1/NM13,1/Hfl       61   òòò÷   ó   ó ó 
  15|1/Hel28              6   òûòø   ó   ó ó 
  6|1/Hel34              13   ò÷ ó   ó   ó ó 
  18|1/Hel33              8   òûòôòø ó   ó ùòòòø 
  107|1/Hel37            53   ò÷ ó ó ó   ó ó   ó 
  110|ACF,8              56   òòòú ùò÷   ó ó   ó 
  88|1/GT161b            35   òòò÷ ó     ó ó   ó 
  76|1/Hel41             23   òòòòò÷     ó ó   ó 
  104|1/Am13,2           50   òòòòòòòòòòò÷ ó   ó 
  130|1/GCy,5-1          75   òòòòòòòûòòòòòú   ó 
  142|1/OM13,5           87   òòòòòòò÷     ó   ó 
  82|1/ACF,8-5           29   òòòûòòòø     ó   ó 
  99|1/CCy,8-1           46   òòò÷   ùòòòòò÷   ó 
  86|1/CCy,8             33   òòòòòòò÷         ó 
  8|1/Bie68aa der.I      15   òòòòòòòòòûòòòòòòòú 
  125|1/GCy,5-3          70   òòòòòòòòò÷       ùòø 
  10|1/Hel35              1   òòòòòòòòòûòòòòòòòú ó 
  74|1/Hel25             21   òòòòòòòòò÷       ó ó 
  113|Hel11,zellen       58   òòòòòòòòòòòòòòòòò÷ ó 
Hexanetriols 30-35 
Lactones 49a and 49b, C35 
terpenes 26 and 27 
Phosphate artifact 19a 
C16:0-OH, C16:0-(O)OH, C16:1-(O)OH 
Long-chain FA esters 
 
S
O
OH
 
Hexanetriols 30-35 
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Dendogram 8.3  Continued. 
   
  83|1/GCy,5             30   òòòòòòòòòòòòòòòòòòòôòø 
  123|1/FPep,1           68   òûòø               ó ó 
  138|1/Hel38            83   ò÷ ùòòòø           ó ó 
  122|1/Ocy,5            67   òòò÷   ùòòòòòòòòòòò÷ ó 
  70|1/Hel29             17   òòòûòòò÷             ó 
  81|1/Ocy,8             28   òòò÷                 ó 
  132|1/KCy,14           77   òø                   ùòø 
  150|1/ST204b           94   òôòòòòòòòòòòòòòø     ó ó 
  139|1/ACF,8-3          84   ò÷             ó     ó ó 
  108|1/ST204a           54   òòòûòòòø       ó     ó ó 
  109|1/Bio35            55   òòò÷   ùòø     ó     ó ó 
  73|1/Ncy,3             20   òòòòòòò÷ ó     ó     ó ó 
  17|1/Hel17              7   òòòûòòòø ùòòòø ùòòòòò÷ ó 
  2|1/Hel12               9   òòò÷   ó ó   ó ó       ó 
  126|1/ACF,5*           71   òûòòòø ó ó   ó ó       ó 
  137|1/Hg,4             82   ò÷   ó ùò÷   ó ó       ó 
  140|1/Bio34            85   òûòø ó ó     ó ó       ó 
  148|1/ACF,5 Hfl        92   ò÷ ó ó ó     ùò÷       ó 
  147|1/Bio43            91   òòòôòú ó     ó         ó 
  128|1/ICy,7            73   òûòú ùò÷     ó         ó 
  149|1/OCy,4            93   ò÷ ó ó       ó         ó 
  71|1/Hel15             18   òòò÷ ó       ó         ó 
  105|1/Hel31            51   òòòòò÷       ó         ó 
  91|1/Amp,2             38   òòòòòòòòòòòòò÷         ùòø 
  80|1/GW73a             27   òòòûòø                 ó ó 
  124|1/Hel135bb         69   òòò÷ ùòòòòòòòø         ó ó 
  4|1/Bie68aa            11   òòòòò÷       ùòòòòòòòòòú ó 
  11|1/91bb               2   òòòòòòòûòòòòò÷         ó ó 
  120|1/GT161a           65   òòòòòòò÷               ó ùòòòòòòòø 
  77|1/107aa             24   òòòø                   ó ó       ó 
  111|1/107ba            57   òòòôòòòòòòòòòòòòòø     ó ó       ó 
  127|1/101ba            72   òòò÷             ùòòòòò÷ ó       ó 
  72|1/115aa             19   òòòòòòòòòòòòòòòòò÷       ó       ùòòòø 
  75|1/Hel23             22   òûòòòòòø                 ó       ó   ó 
  79|1/Hel32             26   ò÷     ùòòòòòòòòòòòòòòòòò÷       ó   ó 
  84|1/Lox155ab          31   òòòòòûò÷                         ó   ùòòòòòòòòòòòø 
  94|1/Hel26 Ros         41   òòòòò÷                           ó   ó           ó 
  144|1/MCy,4            88   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷   ó           ó 
  133|1/ACF,5-5          78   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷           ó 
  85|1/GWGO/1571         32   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ 
9-C18:1-NH2 
C16:0-NH2, 9-C18:1-NH2, 
C16:0-iPr 
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Dendogram 8.4  Subset STM2; PCA/HCA, 79% of the variance extracted, average linkage, quadratic 
Euclidean distance. 
 
                                     Rescaled Distance Cluster Combine 
 
          C A S E            0         5        10        15        20        25 
  Label                 Num  +---------+---------+---------+---------+---------+ 
 
  102|1/IHg,4            48   òø 
  129|1/IHg,3            74   òôòòòòòòòòòòòø 
  90|1/ACF,5*            37   ò÷           ùòòòø 
  142|1/OM13,5           87   òòòòòòòòòòòòò÷   ó 
  77|1/107aa             24   òûòòòø           ó 
  111|1/107ba            57   ò÷   ùòòòòòø     ó 
  127|1/101ba            72   òòòòò÷     ùòòòòòú 
  72|1/115aa             19   òòòòòòòòòòò÷     ó 
  4|1/Bie68aa            11   òòòòòûòòòòòø     ó 
  109|1/Bio35            55   òòòòò÷     ùòø   ó 
  8|1/Bie68aa der.I      15   òòòòòòòòòòò÷ ó   ó 
  140|1/Bio34            85   òòòòòòòûòòòòòôòòòú 
  147|1/Bio43            91   òòòòòòò÷     ó   ó 
  96|1/GCy,1             43   òòòûòòòø     ó   ó 
  128|1/ICy,7            73   òòò÷   ùòòòø ó   ó 
  149|1/OCy,4            93   òòòòòòò÷   ó ó   ó 
  86|1/CCy,8             33   òòòûòòòòòòòú ó   ó 
  125|1/GCy,5-3          70   òòò÷       ùò÷   ó 
  75|1/Hel23             22   òø         ó     ùòø 
  79|1/Hel32             26   òôòòòø     ó     ó ó 
  107|1/Hel37            53   ò÷   ó     ó     ó ó 
  10|1/Hel35              1   òø   ùòòòø ó     ó ó 
  74|1/Hel25             21   òôòø ó   ó ó     ó ó 
  105|1/Hel31            51   ò÷ ùò÷   ó ó     ó ó 
  70|1/Hel29             17   òòò÷     ó ó     ó ó 
  14|1/Hel30              5   òòòòòûòòòú ó     ó ó 
  9|1//0005              16   òòòòò÷   ùò÷     ó ó 
  87|1/Hel14             34   òûòø     ó       ó ó 
  136|1/Hel24            81   ò÷ ùòòòø ó       ó ó 
  6|1/Hel34              13   òòò÷   ó ó       ó ó 
  119|1//0004            64   òòòòòòòú ó       ó ó 
  80|1/GW73a             27   òûòø   ó ó       ó ó 
  108|1/ST204a           54   ò÷ ó   ó ó       ó ó 
  3|1/Hel36              10   òûòú   ó ó       ó ó 
  121|1/Bio32            66   ò÷ ó   ó ó       ó ó 
  93|1/AM13,1            40   òòòôòø ó ó       ó ó 
  91|1/Amp,2             38   òûòú ó ó ó       ó ó 
  137|1/Hg,4             82   ò÷ ó ó ó ó       ó ó 
  126|1/ACF,5*           71   òòòú ùòú ó       ó ó 
  117|1/MPep,2           62   òòòú ó ó ó       ó ó 
  82|1/ACF,8-5           29   òòò÷ ó ùò÷       ó ó 
  94|1/Hel26 Ros         41   òòòûòú ó         ó ó 
  101|1/H135ba           47   òòò÷ ó ó         ó ó 
  131|1/Hel13            76   òòòòò÷ ó         ó ó 
  132|1/KCy,14           77   òø     ó         ó ó 
  150|1/ST204b           94   òôòòòø ó         ó ó 
  139|1/ACF,8-3          84   ò÷   ó ó         ó ó 
  84|1/Lox155ab          31   òø   ó ó         ó ó 
  88|1/GT161b            35   òôòø ó ó         ó ó 
  97|1/CCy,8 Hfl         44   ò÷ ó ùòú         ó ó 
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Dendogram 8.4  Continued. 
   
  81|1/Ocy,8             28   òø ó ó ó         ó ùòø 
  122|1/Ocy,5            67   òú ó ó ó         ó ó ó 
  123|1/FPep,1           68   òôòú ó ó         ó ó ó 
  120|1/GT161a           65   òú ùò÷ ó         ó ó ó 
  124|1/Hel135bb         69   ò÷ ó   ó         ó ó ó 
  76|1/Hel41             23   òûòú   ó         ó ó ó 
  138|1/Hel38            83   ò÷ ó   ó         ó ó ó 
  18|1/Hel33              8   òòòú   ó         ó ó ùòø 
  2|1/Hel12               9   òòò÷   ó         ó ó ó ó 
  95|1//0025             42   òòòòòòò÷         ó ó ó ó 
  83|1/GCy,5             30   òòòòòòòòòòòòòòòòò÷ ó ó ó 
  89|1/ACF,8-1           36   òòòòòòòòòòòòòòòòòòòú ó ó 
  114|3497-50l,Fetts.    59   òòòòòòòòòòòòòòòòòûò÷ ó ó 
  145|1//0001            89   òòòòòòòòòòòòòòòòò÷   ó ó 
  17|1/Hel17              7   òòòòòòòòòòòûòòòòòòòòò÷ ùòø 
  92|1/Hel19             39   òòòòòòòòòòò÷           ó ó 
  11|1/91bb               2   òòòòòòòòòûòòòòòòòòòòòòòú ó 
  15|1/Hel28              6   òòòòòòòòò÷             ó ó 
  7|1/Hel27              14   òòòòòòòòòòòòòòòûòòòòòòò÷ ó 
  135|1/ACP,4LB          80   òòòòòòòòòòòòòòò÷         ùòø 
  110|ACF,8              56   òòòòòòòòòòòòòûòòòòòòòòòòòú ó 
  141|1/KCy,10           86   òòòòòòòòòòòòò÷           ó ó 
  106|1/AMP3             52   òòòòòòòòòòòòòòòòòòòòòòòòò÷ ó 
  113|Hel11,zellen       58   òòòòòòòòòòòòòòòòòûòòòòòòòòòôòø 
  118|B1616              63   òòòòòòòòòòòòòòòòò÷         ó ó 
  73|1/Ncy,3             20   òòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ó 
  98|HKI 129-1           45   òòòòòûòòòòòòòòòòòòòòòòòòòòòòòôòø 
  146|HKI129-2           90   òòòòò÷                       ó ùòø 
  5|1/Icy,2              12   òòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ó ó 
  116|1/NM13,1/Hfl       61   òòòòòòòòòòòòòòòòòòòûòòòòòòòòòòò÷ ùòø 
  148|1/ACF,5 Hfl        92   òòòòòòòòòòòòòòòòòòò÷             ó ó 
  71|1/Hel15             18   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòûò÷ ó 
  104|1/Am13,2           50   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷   ó 
  134|1/ACP,4            79   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòôòø 
  133|1/ACF,5-5          78   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòú ùòòòø 
  85|1/GWGO/1571         32   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ó   ùòø 
  12|1/115ba              3   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷   ó ùòø 
  144|1/MCy,4            88   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ó ó 
  13|1//0024              4   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ùòø 
  103|1/HKI136L          49   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòú ùòø 
  78|1/Hel18             25   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ó ó 
  99|1/CCy,8-1           46   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ó 
  115|HKI135L            60   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòú 
  130|1/GCy,5-1          75   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷   
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Dendogram 8.5  Subset STM3; HCA, Average linkage, quadratic Euclidean distance. 
 
 
                                     Rescaled Distance Cluster Combine 
 
          C A S E            0         5        10        15        20        25 
  Label                 Num  +---------+---------+---------+---------+---------+ 
 
  151|1/AMP,2             2   òø 
  186|GW14/587           36   òú 
  175|1/Hel39            25   òú 
  150|1/ST204b            1   òôòø 
  187|GW64/1571a         37   òú ó 
  161|Bio43 (1mg)        11   òú ó 
  233|Hel57a (1mg)       79   ò÷ ó 
  195|Bio28 (1mg)        43   òòòú 
  154|1/ACy,4             5   òûòú 
  173|1/Ccy,8            23   ò÷ ùòòòòòòòòòø 
  220|Bio33 (1mg)        66   òòòú         ó 
  169|MBSohiobol         19   òòò÷         ó 
  165|Hel53a (2mg)       15   òø           ó 
  222|Hel72 (5mg)        68   òôòø         ùòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòø 
  223|Hel48b/4.5 (2mg)   69   ò÷ ó         ó                                   ó 
  153|1/90aa              4   òòòôòø       ó                                   ó 
  225|Bio30 (2mg)        71   òòò÷ ùòòòø   ó                                   ó 
  184|Hel66b (4mg)       34   òòòòò÷   ùòø ó                                   ó 
  188|Bio38 (1mg)        38   òòòòòûòòò÷ ùò÷                                   ó 
  226|ACF,8-5 (1mg)      72   òòòòò÷     ó                                     ó 
  170|Hel59b (4mg)       20   òòòòòòòòòòò÷                                     ó 
  196|GW24/1838(rot)     44   òòòòòûòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòø ó 
  229|Bio26 (4mg)        75   òòòòò÷                                         ó ó 
  179|Bio19 (4mg)        29   òòòòòòòòòûòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòø     ó ó 
  238|ANT321 (2mg)       83   òòòòòòòòò÷                               ó     ó ó 
  182|Ccy,8-5 (2mg)      32   òòòòòûòø                                 ó     ó ó 
  193|Bio41 (4mg)        41   òòòòò÷ ùòòòòòòòòòòòòòòòòòòòø             ó     ó ó 
  230|Bio14 (2mg)        76   òòòòòòò÷                   ùòòòòòø       ó     ó ó 
  227|ANT253(RE)         73   òòòòòòòòòòòòòòòòòòòòòòòòòòò÷     ó       ó     ó ó 
  202|ANT323 (2mg)       49   òòòûòòòòòòòø                     ó       ó     ó ó 
  215|ANT46 (2mg)        61   òòò÷       ùòòòòòòòòòòòòòòòòòø   ó       ó     ó ó 
  102|1/IHg,4            88   òûòòòø     ó                 ó   ó       ó     ó ó 
  129|1/IHg,3            89   ò÷   ùòòòòò÷                 ó   ó       ó     ó ó 
  90|1/ACF,5             90   òòòòò÷                       ó   ó       ó     ó ó 
  183|Bio11 (1mg) Ros    33   òòòòòòòòòòòòòûòòòòòòòòòø     ó   ó       ó     ó ó 
  207|Hel63b (7mg)       53   òòòòòòòòòòòòò÷         ó     ó   ó       ó     ùò÷ 
  178|Bio25 (2mg)        28   òòòòòòòòòûòø           ó     ó   ó       ó     ó 
  206|Bio15 (4mg)        52   òòòòòòòòò÷ ùòòòòòòòòòø ó     ó   ó       ó     ó 
  158|1/Bio46             9   òòòòòòòòòòò÷         ó ó     ó   ó       ó     ó 
  208|Bio24 (1mg) Ros    54   òòòòòòòûòø           ó ó     ó   ó       ó     ó 
  228|Bio42(1mg)         74   òòòòòòò÷ ùòòòø       ó ó     ó   ó       ó     ó 
  156|1/GCy,5Hfl          7   òòòòòòòòò÷   ùòòòòòø ó ó     ó   ó       ó     ó 
  166|Hel68 (3mg)        16   òòòòòòòòòòòòò÷     ó ó ó     ó   ó       ó     ó 
  191|Bio16 (1mg)        40   òòòòòûòòòòòø       ó ó ùòø   ó   ó       ó     ó 
  221|Hel46b (1mg) Ros   67   òòòòò÷     ó       ó ó ó ó   ó   ó       ó     ó 
  190|Bio9 (1mg)         39   òòòòòòòòòòòú       ó ó ó ó   ó   ó       ó     ó 
  167|GW24/1694          17   òòòòòûòø   ó       ó ó ó ó   ó   ùòø     ó     ó 
  211|Bio7 (1mg) Ros     57   òòòòò÷ ùòø ó       ó ó ó ó   ó   ó ó     ó     ó 
  236|Hel51b (4mg)       81   òòòòòòò÷ ó ùòòòø   ó ó ó ó   ó   ó ó     ó     ó 
  181|Bio1 (2mg)         31   òòòòòø   ùòú   ó   ó ó ó ó   ó   ó ó     ó     ó 
  224|Hel67b (1mg)       70   òòòòòôòø ó ó   ó   ó ó ó ó   ó   ó ó     ùòòòòò÷ 
  218|Hel55b (3mg)       64   òòòòò÷ ùò÷ ó   ó   ó ó ó ó   ó   ó ó     ó 
  232|Hel8(2.) (1mg) Ros 78   òòòûòø ó   ó   ó   ùòú ó ó   ùòòòú ó     ó 
  242|Hel1(2.) (1mg) Ros 86   òòò÷ ùò÷   ó   ó   ó ùò÷ ó   ó   ó ó     ó 
9-C18:1-NH2 
Phosphate artifact 19a 
Aromatic 
N-Ac-amides 
Long-chain FA esters 
Long-chain ketones 
and alkenes 
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Dendogram 8.5  Continued. 
 
  237|Hel8(1)(3)(1mg)Ros 82   òòòòò÷     ó   ùòø ó ó   ó   ó   ó ó     ó 
  205|Bio8 (2mg)         51   òòòòòòòòòòò÷   ó ó ó ó   ó   ó   ó ó     ó 
  168|Hel73 (1mg)        18   òòòòòûòòòòòòòø ó ó ó ó   ó   ó   ó ó     ó 
  231|Bio27 (1mg)        77   òòòòò÷       ùòú ó ó ó   ó   ó   ó ó     ó 
  210|Hel5(2.) (1mg)     56   òòòòòòòòòòòòò÷ ó ó ó ó   ó   ó   ó ó     ó 
  212|Bio29 (3mg)        58   òòòûòòòø       ó ó ó ó   ó   ó   ó ó     ó 
  235|Bio4 (2mg)         80   òòò÷   ùòòòòòø ó ó ó ó   ùòø ó   ó ó     ó 
  172|Bio5 (1mg)         22   òòòòòûò÷     ó ó ó ó ó   ó ó ó   ó ó     ó 
  197|Bio37 (2mg)        45   òòòòò÷       ó ó ó ó ó   ó ó ó   ó ó     ó 
  203|Bio23 (6mg)        50   òòòòòòòûòòòø ó ó ó ó ó   ó ó ó   ó ó     ó 
  217|Hel71 (3mg)        63   òòòòòòò÷   ó ó ó ùò÷ ó   ó ó ó   ó ó     ó 
  155|1/GCy,5-5           6   òòòûòø     ùòú ó ó   ó   ó ó ó   ó ùòø   ó 
  176|HKIB243-2          26   òòò÷ ùòòòø ó ùò÷ ó   ó   ó ó ó   ó ó ó   ó 
  239|VH Hel10 Fett Ros  84   òòòòò÷   ó ó ó   ó   ó   ó ó ó   ó ó ó   ó 
  185|Hel43b (1mg)       35   òòòòòûòòòôò÷ ó   ó   ó   ó ó ó   ó ó ó   ó 
  200|Hel57b (1mg)       47   òòòòò÷   ó   ó   ó   ó   ó ó ó   ó ó ó   ó 
  177|Hel3(2.) (1mg)     27   òòòòòòòòò÷   ó   ó   ó   ó ó ó   ó ó ó   ó 
  201|ANT17 (1mg)        48   òòòòòòòòòòòòò÷   ó   ó   ó ó ó   ó ó ó   ó 
  213|Bio2 (1mg)         59   òòòòòòòòòòòûòø   ó   ó   ó ó ó   ó ó ó   ó 
  214|Bio22 (1mg)        60   òòòòòòòòòòò÷ ùòòòú   ó   ó ó ó   ó ó ó   ó 
  243|Hel79 (1mg)        87   òòòòòòòòòòòòò÷   ó   ó   ó ùò÷   ó ó ó   ó 
  162|DSG46              12   òòòòòòòòòòòòòòòòò÷   ó   ó ó     ó ó ó   ó 
  216|ANT358 (2mg)       62   òòòòòòòòòòòòòòòòòòòòòú   ó ó     ó ó ó   ó 
  152|1//0019             3   òòòòòòòòòòòòòòòòòòòòò÷   ó ó     ó ó ùòòò÷ 
  219|Hel74 (1mg)        65   òòòòòòòòòòòòòòòòòòòòòòòòò÷ ó     ó ó ó 
  240|G410               85   òòòòòòòòòòòòòòòòòòòòòòòòòòòú     ó ó ó 
  164|1/107aa            14   òòòòòòòòòòòòòòòòòòòòòòòòòòò÷     ó ó ó 
  157|1/GW73b             8   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ó ó 
  199|Bio13 (1mg) Ros    46   òòòòòòòòòòòûòòòòòòòòòòòòòòòòòòòòòø ó ó 
  209|KVCyB16 (2,5mg)    55   òòòòòòòòòòò÷                     ó ó ó 
  171|B6935              21   òòòòòòòûòòòø                     ùò÷ ó 
  180|GW19/1534 (rot)    30   òòòòòòò÷   ùòòòòòòòòòø           ó   ó 
  174|B7693              24   òòòòòòòòòòò÷         ùòòòòòòòø   ó   ó 
  194|B1751              42   òòòòòòòòòòòòòòòòòòòòò÷       ùòòò÷   ó 
  160|GW16/1546          10   òòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷       ó 
  163|G49                13   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ 
FA Me esters 
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Dendogram 8.6  Subset STM3; PCA/HCA, 74% of the variance extracted, average linkage, quadratic 
Euclidean distance. 
 
                                     Rescaled Distance Cluster Combine 
 
          C A S E            0         5        10        15        20        25 
  Label                 Num  +---------+---------+---------+---------+---------+ 
 
  102|1/IHg,4            88   òûòòòø 
  129|1/IHg,3            89   ò÷   ùòòòòòòòòòòòø 
  90|1/ACF,5             90   òòòòò÷           ó 
  180|GW19/1534 (rot)    30   òòòòòûòòòòòø     ó 
  194|B1751              42   òòòòò÷     ùòòòòòú 
  174|B7693              24   òòòòòòòòòòò÷     ó 
  176|HKIB243-2          26   òòòòòòòûòòòø     ó 
  209|KVCyB16 (2,5mg)    55   òòòòòòò÷   ùòòòø ó 
  168|Hel73 (1mg)        18   òòòòòòòòòòò÷   ó ó 
  197|Bio37 (2mg)        45   òòòûòòòø       ó ó 
  212|Bio29 (3mg)        58   òòò÷   ùòòòòòòòú ó 
  172|Bio5 (1mg)         22   òòòòòòò÷       ó ó 
  219|Hel74 (1mg)        65   òòòòòø         ó ó 
  243|Hel79 (1mg)        87   òòòòòôòòòòòòòø ó ó 
  226|ACF,8-5 (1mg)      72   òòòòò÷       ó ó ó 
  151|1/AMP,2             2   òø           ó ó ó 
  186|GW14/587           36   òú           ó ó ó 
  150|1/ST204b            1   òôòø         ó ó ó 
  187|GW64/1571a         37   ò÷ ó         ó ó ó 
  173|1/Ccy,8            23   òø ó         ó ó ó 
  184|Hel66b (4mg)       34   òôòú         ó ó ó 
  161|Bio43 (1mg)        11   ò÷ ó         ó ó ó 
  169|MBSohiobol         19   òòòôòòòø     ó ó ó 
  171|B6935              21   òòòú   ó     ó ó ó 
  175|1/Hel39            25   òòò÷   ó     ó ó ó 
  205|Bio8 (2mg)         51   òòòø   ó     ó ùòú 
  232|Hel8(2.) (1mg) Ros 78   òòòôòòòú     ó ó ó 
  242|Hel1(2.) (1mg)     86   òòò÷   ó     ó ó ó 
  216|ANT358 (2mg)       62   òòòûòø ó     ó ó ó 
  230|Bio14 (2mg)        76   òòò÷ ó ó     ó ó ó 
  178|Bio25 (2mg)        28   òûòø ó ó     ó ó ó 
  206|Bio15 (4mg)        52   ò÷ ó ó ó     ó ó ó 
  231|Bio27 (1mg)        77   òòòôòú ó     ó ó ó 
  179|Bio19 (4mg)        29   òòò÷ ó ó     ó ó ó 
  183|Bio11 (1mg) Ros    33   òø   ó ó     ó ó ó 
  211|Bio7 (1mg) Ros     57   òú   ó ó     ó ó ó 
  235|Bio4 (2mg)         80   òú   ùòú     ùòú ó 
  236|Hel51b (4mg)       81   òú   ó ó     ó ó ùòòòø 
  191|Bio16 (1mg)        40   òú   ó ó     ó ó ó   ó 
  199|Bio13 (1mg) Ros    46   òú   ó ó     ó ó ó   ó 
  225|Bio30 (2mg)        71   òú   ó ó     ó ó ó   ó 
  200|Hel57b (1mg)       47   òú   ó ó     ó ó ó   ó 
  165|Hel53a (2mg)       15   òú   ó ó     ó ó ó   ó 
  195|Bio28 (1mg)        43   òôòø ó ó     ó ó ó   ó 
  223|Hel48b/4.5 (2mg)   69   òú ó ó ó     ó ó ó   ó 
  222|Hel72 (5mg)        68   òú ó ó ó     ó ó ó   ó 
  170|Hel59b (4mg)       20   òú ó ó ó     ó ó ó   ó 
  158|1/Bio46             9   òú ó ó ùòø   ó ó ó   ó 
  220|Bio33 (1mg)        66   òú ó ó ó ó   ó ó ó   ó 
  154|1/ACy,4             5   òú ó ó ó ó   ó ó ó   ó 
  188|Bio38 (1mg)        38   òú ó ó ó ó   ó ó ó   ó 
  233|Hel57a (1mg)       79   òú ó ó ó ó   ó ó ó   ó 
  221|Hel46b (1mg) Ros   67   òú ó ó ó ó   ó ó ó   ó 
  185|Hel43b (1mg)       35   ò÷ ó ó ó ó   ó ó ó   ùòø 
  224|Hel67b (1mg)       70   òòòú ó ó ó   ó ó ó   ó ó 
9-C18:1-NH2 
Diketopiperazines 
Appendix 
134
 
Dendogram 8.6  Continued. 
 
   
  228|Bio42(1mg)         74   òòòôòú ó ùòø ó ó ó   ó ó 
  207|Hel63b (7mg)       53   òòòú ó ó ó ó ó ó ó   ó ó 
  239|VH Hel10 Fett Ros  84   òòò÷ ó ó ó ó ó ó ó   ó ó 
  155|1/GCy,5-5           6   òòòòò÷ ó ó ó ó ó ó   ó ó 
  181|Bio1 (2mg)         31   òòòûòø ó ó ó ó ó ó   ó ó 
  218|Hel55b (3mg)       64   òòò÷ ùòú ó ùò÷ ó ó   ó ó 
  237|Hel8(1)(3)(1mg)Ros 82   òòòòò÷ ó ó ó   ó ó   ó ó 
  182|Ccy,8-5 (2mg)      32   òòòòòòòú ó ó   ó ó   ó ùòø 
  160|GW16/1546          10   òòòòòòò÷ ó ó   ó ó   ó ó ó 
  153|1/90aa              4   òòòòòòòòò÷ ó   ó ó   ó ó ó 
  229|Bio26 (4mg)        75   òòòòòòòòòòò÷   ó ó   ó ó ó 
  210|Hel5(2.) (1mg)     56   òòòòòòòòòòòòòòò÷ ó   ó ó ó 
  202|ANT323 (2mg)       49   òòòòòòòûòòòòòø   ó   ó ó ùòòòø 
  215|ANT46 (2mg)        61   òòòòòòò÷     ùòòò÷   ó ó ó   ó 
  208|Bio24 (1mg) Ros    54   òòòòòòòòòòòòò÷       ó ó ó   ó 
  162|DSG46              12   òòòûòòòòòòòòòòòòòòòòò÷ ó ó   ó 
  167|GW24/1694          17   òòò÷                   ó ó   ó 
  193|Bio41 (4mg)        41   òòòòòòòòòòòòòòòòòòòòòòò÷ ó   ó 
  177|Hel3(2.) (1mg)     27   òòòòòòòòòòòòòòòòòòòòòòòòò÷   ùòø 
  152|1//0019             3   òòòòòòòòòòòòòòòûòòòòòòòòòòòòòú ó 
  157|1/GW73b             8   òòòòòòòòòòòòòòò÷             ó ó 
  196|GW24/1838(rot)     44   òòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ó 
  156|1/GCy,5Hfl          7   òòòòòòòòòòòòòòòòòòòòòòòòòòòûòòòôòø 
  166|Hel68 (3mg)        16   òòòòòòòòòòòòòòòòòòòòòòòòòòò÷   ó ó 
  227|ANT253(RE)         73   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ó 
  203|Bio23 (6mg)        50   òòòòòòòòòòòòòòòòòòòòòòòûòòòòòòòòòôòòòø 
  217|Hel71 (3mg)        63   òòòòòòòòòòòòòòòòòòòòòòò÷         ó   ùòø 
  190|Bio9 (1mg)         39   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷   ó ó 
  213|Bio2 (1mg)         59   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ùòø 
  214|Bio22 (1mg)        60   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòú ùòòòòòø 
  163|G49                13   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ó     ùòø 
  238|ANT321 (2mg)       83   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷     ó ó 
  201|ANT17 (1mg)        48   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ó 
  164|1/107aa            14   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòú 
  240|G410               85   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ 
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Dendogram 8.7  Subset STM4; HCA, average linkage, quadratic Euclidean distance. 
 
                                    Rescaled Distance Cluster Combine 
 
          C A S E           0         5        10        15        20        25 
  Label                Num  +---------+---------+---------+---------+---------+ 
 
  55|Pic007             37   òûòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòø 
  60|Pic010             42   ò÷                                           ó 
  53|Pic004             35   òø                                           ó 
  57|Pic006             39   òú                                           ó 
  35|Pic003             17   òôòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòø     ó 
  61|Pic024             43   ò÷                                     ó     ó 
  245|Pic004 der.Ib     70   òûòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòø ó     ó 
  246|Pic004 der.Ia     71   ò÷                                   ó ó     ó 
  46|Bio139             28   òòòòòûòòòòòòòòòòòø                   ó ó     ó 
  56|Bio135             38   òòòòò÷           ó                   ó ó     ó 
  19|Bio151              1   òûòòòø           ó                   ó ó     ùòòòø 
  23|Bio215              5   ò÷   ùòòòø       ó                   ó ó     ó   ó 
  62|Bio137             44   òòòòò÷   ùòòòòòø ó                   ó ó     ó   ó 
  27|Pic104              9   òòòòòòòòò÷     ó ó                   ó ó     ó   ó 
  102|1/IHg,4           64   òûòø           ó ó                   ó ó     ó   ó 
  129|1/IHg,3           65   ò÷ ùòòòòòòòòòø ó ó                   ó ó     ó   ó 
  90|1/ACF,5            66   òòò÷         ó ó ó                   ó ó     ó   ó 
  329|GW3/1576Fett656   59   òòòòòûòòòòòòòôòú ó                   ó ó     ó   ó 
  334|GW10/2517FettS4   62   òòòòò÷       ó ó ó                   ó ó     ó   ó 
  328|Ccy8CFBFettR2     58   òòòûòòòòòòòòòú ó ó                   ó ó     ó   ó 
  332|GW26/1546,F1170   61   òòò÷         ó ó ó                   ó ùòòòòò÷   ó 
  47|Bio208             29   òòòòòûòòòø   ó ó ó                   ó ó         ó 
  63|Bio138             45   òòòòò÷   ùòø ó ó ó                   ó ó         ó 
  247|Bio210 der.IIa/1  72   òòòûòòòø ó ó ó ó ó                   ó ó         ó 
  249|Bio210 der.IIb/2  74   òòò÷   ùò÷ ó ó ó ó                   ó ó         ó 
  248|Bio210 der.IIa/1  73   òòòòòòò÷   ó ó ó ó                   ó ó         ó 
  20|Bio140              2   òòòûòòòòòø ó ó ó ó                   ó ó         ó 
  64|Bio147             46   òòò÷     ùòôò÷ ùòú                   ó ó         ó 
  68|Bio134             50   òòòòòòòòò÷ ó   ó ó                   ó ó         ó 
  36|Bie68a             18   òòòòòòòûòø ó   ó ó                   ó ó         ó 
  327|B7693Fett1016     57   òòòòòòò÷ ó ó   ó ó                   ó ó         ó 
  25|Pic011              7   òòòûòòòø ó ó   ó ó                   ó ó         ó 
  65|Bio144             47   òòò÷   ùòú ó   ó ó                   ó ó         ó 
  45|Pic008             27   òòòòòòò÷ ó ó   ó ó                   ó ó         ó 
  326|Ccy8FettR         56   òòòûòòòòòú ó   ó ó                   ó ó         ó 
  335|Hel51b,V1         63   òòò÷     ó ó   ó ó                   ó ó         ó 
  43|Pic107             25   òòòûòòòø ó ó   ó ó                   ó ó         ó 
  58|Pic108             40   òòò÷   ó ó ó   ó ó                   ùò÷         ó 
  44|Pic101             26   òûòòòø ó ó ó   ó ó                   ó           ó 
  51|Pic111             33   ò÷   ùòú ó ó   ó ó                   ó           ó 
  28|Pic013             10   òòòòò÷ ó ùò÷   ó ó                   ó           ó 
  21|Bio211              3   òòòûòø ó ó     ó ó                   ó           ó 
  69|Bio211/2           51   òòò÷ ó ó ó     ó ó                   ó           ó 
  40|Bio123             22   òòòòòú ó ó     ó ó                   ó           ó 
  31|Bio136             13   òòòòòú ó ó     ó ó                   ó           ó 
  37|Bio209             19   òòòòòú ó ó     ó ó                   ó           ó 
  39|Bio148             21   òòòûòú ó ó     ó ó                   ó           ó 
  50|Bio212             32   òòò÷ ó ó ó     ó ó                   ó           ó 
  54|Pic109             36   òòòø ó ó ó     ó ùòòòòòø             ó           ó 
  244|Bio210 der.IIb/1  69   òòòôòôòú ó     ó ó     ó             ó           ó 
  34|Bio145             16   òòòú ó ó ó     ó ó     ó             ó           ó 
  59|Pic021             41   òòò÷ ó ó ó     ó ó     ó             ó           ó 
  42|Pic018             24   òûòø ó ùòú     ó ó     ó             ó           ó 
  48|Pic009*            30   ò÷ ó ó ó ó     ó ó     ó             ó           ó 
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Dendogram 8.7  Continued. 
 
 
  52|Pic012             34   òòòôòú ó ó     ó ó     ó             ó           ó 
  29|Bio149             11   òûòú ó ó ó     ó ó     ó             ó           ó 
  49|Pic023             31   ò÷ ó ó ó ó     ó ó     ó             ó           ó 
  30|Bio213             12   òûòú ó ó ó     ó ó     ó             ó           ó 
  33|Bio214             15   ò÷ ó ó ó ó     ó ó     ó             ó           ó 
  318|Pic009FN*         67   òòò÷ ó ó ó     ó ó     ùòòòø         ó           ó 
  32|Bio205 Ros         14   òòòòòú ó ó     ó ó     ó   ó         ó           ó 
  24|Bio150              6   òòòûòú ó ó     ó ó     ó   ó         ó           ó 
  331|921,Fett921       60   òòò÷ ó ó ó     ó ó     ó   ó         ó           ó 
  26|Bio204 Ros          8   òòòòòú ó ó     ó ó     ó   ó         ó           ó 
  41|Pic002             23   òòòòò÷ ó ó     ó ó     ó   ó         ó           ó 
  38|Pic017             20   òòòòòòò÷ ó     ó ó     ó   ùòòòø     ó           ó 
  22|Hel38               4   òòòòòòòòò÷     ó ó     ó   ó   ó     ó           ó 
  325|GW10/2517Fett89   55   òòòòòòòòòòòòòòò÷ ó     ó   ó   ó     ó           ó 
  234|Bio210 der.I      68   òòòòòòòòòòòòòòòòòú     ó   ó   ùòòòòò÷           ó 
  323|Hel45c-C6 Ros     53   òòòòòòòòòòòòòòòòò÷     ó   ó   ó                 ó 
  66|Bio133             48   òòòòòòòòòòòòòòòòòòòòòòò÷   ó   ó                 ó 
  320|DSQ2S             52   òòòòòòòòòòòòòòòòòòòòòòòòòòò÷   ó                 ó 
  67|Bio210             49   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷                 ó 
  324|DSQB7             54   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ 
 
 
 
 
Long-chain alkenes 
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Dendogram 8.8  Subset STM4; PCA/HCA, 75% of the variance extracted, average linkage, quadratic 
Euclidean distance. 
 
 
                                    Rescaled Distance Cluster Combine 
 
          C A S E           0         5        10        15        20        25 
  Label                Num  +---------+---------+---------+---------+---------+ 
 
  55|Pic007             37   òø 
  60|Pic010             42   òú 
  35|Pic003             17   òú 
  57|Pic006             39   òôòø 
  53|Pic004             35   òú ó 
  61|Pic024             43   ò÷ ùòòòòòø 
  324|DSQB7             54   òòòú     ó 
  245|Pic004 der.Ib     70   òûò÷     ó 
  246|Pic004 der.Ia     71   ò÷       ó 
  20|Bio140              2   òòòûòòòòòú 
  64|Bio147             46   òòò÷     ó 
  27|Pic104              9   òûòø     ó 
  66|Bio133             48   ò÷ ó     ùòø 
  19|Bio151              1   òø ùòòòòòú ó 
  23|Bio215              5   òú ó     ó ó 
  68|Bio134             50   òôò÷     ó ó 
  62|Bio137             44   ò÷       ó ó 
  59|Pic021             41   òûòø     ó ó 
  69|Bio211/2           51   ò÷ ùòø   ó ó 
  54|Pic109             36   òòò÷ ùòòòú ó 
  39|Bio148             21   òòòòò÷   ó ó 
  25|Pic011              7   òø       ó ó 
  45|Pic008             27   òú       ó ó 
  65|Bio144             47   òôòø     ó ó 
  26|Bio204 Ros          8   ò÷ ó     ó ùòø 
  21|Bio211              3   òòòôòø   ó ó ó 
  41|Pic002             23   òòò÷ ó   ó ó ó 
  247|Bio210 der.IIa/1  72   òûòø ùòø ó ó ó 
  248|Bio210 der.IIa/2  73   ò÷ ùòú ó ó ó ó 
  63|Bio138             45   òûòú ó ó ó ó ó 
  249|Bio210 der.IIb/2  74   ò÷ ó ó ùò÷ ó ó 
  67|Bio210             49   òòò÷ ó ó   ó ó 
  46|Bio139             28   òòòòò÷ ó   ó ùòø 
  43|Pic107             25   òòòòòòò÷   ó ó ó 
  30|Bio213             12   òòòûòòòòòø ó ó ó 
  33|Bio214             15   òòò÷     ó ó ó ó 
  31|Bio136             13   òòòûòø   ùò÷ ó ó 
  37|Bio209             19   òòò÷ ùòø ó   ó ó 
  42|Pic018             24   òòòòò÷ ùò÷   ó ó 
  29|Bio149             11   òòòòòòò÷     ó ó 
  329|GW3/1576Fett656   59   òòòòòûòòòòòòò÷ ùòòòø 
  334|GW10/2517FettS4   62   òòòòò÷         ó   ó 
  40|Bio123             22   òòòòòòòòòòòòòûòú   ó 
  234|Bio210 der.I      68   òòòòòòòòòòòòò÷ ó   ó 
  323|Hel45c-C6 Ros     53   òòòòòòòòòòòòòòò÷   ó 
  34|Bio145             16   òûòòòòòòòòòòòòòòòòòú 
  244|Bio210 der.IIb/1  69   ò÷                 ó 
  47|Bio208             29   òòòòòø             ó 
  50|Bio212             32   òòòòòôòòòòòòòòòòòòòú 
  49|Pic023             31   òòòòò÷             ùòø 
  24|Bio150              6   òòòòòòòòòòòòòòòòòòòú ó 
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Dendogram 8.8  Continued. 
 
  102|1/IHg,4           64   òûòø               ó ó 
  129|1/IHg,3           65   ò÷ ùòòòòòòòòòòòòòòò÷ ó 
  90|1/ACF,5            66   òòò÷                 ó 
  38|Pic017             20   òòòûòòòòòòòòòòòòòòòòòôòòòø 
  56|Bio135             38   òòò÷                 ó   ó 
  36|Bie68a             18   òòòòòòòòòûòòòø       ó   ùòø 
  332|GW26/1546,F1170   61   òòòòòòòòò÷   ùòòòòòòò÷   ó ó 
  327|B7693Fett1016     57   òòòòòòòòòòòòò÷           ó ó 
  44|Pic101             26   òòòòòòòûòòòòòòòòòòòòòòòòò÷ ó 
  51|Pic111             33   òòòòòòò÷                   ó 
  32|Bio205 Ros         14   òòòòòòòòòòòòòòòòòòòòòûòòòòòú 
  328|Ccy8CFBFettR2     58   òòòòòòòòòòòòòòòòòòòòò÷     ùòòòòòø 
  52|Pic012             34   òòòòòòòòòòòòòòòòòòòòòòòòòòòú     ó 
  22|Hel38               4   òòòòòòòòòòòòòòòòòòòòòòòòòòò÷     ùòòòø 
  335|Hel51b,V1         63   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòú   ùòòòø 
  326|Ccy8FettR         56   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷   ó   ó 
  331|921,Fett921       60   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷   ùòø 
  28|Pic013             10   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòú ùòø 
  58|Pic108             40   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ó ó 
  48|Pic009*            30   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ùòòòø 
  318|Pic009FN*         67   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòú   ó 
  325|GW10/2517Fett89   55   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷   ó 
  320|DSQ2S             52   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ 
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Dendogram 8.9   Subset STM5; HCA, average linkage, quadratic Euclidean distance. 
 
 
                                     Rescaled Distance Cluster Combine 
 
          C A S E            0         5        10        15        20        25 
  Label                 Num  +---------+---------+---------+---------+---------+ 
 
  274|Bio231             24   òûòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòø 
  299|Pic005             47   ò÷                                               ó 
  252|GCy,5               3   òûòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòø   ó 
  275|Bio236             25   ò÷                                           ó   ó 
  268|Hel23              18   òòòòòûòø                                     ó   ó 
  282|GW7/1541           31   òòòòò÷ ùòòòòòòòø                             ó   ó 
  310|GW90a              57   òòòòòòò÷       ó                             ó   ó 
  102|1/IHg,4            62   òûòø           ó                             ó   ó 
  129|1/IHg,3            63   ò÷ ùòòòòòòòòòòòú                             ó   ó 
  90|1/ACF,5             64   òòò÷           ó                             ó   ó 
  267|GW11/919           17   òòòòòòòòòòòûòòòú                             ó   ó 
  293|Hel26  Ros         42   òòòòòòòòòòò÷   ó                             ó   ó 
  256|Pic022              6   òòòòòûòòòòòòòòòú                             ó   ó 
  295|Hel73              44   òòòòò÷         ùòø                           ó   ó 
  270|AM13,1 weiß*       20   òûòø           ó ó                           ó   ó 
  286|Hel10  Ros         35   ò÷ ùòòòòòø     ó ó                           ó   ó 
  273|Bio001             23   òòò÷     ùòø   ó ó                           ó   ó 
  265|Pic019             15   òûòòòø   ó ó   ó ó                           ó   ó 
  283|Pic016             32   ò÷   ùòòò÷ ó   ó ó                           ó   ó 
  258|Bio017              8   òòòûò÷     ó   ó ó                           ó   ó 
  298|Hel45  Ros         46   òòò÷       ùòø ó ó                           ó   ó 
  306|Bio007  Ros        53   òòòòòòòòòòòú ó ó ó                           ó   ó 
  262|Hel11              12   òòòòòòòòòòò÷ ó ó ó                           ó   ó 
  279|AM13,1*            29   òòòòòûòø     ó ó ó                           ó   ó 
  301|MPep,2             49   òòòòò÷ ùòòòòòôòú ó                           ó   ó 
  276|Hel13              26   òòòòòòò÷     ó ó ó                           ó   ó 
  257|ST204               7   òòòûòø       ó ó ó                           ó   ó 
  290|GT161a             39   òòò÷ ùòòòòòø ó ó ó                           ó   ó 
  309|Hel68              56   òòòòò÷     ó ó ó ó                           ó   ó 
  285|GW13/580           34   òûòø       ó ó ó ó                           ó   ó 
  288|GW44/1326          37   ò÷ ùòø     ó ó ó ó                           ó   ó 
  300|GW23/1540          48   òòò÷ ó     ó ó ó ó                           ùòø ó 
  278|Gw24/1694          28   òòòûòôòòòòòú ó ó ó                           ó ó ó 
  291|GW7/882            40   òòò÷ ó     ùò÷ ó ó                           ó ó ó 
  303|Bio008             51   òòòòò÷     ó   ó ó                           ó ó ó 
  260|GW22/1326          10   òòòûòòòòòø ó   ó ó                           ó ó ó 
  296|GW19/1343          45   òòò÷     ó ó   ó ó                           ó ó ó 
  253|GW62/1540 rot       4   òòòø     ó ó   ó ó                           ó ó ó 
  287|GW7/1330           36   òòòôòø   ó ó   ó ó                           ó ó ó 
  263|QW20/1702 rot      13   òòò÷ ó   ó ó   ó ó                           ó ó ó 
  294|GW69/1540 pink     43   òòòòòôòø ó ó   ó ó                           ó ó ó 
  259|GW2/1332 rot        9   òòòòò÷ ó ó ó   ó ó                           ó ó ó 
  254|GW20/1298           5   òòòòòø ó ó ó   ó ó                           ó ó ó 
  317|Alkane std.        61   òòòòòú ó ó ó   ó ó                           ó ó ó 
  284|GW2/1343           33   òòòø ùòú ó ó   ó ó                           ó ó ó 
  289|RK339 rot          38   òòòôòú ùòú ó   ó ùòø                         ó ó ó 
  277|GW27/2506 gruen    27   òòòú ó ó ó ó   ó ó ó                         ó ó ó 
  314|GW29/1540          59   òòòú ó ó ó ó   ó ó ó                         ó ùò÷ 
  304|RK339gelb          52   òòò÷ ó ó ùò÷   ó ó ó                         ó ó 
  251|GW14/587            2   òòòòò÷ ó ó     ó ó ó                         ó ó 
  261|Bio232             11   òòòòòòòú ó     ó ó ó                         ó ó 
  292|Amp,3              41   òòòòòòòú ó     ó ó ùòòòòòø                   ó ó 
N
O
H
 
Aromatic acids, 
FAs, indole  
derivatives 
Alkene 45c, indole 
derivatives, 
C35 terpenes 26,27 
 
N C17
O
 
C35 terpenes 
Aromatic acids, 
FAs,  
C35 terpenes 26, 27 
Aliphatic amides, 
FAs, C35 terpenes 
 
N C17
O
 
Appendix 
140
 
Dendogram 8.9   Continued. 
   
  302|Hel12              50   òòòòòòò÷ ó     ó ó ó     ó                   ó ó 
  266|Bio237             16   òòòòòòòòòú     ó ó ó     ó                   ó ó 
  250|GW14/709            1   òòòòòòòòò÷     ó ó ó     ó                   ó ó 
  280|NCy,3              30   òòòòòòòòòòòòòòò÷ ó ó     ó                   ó ó 
  272|Hel74              22   òòòòòòòòòòòòòòòòòú ó     ó                   ó ó 
  269|Bio221             19   òòòòòòòòòòòòòòòòò÷ ó     ùòòòø               ó ó 
  308|ACy,4              55   òòòòòòòòòòòòòòòòòòò÷     ó   ó               ó ó 
  307|Bio024  Ros        54   òòòòòòòòòòòòòòòòòòòòòòòòòú   ùòø             ó ó 
  264|FPep,1             14   òòòòòòòòòòòòòòòòòòòòòòòòò÷   ó ùòòòòòòòòòòòòò÷ ó 
  271|GW29/1496          21   òòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ó               ó 
  313|GW19/1251          58   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷               ó 
  316|Solvent            60   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ 
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Dendogram 8.10  Subset STM5; PCA/HCA, 76% of the variance extracted, average linkage, 
quadratic Euclidean distance. 
 
                                     Rescaled Distance Cluster Combine 
 
          C A S E            0         5        10        15        20        25 
  Label                 Num  +---------+---------+---------+---------+---------+ 
 
  102|1/IHg,4            62   òûòø 
  129|1/IHg,3            63   ò÷ ùòòòòòòòòòòòòòòòø 
  90|1/ACF,5             64   òòò÷               ó 
  263|QW20/1702 rot      13   òòòòòòòòòûòòòòòòòø ó 
  284|GW2/1343           33   òòòòòòòòò÷       ó ó 
  287|GW7/1330           36   òòòòòòòòòòòûòòòòòú ó 
  294|GW69/1540 pink     43   òòòòòòòòòòò÷     ó ó 
  257|ST204               7   òòòûòòòø         ó ùòòòòòø 
  309|Hel68              56   òòò÷   ùòòòòòø   ó ó     ó 
  272|Hel74              22   òòòòòòò÷     ó   ó ó     ó 
  277|GW27/2506 gruen    27   òòòûòø       ó   ó ó     ó 
  285|GW13/580           34   òòò÷ ó       ó   ó ó     ó 
  288|GW44/1326          37   òûòø ùòø     ó   ó ó     ó 
  291|GW7/882            40   ò÷ ó ó ó     ùòòòú ó     ó 
  300|GW23/1540          48   òòòôòú ùòòòø ó   ùò÷     ó 
  260|GW22/1326          10   òòò÷ ó ó   ó ó   ó       ó 
  278|Gw24/1694          28   òòòòò÷ ó   ó ó   ó       ó 
  296|GW19/1343          45   òòòòòòò÷   ó ó   ó       ó 
  274|Bio231             24   òø         ó ó   ó       ó 
  299|Pic005             47   òú         ùò÷   ó       ó 
  275|Bio236             25   òú         ó     ó       ó 
  316|Solvent            60   òôòòòòòòòòòú     ó       ó 
  252|GCy,5               3   ò÷         ó     ó       ó 
  267|GW11/919           17   òòòòòûòòòø ó     ó       ó 
  308|ACy,4              55   òòòòò÷   ó ó     ó       ó 
  264|FPep,1             14   òûòòòòòòòú ó     ó       ó 
  279|AM13,1*            29   ò÷       ó ó     ó       ó 
  295|Hel73              44   òûòø     ùò÷     ó       ó 
  302|Hel12              50   ò÷ ó     ó       ó       ó 
  298|Hel45  Ros         46   òûòú     ó       ó       ó 
  303|Bio008             51   ò÷ ùòø   ó       ó       ó 
  301|MPep,2             49   òòòú ó   ó       ó       ó 
  273|Bio001             23   òø ó ó   ó       ó       ó 
  286|Hel10  Ros         35   òú ó ó   ó       ó       ó 
  258|Bio017              8   òú ó ó   ó       ó       ùòø 
  293|Hel26  Ros         42   òôòú ó   ó       ó       ó ó 
  306|Bio007  Ros        53   òú ó ó   ó       ó       ó ó 
  256|Pic022              6   ò÷ ó ó   ó       ó       ó ó 
  270|AM13,1 weiß*       20   òòòú ùòòò÷       ó       ó ó 
  262|Hel11              12   òòò÷ ó           ó       ó ó 
  259|GW2/1332 rot        9   òòòòòú           ó       ó ó 
  276|Hel13              26   òòòòò÷           ó       ó ó 
  280|NCy,3              30   òòòòòòòòòòòòòòòòò÷       ó ó 
  269|Bio221             19   òòòòòòòòòòòòòòòòòòòòòòòòòú ó 
  265|Pic019             15   òòòòòòòòòòòòòûòòòòòòòòòòò÷ ùòø 
  283|Pic016             32   òòòòòòòòòòòòò÷             ó ó 
  268|Hel23              18   òòòòòòòòòòòòòòòûòòòòòòòòòòòú ó 
  282|GW7/1541           31   òòòòòòòòòòòòòòò÷           ó ó 
  304|RK339gelb          52   òòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ùòø 
  271|GW29/1496          21   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòú ó 
  254|GW20/1298           5   òòòòòòòòòòòòòòòòòûòòòòòòòòòòò÷ ùòø 
  310|GW90a              57   òòòòòòòòòòòòòòòòò÷             ó ó 
  314|GW29/1540          59   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ó 
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Dendogram 8.10  Continued. 
 
  307|Bio024  Ros        54   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòôòø 
  292|Amp,3              41   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòú ùòòòø 
  313|GW19/1251          58   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ó   ùòø 
  253|GW62/1540 rot       4   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷   ó ùòòòø 
  261|Bio232             11   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ó   ó 
  290|GT161a             39   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷   ùòø 
  289|RK339 rot          38   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòú ó 
  251|GW14/587            2   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ùòø 
  250|GW14/709            1   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòú ó 
  266|Bio237             16   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ó 
  317|Alkane std.        61   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ 
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Dendogram 8.11  The entire data set of derivatized lipophilic extracts; HCA, average linkage, 
quadratic Euclidean distance; samples in bold contain the C35 terpenes 26 and 27. 
 
 
                                     Rescaled Distance Cluster Combine 
 
          C A S E            0         5        10        15        20        25 
  Label                 Num  +---------+---------+---------+---------+---------+ 
 
  522|GW4/3241          385   òø 
  526|GW15/3246         388   òôòòòòòòòòòòòø 
  508|GW7/1872          373   ò÷           ó 
  379|Öl Hel53          278   òòòûòø       ùòòòòòòòòòòòòòø 
  459|B7900             322   òòò÷ ó       ó             ó 
  499|DFL27  Ros        363   òûòø ùòòòòòòò÷             ó 
  532|GW16/3128         394   ò÷ ùòú                     ó 
  439|GW3/587           311   òòò÷ ó                     ó 
  528|GW11/1900         390   òòòòò÷                     ó 
  280|NCy,3             189   òòòòòòòûòòòòòòòòòòòòòòòø   ó 
  434|Hel69             306   òòòòòòò÷               ó   ó 
  194|B1751              98   òòòûòòòòòòòòòòòòòòòòòòòú   ó 
  535|GW14/2108         397   òòò÷                   ó   ó 
  139|1/ACF,8-3          42   òø                     ó   ó 
  169|MBSohiobol         73   òú                     ó   ó 
  154|1/ACy,4            58   òôòòòòòòòø             ó   ó 
  173|1/Ccy,8            77   òú       ó             ó   ó 
  132|1/KCy,14           35   òú       ó             ó   ó 
  195|Bio28              99   òú       ó             ó   ó 
  151|1/AMP,2*           55   òú       ó             ó   ó 
  186|GW14/587           91   òú       ó             ó   ó 
  175|1/Hel39            79   òú       ó             ó   ó 
  150|1/ST204b           54   òú       ó             ó   ó 
  187|GW64/1571a         92   òú       ó             ó   ó 
  220|Bio33             125   òú       ó             ó   ó 
  233|Hel57a            139   òú       ó             ó   ó 
  161|Bio43*             65   ò÷       ó             ó   ó 
  137|1/Hg,4             40   òø       ó             ó   ó 
  221|Hel46b  Ros       126   òôòø     ó             ó   ó 
  258|Bio017            164   ò÷ ùòø   ó             ó   ó 
  126|1/ACF,5*           28   òûò÷ ó   ùòòòòòòòòòòòø ó   ó 
  170|Hel59b*            74   ò÷   ó   ó           ó ó   ó 
  165|Hel53a             69   òø   ó   ó           ó ó   ó 
  222|Hel72             127   òú   ó   ó           ó ó   ó 
  223|Hel48b            128   òú   ó   ó           ó ó   ó 
  225|Bio30             130   òôòø ó   ó           ó ó   ó 
  147|1/Bio43*           50   ò÷ ó ó   ó           ó ó   ó 
  184|Hel66b             89   òòòú ùòòòú           ó ó   ó 
  148|1/ACF,5* Hfl       51   òòòôòú   ó           ó ó   ó 
  153|1/90aa             57   òòò÷ ó   ó           ó ó   ó 
  140|1/Bio34            44   òûòø ó   ó           ó ó   ó 
  167|GW24/1694          71   ò÷ ó ó   ó           ó ó   ó 
  71|1/Hel15            439   òòòú ó   ó           ó ó   ó 
  128|1/ICy,7            30   òûòú ó   ó           ó ó   ó 
  188|Bio38 (1mg)        93   ò÷ ó ó   ó           ó ó   ó 
  149|1/OCy,4  Ros       52   òòòôòú   ó           ó ó   ó 
  226|ACF,8-5*          131   òòòú ó   ó           ó ó   ó 
  267|GW11/919          174   òòò÷ ó   ó           ùòú   ó 
  105|1/Hel31             6   òòòòòú   ó           ó ó   ó 
  190|Bio9               95   òòòòò÷   ó           ó ó   ó 
  109|1/Bio35            10   òòòø     ó           ó ó   ó 
  191|Bio16              96   òòòôòø   ó           ó ó   ó 
  108|1/ST204a            9   òòò÷ ùòø ó           ó ó   ó 
  256|Pic022            162   òòòòò÷ ùò÷           ó ó   ó 
  73|1/Ncy,3            441   òòòòòòò÷             ó ó   ó 
  338|GW27/1627* 2.     243   òòòûòòòòòø           ó ó   ó 
  343|B8245*/II         248   òòò÷     ó           ó ó   ó 
  332|GW26/1546,F1170   238   òûòø     ó           ó ó   ó 
  337|GW71/2497* 2.     242   ò÷ ó     ùòòòòòòòòòòòú ó   ó 
  328|Ccy8CFBFettR2     234   òòòôòø   ó           ó ó   ó 
  344|GW29/1540* 2.     249   òòò÷ ùòø ó           ó ó   ó 
  364|GW12/3995         270   òòòòò÷ ùò÷           ó ó   ó 
  349|Bio232            254   òòòòòòò÷             ó ó   ó 
  75|1/Hel23*           443   òûòòòòòø             ó ó   ó 
  79|1/Hel32            447   ò÷     ó             ó ó   ó 
  84|1/Lox155ab         453   òòòòòûòôòòòòòòòòòòòø ó ó   ó 
  94|1/Hel26*  Ros      464   òòòòò÷ ó           ó ó ó   ó 
  293|Hel26*  Ros       202   òòòòòòò÷           ó ó ó   ó 
  144|1/MCy,4            47   òûòø               ó ó ó   ó 
  264|FPep,1*           171   ò÷ ùòø             ó ó ó   ó 
  56|Bio135             422   òòò÷ ó             ùò÷ ó   ó 
  193|Bio41              97   òûòø ùòòòòòòòòòòòòòú   ó   ó 
  46|Bio139             333   ò÷ ó ó             ó   ó   ó 
  182|Ccy,8-5            87   òòòôò÷             ó   ó   ó 
  230|Bio14             136   òòò÷               ó   ó   ó 
9-C18:1-NH2, 
diketopiperazines, 
C35 terpenes 
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Dendogram 8.11  Continued. 
 
 
  340|Bio237            246   òûòòòòòòòòòòòòòòòòòú   ó   ó 
  351|Hel74*            257   ò÷                 ó   ó   ó 
  127|1/101ba            29   òòòø               ó   ó   ó 
  164|1/107aa            68   òòòôòòòòòø         ó   ó   ó 
  111|1/107ba            13   òòòú     ó         ó   ó   ó 
  77|1/107aa            445   òòò÷     ùòòòø     ó   ó   ó 
  480|GW10/3428         345   òòòûòòòø ó   ó     ó   ó   ó 
  486|GW25/1905         351   òòò÷   ùò÷   ùòòòø ó   ó   ó 
  352|GW90a*            258   òòòòòòò÷     ó   ó ó   ó   ó 
  488|GW14/1869         353   òòòòòòòòòòòòò÷   ó ó   ó   ó 
  240|G410              147   òòòòòòòòòòòòòûòòòú ó   ó   ó 
  308|ACy,4             217   òòòòòòòòòòòòò÷   ó ó   ó   ó 
  270|AM13,1* weiß      178   òûòø             ó ó   ó   ó 
  286|Hel10*  Ros       194   ò÷ ó             ùò÷   ó   ó 
  273|Bio001*           181   òòòôòòòø         ó     ó   ó 
  91|1/Amp,2*           461   òòò÷   ùòòòòòòòòòú     ó   ó 
  534|GW13/2973         396   òòòòòòò÷         ó     ó   ó 
  10|1/Hel35             11   òòòòòòòûòòòòòòòòòú     ó   ó 
  74|1/Hel25            442   òòòòòòò÷         ó     ó   ó 
  120|1/GT161a           22   òòòòòòòòòòòòòûòòòú     ó   ó 
  503|GW21/1495         369   òòòòòòòòòòòòò÷   ó     ó   ó 
  268|Hel23*            175   òòòòòø           ó     ó   ó 
  72|1/115aa            440   òòòòòôòø         ó     ó   ó 
  282|GW7/1541          190   òòòòò÷ ùòòòòòòòòòú     ó   ó 
  310|GW90a*            220   òòòòòûò÷         ó     ó   ó 
  493|GW6/3202          359   òòòòò÷           ó     ó   ó 
  437|GW27/2506* 1.     309   òûòø             ó     ó   ó 
  438|GW27/2506* 2.     310   ò÷ ùòø           ó     ó   ó 
  355|Oel Can.(Trunk)   261   òòò÷ ùòòòø       ó     ó   ó 
  323|Hel45c-C6*  Ros   229   òòòòò÷   ùòø     ó     ó   ó 
  468|DFL38  Ros        331   òòòòòòòòò÷ ùòòòòòú     ó   ó 
  227|ANT253(RE)        132   òòòòòòòòòòò÷     ó     ó   ó 
  462|Pic069  Ros       325   òòòûòø           ó     ó   ó 
  544|GW1/5809          407   òòò÷ ùòø         ó     ó   ó 
  160|GW16/1546          64   òòòòò÷ ùòòòòòòòòòú     ó   ó 
  500|GW1/3268          366   òòòòòòò÷         ó     ó   ó 
  70|1/Hel29            438   òòòûòø           ó     ó   ó 
  81|1/Ocy,8            450   òòò÷ ó           ó     ó   ó 
  123|1/FPep,1*          25   òòòø ùòòòø       ó     ó   ó 
  138|1/Hel38*           41   òòòôòú   ó       ó     ó   ó 
  122|1/Ocy,5            24   òòò÷ ó   ùòòòòòø ó     ó   ó 
  157|1/GW73b            61   òòòòò÷   ó     ó ó     ó   ó 
  104|1/Am13,2            5   òòòòòòòûò÷     ó ó     ó   ó 
  38|Pic017             281   òòòòòòò÷       ó ó     ó   ó 
  19|Bio151             103   òûòòòø         ó ó     ó   ó 
  23|Bio215*            146   ò÷   ùòø       ó ó     ó   ó 
  27|Pic104             188   òòòòò÷ ùòòòòòòòôòú     ó   ó 
  62|Bio137             429   òòòòòòò÷       ó ó     ó   ó 
  348|GW10/1811         253   òòòûòòòòòø     ó ó     ó   ó 
  464|Pic070  Ros       327   òòò÷     ùòòòø ó ó     ó   ó 
  354|GW27/1627* 1.     260   òòòòòòòòò÷   ùòú ó     ó   ó 
  367|B5543(MA2)        273   òòòòòòòòòòòòò÷ ó ó     ó   ó 
  257|ST204             163   òûòø           ó ó     ó   ó 
  436|B8652             308   ò÷ ùòø         ó ó     ó   ó 
  420|KVLC4(GW13/1783)  296   òûòú ó         ó ó     ó   ó 
  474|GW12/1492         338   ò÷ ó ó         ó ó     ó   ó 
  472|GW6/3311          336   òø ó ùòø       ó ó     ó   ó 
  476|GW8/3391          340   òôò÷ ó ó       ó ó     ó   ó 
  376|Öl B7176          275   òú   ó ùòø     ó ó     ó   ó 
  490|GW31/1539         356   ò÷   ó ó ó     ó ó     ó   ó 
  494|GW6/3428          360   òòòòò÷ ó ùòòòòòú ó     ó   ó 
  309|Hel68*            218   òòòòòòò÷ ó     ó ó     ó   ó 
  519|GW37/3236         383   òòòòòòòòò÷     ó ó     ó   ó 
  125|1/GCy,5-3          27   òòòûòòòø       ó ó     ó   ó 
  325|GW10/2517Fett890  231   òòò÷   ùòòòòòòòú ó     ó   ó 
  8|1/Bie68aa der.I     459   òòòòòòò÷       ó ó     ó   ó 
  219|Hel74*            123   òòòûòòòòòòòø   ó ó     ó   ó 
  234|Bio210 der.I      140   òòò÷       ùòòòú ó     ó   ó 
  86|1/CCy,8            455   òòòòòûòòòòò÷   ó ó     ó   ó 
  99|1/CCy,8-1          469   òòòòò÷         ó ó     ó   ó 
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Dendogram 8.11  Continued. 
 
 
  515|GW6/3535          380   òûòø           ó ó     ó   ó 
  551|GW48/3236         414   ò÷ ó           ó ó     ó   ó 
  513|GW29/3371         378   òòòôòòòòòø     ó ó     ó   ó 
  238|ANT321            144   òòò÷     ó     ó ó     ó   ó 
  179|Bio19              83   òûòø     ó     ó ó     ó   ó 
  401|B4475             285   ò÷ ó     ó     ó ó     ó   ó 
  145|1//0001            48   òø ó     ó     ó ó     ó   ó 
  3|1/Hel36             283   òú ó     ùòòòø ó ó     ó   ó 
  87|1/Hel14            456   òú ùòø   ó   ó ó ó     ó   ó 
  9|1//0005             470   òôòú ó   ó   ó ó ó     ó   ó 
  121|1/Bio32            23   ò÷ ó ó   ó   ó ó ó     ó   ó 
  114|3497-50l,Fetts.    15   òòò÷ ó   ó   ó ó ó     ó   ó 
  507|GW3/3537          372   òòòø ó   ó   ó ó ó     ó   ó 
  514|GW13/1783         379   òòòôòôòòò÷   ó ó ó     ó   ó 
  484|GW22/3234         349   òòò÷ ó       ó ó ó     ó   ó 
  460|B7500             221   òòòø ó       ó ó ó     ó   ó 
  457|B7486             321   òòòú ó       ó ó ó     ó   ó 
  540|GW4/3292          403   òòòôòú       ó ó ó     ó   ó 
  350|GW23/1540         256   òûòú ó       ó ó ó     ó   ó 
  548|GW14/3240         410   ò÷ ó ó       ó ó ó     ó   ó 
  250|GW14/709          157   òòò÷ ó       ó ó ó     ó   ó 
  523|GW5/5811          386   òòòòò÷       ó ó ó     ó   ó 
  329|GW3/1576Fett656   235   òòòòòûòòòòòòòú ó ó     ó   ó 
  334|GW10/2517FettS41  239   òòòòò÷       ó ó ó     ó   ó 
  166|Hel68*             70   òòòûòø       ó ó ó     ó   ó 
  78|1/Hel18            446   òòò÷ ùòòòø   ó ó ó     ó   ó 
  228|Bio42(1mg)        133   òòòûò÷   ùòòòú ó ó     ó   ó 
  92|1/Hel19            462   òòò÷     ó   ó ó ó     ó   ó 
  271|GW29/1496         179   òòòòòòòòò÷   ó ó ó     ó   ó 
  247|Bio210 der.IIa/1  153   òòòûòø       ó ó ó     ó   ó 
  249|Bio210 der.IIb/2  155   òòò÷ ùòòòø   ó ó ó     ó   ó 
  248|Bio210 der.IIa/2  154   òòòòò÷   ó   ó ó ó     ó   ó 
  285|GW13/580          193   òûòø     ó   ó ó ó     ó   ó 
  288|GW44/1326         196   ò÷ ùòø   ùòòòú ó ó     ó   ó 
  300|GW23/1540         210   òòò÷ ó   ó   ó ó ó     ó   ó 
  229|Bio26             134   òòòø ó   ó   ó ó ó     ó   ó 
  47|Bio208             344   òòòôòôòø ó   ó ó ó     ó   ó 
  303|Bio008*           213   òòò÷ ó ùò÷   ó ó ó     ó   ó 
  196|GW24/1838(rot)    100   òòòòò÷ ó     ó ó ó     ó   ó 
  63|Bio138             430   òòòòòòò÷     ó ó ó     ó   ó 
  463|Hel42             326   òòòòòòòòòûòòòú ó ó     ó   ó 
  545|GW5/3293          408   òòòòòòòòò÷   ó ó ó     ó   ó 
  306|Bio007* Ros       215   òòòòòûòòòòòòòú ó ó     ó   ó 
  346|Oel Can.(Seeds)   251   òòòòò÷       ó ó ó     ó   ó 
  183|Bio11  Ros         88   òòòòòòòûòòòø ó ó ó     ó   ó 
  207|Hel63b            110   òòòòòòò÷   ó ó ó ó     ó   ó 
  485|Bio271            350   òòòûòòòòòø ó ó ó ó     ùòòòú 
  518|Bio275            382   òòò÷     ó ó ó ó ó     ó   ó 
  470|GW14/3538         334   òòòûòø   ó ó ùò÷ ó     ó   ó 
  482|DFL31  Ros        347   òòò÷ ùòø ó ó ó   ó     ó   ó 
  178|Bio25              82   òòòûò÷ ó ó ó ó   ó     ó   ó 
  345|Schuk 15          250   òòò÷   ó ó ó ó   ó     ó   ó 
  278|Gw24/1694         186   òòòûòòòôòú ó ó   ó     ó   ó 
  291|GW7/882           200   òòò÷   ó ó ó ó   ó     ó   ó 
  465|B7435             328   òûòòòø ó ó ó ó   ó     ó   ó 
  524|DFL12  Ros        387   ò÷   ó ó ó ó ó   ó     ó   ó 
  378|Öl Bio215*        277   òòòø ó ó ó ó ó   ó     ó   ó 
  471|GW9/2668          335   òòòú ó ó ó ó ó   ó     ó   ó 
  28|Pic013             198   òòòôòú ó ó ó ó   ó     ó   ó 
  489|GW9/2122          354   òòò÷ ùò÷ ùòôòú   ó     ó   ó 
  496|Bio273            361   òø   ó   ó ó ó   ó     ó   ó 
  510|Bio279            375   òôòø ó   ó ó ó   ó     ó   ó 
  158|1/Bio46            62   ò÷ ùòú   ó ó ó   ó     ó   ó 
  549|DFL30  Ros        411   òòò÷ ó   ó ó ó   ó     ó   ó 
  113|Hel11*,zellen      14   òòòòò÷   ó ó ó   ó     ó   ó 
  487|GW3/1542          352   òòòòòòòòòú ó ó   ó     ó   ó 
  272|Hel74*            180   òòòòòòòòò÷ ó ó   ó     ó   ó 
  130|1/GCy,5-1          33   òòòòòûòø   ó ó   ó     ó   ó 
  530|GW12/3246         393   òòòòò÷ ùòø ó ó   ó     ó   ó 
  142|1/OM13,5           46   òòòòòòò÷ ùòú ó   ó     ó   ó 
  479|GW8/3394          343   òòòòòòòòò÷ ó ó   ó     ó   ó 
  269|Bio221            176   òòòòòûòòòòòú ó   ó     ó   ó 
  7|1/Hel27             448   òòòòò÷     ó ó   ó     ó   ó 
  171|B6935              75   òòòûòòòø   ó ó   ó     ó   ó 
  180|GW19/1534 (rot)    85   òòò÷   ùòòòú ó   ó     ó   ó 
  199|Bio13  Ros        102   òòòûòòòú   ó ó   ó     ó   ó 
  295|Hel73*            204   òòò÷   ó   ó ó   ó     ó   ó 
  25|Pic011             166   òòòûòòò÷   ó ó   ó     ó   ó 
  65|Bio144             432   òòò÷       ó ó   ó     ó   ó 
C16:0-(O)OH, 
C16:1-(O)OH 
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  20|Bio140             113   òòòûòø     ó ó   ó     ó   ó 
  64|Bio147             431   òòò÷ ùòòòòòú ó   ó     ó   ó 
  68|Bio134*            435   òòòòò÷     ó ó   ó     ó   ó 
  168|Hel73*             72   òòòûòø     ó ó   ó     ó   ó 
  231|Bio27             137   òòò÷ ùòø   ó ó   ó     ó   ó 
  210|Hel5(2.)          114   òòòòò÷ ó   ó ó   ó     ó   ó 
  279|AM13,1*           187   òòòòòø ùòø ó ó   ó     ó   ó 
  301|MPep,2*           211   òòòòòú ó ó ó ó   ó     ó   ó 
  356|MCy,4             262   òûòø ùò÷ ó ó ó   ó     ó   ó 
  361|Bio210*           267   ò÷ ùòú   ó ó ó   ó     ó   ó 
  276|Hel13*            184   òòò÷ ó   ó ó ó   ó     ó   ó 
  477|DFL33             341   òòòòò÷   ó ó ó   ó     ó   ó 
  335|Hel51b,V1         240   òûòø     ó ó ó   ó     ó   ó 
  336|GW71/2497* 1.     241   ò÷ ó     ó ó ó   ó     ó   ó 
  359|B8027             264   òòòôòø   ó ó ó   ó     ó   ó 
  326|Ccy8FettR         232   òòò÷ ùòø ùòú ó   ó     ó   ó 
  430|B1848             303   òòòòò÷ ùòú ó ó   ó     ó   ó 
  431|Bio134* 1.        304   òòòòòòò÷ ó ó ó   ó     ó   ó 
  102|1/IHg,4             3   òûòø     ó ó ó   ó     ó   ó 
  129|1/IHg,3            31   ò÷ ùòø   ó ó ó   ó     ó   ó 
  90|1/ACF,5            460   òòò÷ ùòø ó ó ó   ó     ó   ó 
  202|ANT323            106   òûòø ó ó ó ó ó   ó     ó   ó 
  215|ANT46             119   ò÷ ùò÷ ó ó ó ó   ó     ó   ó 
  89|1/ACF,8-1          458   òòò÷   ó ó ó ó   ó     ó   ó 
  265|Pic019            172   òûòòòø ùòú ó ó   ó     ó   ó 
  283|Pic016            191   ò÷   ùòú ó ó ó   ó     ó   ó 
  208|Bio24  Ros        111   òòòòò÷ ó ó ó ó   ó     ó   ó 
  478|GW5/5754          342   òûòø   ó ó ó ó   ó     ó   ó 
  533|Bio252            395   ò÷ ó   ó ó ó ó   ó     ó   ó 
  536|B5357             398   òûòú   ó ó ó ó   ó     ó   ó 
  543|GW4/5739          406   ò÷ ùòø ó ó ó ó   ó     ó   ó 
  498|B5381             362   òø ó ó ó ó ó ó   ó     ó   ó 
  505|GW10/3234         371   òôòú ó ó ó ó ó   ó     ó   ó 
  461|Pic072  Ros       324   òú ó ùò÷ ó ó ó   ó     ó   ó 
  538|Bio268            400   ò÷ ó ó   ó ó ó   ó     ó   ó 
  483|GW10/3246         348   òòò÷ ó   ó ó ó   ó     ó   ó 
  146|HKI 129-2          49   òûòø ó   ó ó ó   ó     ó   ó 
  98|HKI 129-1          468   ò÷ ùò÷   ó ó ó   ó     ó   ùòø 
  475|GW5/3231          339   òòò÷     ó ó ó   ó     ó   ó ó 
  216|ANT358            120   òòòûòòòòòú ó ó   ó     ó   ó ó 
  467|Bio257            330   òòò÷     ó ó ó   ó     ó   ó ó 
  481|GW5/3289          346   òòòø     ó ó ó   ó     ó   ó ó 
  539|GW5/3315          401   òòòôòòòòòú ó ó   ó     ó   ó ó 
  529|GW19/3239         391   òòò÷     ó ó ó   ó     ó   ó ó 
  243|Hel79 (1mg)       149   òòòòòûòø ó ó ó   ó     ó   ó ó 
  429|KV361(B55546)II   301   òòòòò÷ ó ó ó ó   ó     ó   ó ó 
  118|B1616              19   òòòûòø ó ó ó ó   ó     ó   ó ó 
  260|GW22/1326         167   òòò÷ ùòôòú ó ó   ó     ó   ó ó 
  12|1/115ba             32   òòòø ó ó ó ó ó   ó     ó   ó ó 
  95|1//0025            465   òòòôò÷ ó ó ó ó   ó     ó   ó ó 
  106|1/AMP3*             7   òûòú   ó ó ó ó   ó     ó   ó ó 
  400|GW24/1811         284   ò÷ ó   ó ó ó ó   ó     ó   ó ó 
  206|Bio15             109   òòòú   ó ó ó ó   ó     ó   ó ó 
  296|GW19/1343         205   òòò÷   ó ó ó ó   ó     ó   ó ó 
  45|Pic008             323   òòòòòòò÷ ó ó ó   ó     ó   ó ó 
  469|GW11/3535         332   òòòûòòòø ó ó ó   ó     ó   ó ó 
  97|1/CCy,8 Hfl        467   òòò÷   ó ó ó ó   ó     ó   ó ó 
  15|1/Hel28             63   òûòø   ó ó ó ó   ó     ó   ó ó 
  6|1/Hel34             437   ò÷ ó   ó ó ó ó   ó     ó   ó ó 
  107|1/Hel37             8   òûòú   ó ó ó ó   ó     ó   ó ó 
  18|1/Hel33             94   ò÷ ó   ó ó ó ó   ó     ó   ó ó 
  110|ACF,8              12   òòòôòø ó ó ó ó   ó     ó   ó ó 
  88|1/GT161b           457   òòòú ó ó ó ó ó   ó     ó   ó ó 
  13|1//0024             43   òòò÷ ó ó ó ó ó   ó     ó   ó ó 
  136|1/Hel24            39   òòòø ùòú ó ó ó   ó     ó   ó ó 
  290|GT161a            199   òòòôòú ó ó ó ó   ó     ó   ó ó 
  116|1/NM13,1/Hfl       17   òòòú ó ó ó ó ó   ó     ó   ó ó 
  331|921,Fett921       237   òòò÷ ó ó ó ó ó   ó     ó   ó ó 
  76|1/Hel41            444   òòòòòú ó ó ó ó   ó     ó   ó ó 
  492|GW42/1535         358   òòòòò÷ ùò÷ ó ó   ó     ó   ó ó 
  11|1/91bb              21   òòòòòòòú   ó ó   ó     ó   ó ó 
  174|B7693              78   òûòòòø ó   ó ó   ó     ó   ó ó 
  259|GW2/1332 rot      165   ò÷   ó ó   ó ó   ó     ó   ó ó 
  253|GW62/1540 rot     160   òòòø ó ó   ó ó   ó     ó   ó ó 
  287|GW7/1330          195   òòòôòôòú   ó ó   ó     ó   ó ó 
  263|QW20/1702 rot     170   òòò÷ ó ó   ó ó   ó     ó   ó ó 
  294|GW69/1540 pink    203   òòòòò÷ ó   ó ó   ó     ó   ó ó 
  360|GW14/1750         266   òòòûòø ó   ó ó   ó     ó   ó ó 
  377|Öl GW62/1540      276   òòò÷ ùòú   ó ó   ó     ó   ó ó 
  406|GW13/3993         288   òòòòò÷ ó   ó ó   ó     ó   ó ó 
Hexanetriols 30-35 
Long-chain 
esters 
Lactones 49a, 49b, 
C35 terpenes 26, 27 
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  214|Bio22 (1mg)       118   òòòûòø ó   ó ó   ó     ó   ó ó 
  292|Amp,3*            201   òòò÷ ùòú   ó ó   ó     ó   ó ó 
  537|GW11/3289         399   òòòòò÷ ó   ó ó   ó     ó   ó ó 
  134|1/ACP,4            37   òòòø   ó   ó ó   ó     ó   ó ó 
  213|Bio2              117   òòòôòø ó   ó ó   ó     ó   ó ó 
  547|GW5/3239          409   òòò÷ ùòú   ó ó   ó     ó   ó ó 
  432|AM13,1*           305   òòòòò÷ ó   ó ó   ó     ó   ó ó 
  21|Bio211             124   òòòûòø ó   ó ó   ó     ó   ó ó 
  69|Bio211/2           436   òòò÷ ùòú   ó ó   ó     ó   ó ó 
  302|Hel12*            212   òòòòò÷ ó   ó ó   ó     ó   ó ó 
  411|K- II Fph         291   òûòòòø ó   ó ó   ó     ó   ó ó 
  412|K- III Fph        292   ò÷   ùòú   ó ó   ó     ó   ó ó 
  22|Hel38*             135   òòòòò÷ ó   ó ó   ó     ó   ó ó 
  26|Bio204  Ros        177   òòòòòûòú   ó ó   ó     ó   ó ó 
  41|Pic002             295   òòòòò÷ ó   ó ó   ó     ó   ó ó 
  327|B7693Fett1016     233   òòòûòø ó   ó ó   ó     ó   ó ó 
  440|B6273             313   òòò÷ ó ó   ó ó   ó     ó   ó ó 
  441|GW19/2497         314   òòòûòú ó   ó ó   ó     ó   ó ó 
  491|Bio267            357   òòò÷ ùòú   ó ó   ó     ó   ó ó 
  101|1/H135ba            2   òòòòòú ó   ó ó   ó     ó   ó ó 
  96|1/GCy,1            466   òòòòò÷ ó   ó ó   ó     ó   ó ó 
  17|1/Hel17             84   òòòûòø ó   ó ó   ó     ó   ó ó 
  2|1/Hel12*            209   òòò÷ ó ó   ó ó   ó     ó   ó ó 
  211|Bio7*  Ros        115   òòòûòú ó   ó ó   ó     ó   ó ó 
  236|Hel51b            142   òòò÷ ó ó   ó ó   ó     ó   ó ó 
  218|Hel55b            122   òòòø ó ó   ó ó   ó     ó   ó ó 
  224|Hel67b            129   òòòú ó ó   ó ó   ó     ó   ó ó 
  232|Hel8*(2)  Ros     138   òûòôòú ó   ó ó   ó     ó   ó ó 
  242|Hel1(2)           148   ò÷ ó ó ó   ó ó   ó     ó   ó ó 
  235|Bio4              141   òø ó ó ó   ó ó   ó     ó   ó ó 
  237|Hel8*(1)(3)  Ros  143   òôòú ó ó   ó ó   ó     ó   ó ó 
  212|Bio29             116   ò÷ ó ó ó   ó ó   ó     ó   ó ó 
  131|1/Hel13*           34   òòòú ó ó   ó ó   ó     ó   ó ó 
  261|Bio232            168   òòò÷ ó ó   ó ó   ó     ó   ó ó 
  205|Bio8*             108   òòòòòú ó   ó ó   ó     ó   ó ó 
  40|Bio123             289   òòòòòú ó   ó ó   ó     ó   ó ó 
  555|Hel59* 1431       417   òûòòòú ó   ó ó   ó     ó   ó ó 
  556|Hel59* 1432       418   ò÷   ó ó   ó ó   ó     ó   ó ó 
  43|Pic107             312   òûòòòú ó   ó ó   ó     ó   ó ó 
  58|Pic108             424   ò÷   ó ó   ó ó   ó     ó   ó ó 
  119|1//0004            20   òòòûòú ó   ó ó   ó     ó   ó ó 
  32|Bio205  Ros        236   òòò÷ ó ó   ó ó   ó     ó   ó ó 
  363|B8815             269   òòòòòú ó   ó ó   ó     ó   ó ó 
  365|B6005             271   òòòòòú ó   ó ó   ó     ó   ó ó 
  48|Pic009*            355   òòòø ó ó   ó ó   ó     ó   ó ó 
  52|Pic012             392   òòòú ó ó   ó ó   ó     ó   ó ó 
  37|Bio209             279   òûòú ó ó   ó ó   ó     ó   ó ó 
  42|Pic018             302   ò÷ ùòú ó   ó ó   ó     ó   ó ó 
  217|Hel71             121   òòòú ó ó   ó ó   ó     ó   ó ó 
  203|Bio23             107   òòò÷ ó ó   ó ó   ó     ó   ó ó 
  266|Bio237            173   òòòòòú ó   ó ó   ó     ó   ó ó 
  44|Pic101             318   òûòòòú ó   ó ó   ó     ó   ó ó 
  51|Pic111             384   ò÷   ó ó   ó ó   ó     ó   ó ó 
  277|GW27/2506 gruen   185   òòòûòú ó   ó ó   ó     ó   ó ó 
  82|1/ACF,8-5*         451   òòò÷ ó ó   ó ó   ó     ó   ó ó 
  156|1/GCy,5Hfl         60   òòòø ó ó   ó ó   ó     ó   ó ó 
  66|Bio133             433   òòòôòú ó   ó ó   ó     ó   ó ó 
  135|1/ACP,4LB          38   òòòú ó ó   ó ó   ó     ó   ó ó 
  50|Bio212             374   òòòú ó ó   ó ó   ó     ó   ó ó 
  39|Bio148             282   òòò÷ ùò÷   ó ó   ó     ó   ó ó 
  239|VH Hel10*Fett Ros 145   òòòø ó     ó ó   ó     ó   ó ó 
  93|1/AM13,1*          463   òòòú ó     ó ó   ó     ó   ó ó 
  200|Hel57b            104   òòòú ó     ó ó   ó     ó   ó ó 
  298|Hel45*  Ros       206   òòòôòú     ó ó   ó     ó   ó ó 
  185|Hel43b  Ros        90   òòòú ó     ó ó   ó     ó   ó ó 
  177|Hel3(2.)           81   òòò÷ ó     ó ó   ó     ó   ó ó 
  141|1/KCy,10           45   òø   ó     ó ó   ó     ó   ó ó 
  162|DSG46              66   òôòø ó     ó ó   ó     ó   ó ó 
  244|Bio210 der.IIb/1  150   ò÷ ó ó     ó ó   ó     ó   ó ó 
  14|1/Hel30             53   òø ó ó     ó ó   ó     ó   ó ó 
  5|1/Icy,2             426   òú ó ó     ó ó   ó     ó   ó ó 
  59|Pic021             425   òôòú ó     ó ó   ó     ó   ó ó 
  54|Pic109             412   ò÷ ó ó     ó ó   ó     ó   ó ó 
  34|Bio145             255   òòòú ó     ó ó   ó     ó   ó ó 
  29|Bio149             208   òûòú ó     ó ó   ó     ó   ó ó 
  49|Pic023             364   ò÷ ó ó     ó ó   ó     ó   ó ó 
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  30|Bio213             219   òûòú ó     ó ó   ó     ó   ó ó 
  33|Bio214             245   ò÷ ó ó     ó ó   ó     ó   ó ó 
  181|Bio1*              86   òòòú ó     ó ó   ó     ó   ó ó 
  318|Pic009FN*         226   òòòú ó     ó ó   ó     ó   ó ó 
  117|1/MPep,2*          18   òòòú ó     ó ó   ó     ó   ó ó 
  504|GW21/3538         370   òûòú ó     ó ó   ó     ó   ó ó 
  527|GW27/3236         389   ò÷ ó ó     ó ó   ó     ó   ó ó 
  172|Bio5               76   òø ó ó     ó ó   ó     ó   ó ó 
  289|RK339 rot         197   òôòú ó     ó ó   ó     ó   ó ó 
  541|Bio246            404   ò÷ ùòú     ó ó   ó     ó   ó ó 
  557|Hel59* 1433       419   òûòú ó     ó ó   ó     ó   ó ó 
  558|Hel59* 1434       420   ò÷ ó ó     ó ó   ó     ó   ó ó 
  428|KVC2(GW13/580)II  300   òø ó ó     ó ó   ó     ó   ó ó 
  456|Hel2              320   òú ó ó     ó ó   ó     ó   ó ó 
  502|B6057             368   òú ó ó     ó ó   ó     ó   ó ó 
  512|B5409             377   òú ó ó     ó ó   ó     ó   ó ó 
  67|Bio210*            434   òú ó ó     ó ó   ó     ó   ó ó 
  426|KV44C1(GW44/1571  298   òú ó ó     ó ó   ó     ó   ó ó 
  251|GW14/587          158   òú ó ó     ó ó   ó     ó   ó ó 
  314|GW29/1540*        223   òú ó ó     ó ó   ó     ó   ó ó 
  197|Bio37             101   òôòú ó     ó ó   ó     ó   ó ó 
  443|B6007* 2.         316   òú ó ó     ó ó   ó     ó   ó ó 
  115|HKI135L            16   ò÷ ó ó     ó ó   ó     ó   ó ó 
  176|HKIB243-2          80   òòòú ó     ó ó   ó     ó   ó ó 
  366|Hel23*            272   òòòú ó     ó ó   ó     ó   ó ó 
  454|Bio1* alt         319   òòòú ó     ó ó   ó     ó   ó ó 
  304|RK339gelb         214   òòòú ó     ó ó   ó     ó   ó ó 
  284|GW2/1343          192   òòòú ó     ó ó   ó     ó   ó ó 
  24|Bio150             156   òòòú ó     ó ó   ó     ó   ó ó 
  103|1/HKI136L           4   òòòú ó     ó ó   ó     ó   ó ó 
  466|B7447             329   òòò÷ ó     ó ó   ó     ó   ó ó 
  254|GW20/1298         161   òòòòòú     ó ó   ó     ó   ó ó 
  31|Bio136             227   òòòòòú     ó ó   ó     ó   ó ùòø 
  201|ANT17             105   òòòòòú     ó ó   ó     ó   ó ó ó 
  317|Alkane std.       225   òòòòò÷     ó ó   ó     ó   ó ó ó 
  36|Bie68a*            274   òòòòòòòòòòòú ó   ó     ó   ó ó ó 
  262|Hel11*            169   òòòòòòòòòòò÷ ó   ó     ó   ó ó ó 
  339|B8245*            244   òòòòòòòòòòòòòú   ó     ó   ó ó ó 
  435|B8876             307   òòòòòòòòòòòòò÷   ó     ó   ó ó ó 
  83|1/GCy,5            452   òòòòòòòòòòòòòòòòòú     ó   ó ó ó 
  163|G49                67   òòòòòòòòòòòòòòòòò÷     ó   ó ó ó 
  542|Pic265            405   òòòòòòòòòòòòòòòòòòòòòòòú   ó ó ó 
  152|1//0019            56   òòòòòòòòòòòòòòòòòòòòòòòú   ó ó ó 
  307|Bio024  Ros       216   òòòòòòòòòòòòòòòòòòòòòòò÷   ó ó ó 
  380|Öl GW10/1828      280   òûòø                       ó ó ó 
  402|GW22/1499b        286   ò÷ ùòòòòòòòòòòòòòòòòòòòòòòò÷ ó ó 
  403|GW22/1499a        287   òòò÷                         ó ó 
  124|1/Hel135bb         26   òòòø                         ó ó 
  80|1/GW73a            449   òòòôòø                       ó ó 
  511|Bio250            376   òòò÷ ùòòòø                   ó ó 
  4|1/Bie68aa*          365   òòòòò÷   ùòòòòòòòòòòòòòòòòòòòú ó 
  413|BLANK181102       293   òòòòòòòòò÷                   ó ùòø 
  419|KVC4(GW13/580)    294   òòòûòø                       ó ó ó 
  501|Bio280            367   òòò÷ ùòòòòòòòòòòòòòòòòòòòòòòòú ó ó 
  473|Bio274            337   òòòòò÷                       ó ó ó 
  320|DSQ2S             228   òòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ó ùòø 
  313|GW19/1251         222   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòú ó ó 
  347|GW29/1540* 1.     252   òòòûòòòòòòòòòø                 ó ó ó 
  550|GW1/3124          413   òòò÷         ùòòòòòòòòòòòòòòòòò÷ ó ó 
  410|K- I Fph          290   òòòòòòòòòòòòò÷                   ó ùòø 
  342|GW27/1627* 2./II  247   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ó ó 
  358|GW44/1571B        263   òø                                 ó ó 
  517|GW10/1746         381   òôòòòø                             ó ùòø 
  100|1/IM13,5            1   ò÷   ùòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ó ó 
  209|KVCyB16           112   òòòòò÷                               ó ó 
Long-chain ketones 
and alkenes 
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Dendogram 8.11  Continued. 
 
 
 
  245|Pic004 der.Ib     151   òø                                   ó ó 
  246|Pic004 der.Ia     152   òôòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ùòø 
  133|1/ACF,5-5          36   ò÷                                     ó ó 
  552|B1010             415   òø                                     ó ó 
  553|B1010/2           416   òú                                     ó ó 
  85|1/GWGO/1571        454   òôòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ó 
  353|GW71K1S1          259   òú                                       ó 
  442|B6007* 1.         315   ò÷                                       ó 
  53|Pic004             402   òø                                       ó 
  57|Pic006             423   òú                                       ó 
  275|Bio236            183   òú                                       ùòø 
  155|1/GCy,5-5          59   òôòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòú ó 
  252|GCy,5             159   òú                                       ó ó 
  35|Pic003             265   òú                                       ó ó 
  61|Pic024             428   ò÷                                       ó ó 
  362|FPep,1A           268   òûòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ùòø 
  444|Bio134* 2.        317   ò÷                                         ó ó 
  316|Solvent           224   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòú ùòø 
  427|KVC4P1(Hel38)     299   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ó ó 
  55|Pic007             421   òø                                           ó ó 
  60|Pic010             427   òôòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ùòø 
  274|Bio231            182   òú                                             ó ó 
  299|Pic005            207   ò÷                                             ó ó 
  422|KV1C2(B7278)      297   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ ó 
  324|DSQB7             230   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ 
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Dendogram 8.12  HCA of GC data from the time interval 84-89 min with all samples, average 
linkage, quadratic Euclidean distance; samples in bold contain the C35 terpenes 26 and 27. 
 
 
 
                                     Rescaled Distance Cluster Combine 
 
          C A S E            0         5        10        15        20        25 
  Label                 Num  +---------+---------+---------+---------+---------+ 
 
  539|GW5/3315          263   òø 
  549|DFL30             268   òú 
  134|1/ACP,4            21   òú 
  535|GW14/2108         259   òú 
  537|GW11/3289         261   òú 
  515|GW6/3535          251   òú 
  528|GW11/1900         255   òú 
  490|GW31/1539         218   òú 
  492|GW42/1535         219   òú 
  40|Bio123             188   òú 
  484|GW22/3234         216   òú 
  314|GW29/1540         142   òú 
  359|B8027             170   òú 
  312|GW29/1540         140   òú 
  313|GW19/1251         141   òú 
  291|GW7/882           126   òú 
  294|GW69/1540 pink    128   òú 
  285|GW13/580          121   òú 
  288|GW44/1326         124   òú 
  278|Gw24/1694         117   òú 
  284|GW2/1343          120   òú 
  267|GW11/919          111   òú 
  277|GW27/2506 gruen   116   òú 
  260|GW22/1326         106   òú 
  263|QW20/1702 rot     108   òú 
  250|GW14/709           98   òú 
  251|GW14/587           99   òú 
  401|B4475              67   òú 
  242|Hel1(2.) (1mg)     95   òú 
  246|Pic004 der.Ia      60   òú 
  311|GW19/1251          63   òú 
  187|GW64/1571a         51   òú 
  148|1/ACF,5 Hfl        57   òú 
  142|1/OM13,5           28   òú 
  174|B7693              43   òú 
  254|GW20/1298         102   òôòòòòòø 
  259|GW2/1332 rot      105   òú     ó 
  287|GW7/1330          123   òú     ó 
  300|GW23/1540         133   òú     ó 
  327|B7693Fett1016     149   òú     ó 
  253|GW62/1540 rot     101   ò÷     ùòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòø 
  336|GW71/2497 1.      155   òûòø   ó                                 ó 
  54|Pic109             223   ò÷ ó   ó                                 ó 
  130|1/GCy,5-1          20   òòòôòø ó                                 ó 
  354|GW27/1627 1.      167   òòò÷ ó ó                                 ó 
  110|ACF,8               9   òûòø ùò÷                                 ó 
  167|GW24/1694          39   ò÷ ó ó                                   ó 
  224|Hel67b (1mg)       87   òø ùò÷                                   ó 
  243|Hel79 (1mg)        96   òú ó                                     ó 
  116|1/NM13,1/Hfl       12   òôò÷                                     ó 
  97|1/CCy,8 Hfl        247   òú                                       ó 
  540|GW4/3292          264   òú                                       ó 
  156|1/GCy,5Hfl         35   òú                                       ó 
  530|GW12/3246         256   ò÷                                       ó 
  162|DSG46              37   òø                                       ó 
  239|VH Hel10 Fett      92   òôòòòòòòòòòø                             ó 
  244|Bio210 der.IIb/1   97   ò÷         ó                             ó 
  98|HKI 129-1          248   òø         ó                             ó 
  541|Bio246            265   òú         ó                             ó 
  102|1/IHg,4             3   òú         ó                             ó 
  86|1/CCy,8            237   òú         ó                             ó 
  93|1/AM13,1           244   òú         ó                             ó 
  494|GW6/3428          220   òú         ó                             ó 
  51|Pic111             222   òú         ó                             ó 
  475|GW5/3231          209   òú         ó                             ó 
  480|GW10/3428         213   òú         ó                             ó 
  436|B8652             195   òú         ó                             ó 
  510|Bio279            202   òú         ó                             ó 
  367|B5543(MA2)        176   òú         ó                             ó 
  427|KVC4P1(Hel38)     192   òú         ó                             ó 
  347|GW29/1540 1.      164   òú         ó                             ó 
  365|B6005             174   òú         ó                             ó 
  343|B8245             161   òú         ó                             ó 
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Dendogram 8.12  Continued. 
 
 
  346|Oel Can.(Seeds)   163   òú         ó                             ó 
  339|B8245             157   òú         ùòòòòòòòòòòòòòòòòòø           ó 
  34|Bio145             158   òú         ó                 ó           ó 
  331|921,Fett921       152   òú         ó                 ó           ó 
  332|GW26/1546,F1170   153   òú         ó                 ó           ó 
  214|Bio22 (1mg)        80   òú         ó                 ó           ó 
  318|Pic009FN          144   òú         ó                 ó           ó 
  149|1/OCy,4            31   òú         ó                 ó           ùòòòø 
  201|ANT17 (1mg)        72   òú         ó                 ó           ó   ó 
  129|1/IHg,3            18   òú         ó                 ó           ó   ó 
  146|HKI129-2           30   òú         ó                 ó           ó   ó 
  104|1/Am13,2            5   òú         ó                 ó           ó   ó 
  118|B1616              13   òú         ó                 ó           ó   ó 
  296|GW19/1343         129   òú         ó                 ó           ó   ó 
  202|ANT323 (2mg)       73   òú         ó                 ó           ó   ó 
  90|1/ACF,5            241   òú         ó                 ó           ó   ó 
  350|GW23/1540         166   òôòòòòòòòø ó                 ó           ó   ó 
  215|ANT46 (2mg)        81   òú       ó ó                 ó           ó   ó 
  99|1/CCy,8-1          249   òú       ó ó                 ó           ó   ó 
  238|ANT321 (2mg)       91   òú       ó ó                 ó           ó   ó 
  435|B8876             194   ò÷       ùò÷                 ó           ó   ó 
  328|Ccy8CFBFettR2      64   òø       ó                   ó           ó   ó 
  89|1/ACF,8-1          239   òôòòòòòø ó                   ó           ó   ó 
  113|Hel11,zellen       11   òú     ó ó                   ó           ó   ó 
  141|1/KCy,10           27   ò÷     ó ó                   ó           ó   ó 
  329|GW3/1576Fett656   150   òø     ùò÷                   ó           ó   ó 
  363|B8815             172   òôòòòòòú                     ó           ó   ó 
  376|Öl B7176          178   ò÷     ó                     ó           ó   ó 
  479|GW8/3394          212   òø     ó                     ó           ó   ó 
  513|GW29/3371         250   òôòø   ó                     ó           ó   ó 
  500|GW1/3268          190   ò÷ ùòø ó                     ó           ó   ó 
  507|GW3/3537          201   òø ó ó ó                     ó           ó   ó 
  474|GW12/1492         208   òôò÷ ó ó                     ó           ó   ó 
  440|B6273             197   ò÷   ùò÷                     ó           ó   ó 
  326|Ccy8FettR         148   òûòø ó                       ó           ó   ó 
  82|1/ACF,8-5          234   ò÷ ó ó                       ó           ó   ó 
  498|B5381             187   òø ó ó                       ó           ó   ó 
  478|GW5/5754          211   òú ùò÷                       ó           ó   ó 
  505|GW10/3234         200   òú ó                         ó           ó   ó 
  457|B7486             203   òú ó                         ó           ó   ó 
  460|B7500             204   òú ó                         ó           ó   ó 
  465|B7435             206   òôò÷                         ó           ó   ó 
  526|GW15/3246         253   òú                           ó           ó   ó 
  536|B5357             260   òú                           ó           ó   ó 
  545|GW5/3293          267   òú                           ó           ó   ó 
  145|1//0001            29   ò÷                           ó           ó   ó 
  471|GW9/2668           68   òûòø                         ó           ó   ó 
  543|GW4/5739          266   ò÷ ùòø                       ó           ó   ó 
  469|GW11/3535         207   òòò÷ ùòòòòòø                 ùòòòòòòòòòòò÷   ó 
  176|HKIB243-2          44   òûòø ó     ó                 ó               ó 
  360|GW14/1750          65   ò÷ ùò÷     ó                 ó               ó 
  44|Pic101             196   òòò÷       ó                 ó               ó 
  59|Pic021             224   òø         ó                 ó               ó 
  64|Bio147             225   òú         ó                 ó               ó 
  69|Bio211/2           226   òú         ó                 ó               ó 
  24|Bio150              93   òú         ó                 ó               ó 
  39|Bio148             185   òôòòòòòòòòòú                 ó               ó 
  85|1/GWGO/1571        236   òú         ó                 ó               ó 
  5|1/Icy,2             221   ò÷         ó                 ó               ó 
  482|DFL31             214   òø         ùòòòòòòòòòø       ó               ó 
  534|GW13/2973         258   òú         ó         ó       ó               ó 
  127|1/101ba            17   òú         ó         ó       ó               ó 
  390|Pic009 Fph 5L ud  186   òú         ó         ó       ó               ó 
  444|Bio134/2          199   òú         ó         ó       ó               ó 
  388|Hel12 Fph 5L ud   183   òú         ó         ó       ó               ó 
  389|Pic006 Fph 5L ud  184   òú         ó         ó       ó               ó 
  338|GW27/1627 2.      156   òú         ó         ó       ó               ó 
  342|GW27/1627 2./II   160   òú         ó         ó       ó               ó 
  264|FPep,1            109   òú         ó         ó       ó               ó 
  323|Hel45c-C6         147   òú         ó         ó       ó               ó 
  384|AMP3 Fph 5L ud     66   òú         ó         ó       ó               ó 
  219|Hel74 (1mg)        83   òú         ó         ó       ó               ó 
  164|1/107aa            58   òú         ó         ó       ó               ó 
  180|GW19/1534 (rot)    59   òú         ó         ó       ó               ó 
  183|Bio11 (1mg)        49   òú         ó         ó       ó               ó 
  194|B1751              54   òú         ó         ó       ó               ó 
  181|Bio1 (2mg)         47   òú         ó         ó       ó               ó 
  182|Ccy,8-5 (2mg)      48   òú         ó         ó       ó               ó 
  172|Bio5 (1mg)         41   òú         ó         ó       ó               ó 
  177|Hel3(2.) (1mg)     45   òú         ó         ó       ó               ó 
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Dendogram 8.12  Continued. 
 
 
  154|1/ACy,4            34   òôòòòòòø   ó         ó       ó               ó 
  165|Hel53a (2mg)       38   òú     ó   ó         ó       ó               ó 
  135|1/ACP,4LB          22   ò÷     ó   ó         ó       ó               ó 
  173|1/Ccy,8            42   òø     ó   ó         ó       ó               ó 
  355|Oel Can.(Trunk)   168   òôòòòø ó   ó         ó       ó               ó 
  261|Bio232            107   ò÷   ó ó   ó         ó       ó               ó 
  119|1//0004            14   òø   ó ó   ó         ó       ó               ùòòòø 
  282|GW7/1541          118   òú   ó ùòòò÷         ó       ó               ó   ó 
  205|Bio8 (2mg)         75   òú   ó ó             ó       ó               ó   ó 
  431|Bio134            193   òú   ó ó             ó       ó               ó   ó 
  262|Hel11              61   òú   ó ó             ó       ó               ó   ó 
  265|Pic019            110   òú   ó ó             ó       ó               ó   ó 
  270|AM13,1 weiß       113   òú   ó ó             ó       ó               ó   ó 
  286|Hel10             122   òôòø ó ó             ó       ó               ó   ó 
  258|Bio017            104   òú ó ùò÷             ó       ó               ó   ó 
  306|Bio007            137   òú ó ó               ó       ó               ó   ó 
  298|Hel45             130   òú ó ó               ùòòòòòòò÷               ó   ó 
  170|Hel59b (4mg)       40   òú ó ó               ó                       ó   ó 
  191|Bio16 (1mg)        52   òú ó ó               ó                       ó   ó 
  193|Bio41 (4mg)        53   òú ó ó               ó                       ó   ó 
  273|Bio001            114   òú ó ó               ó                       ó   ó 
  106|1/AMP3              7   òú ó ó               ó                       ó   ó 
  218|Hel55b (3mg)       82   òú ó ó               ó                       ó   ó 
  256|Pic022            103   òú ó ó               ó                       ó   ó 
  207|Hel63b (7mg)       76   òú ùò÷               ó                       ó   ó 
  302|Hel12             135   òú ó                 ó                       ó   ó 
  200|Hel57b (1mg)       71   òú ó                 ó                       ó   ó 
  131|1/Hel13            56   ò÷ ó                 ó                       ó   ó 
  524|DFL12             252   òø ó                 ó                       ó   ó 
  533|Bio252            257   òú ó                 ó                       ó   ó 
  461|Pic072            205   òú ó                 ó                       ó   ó 
  538|Bio268            262   òú ó                 ó                       ó   ó 
  185|Hel43b (1mg)       50   òú ó                 ó                       ó   ó 
  221|Hel46b (1mg)       85   òú ó                 ó                       ó   ó 
  295|Hel73              62   òú ó                 ó                       ó   ó 
  208|Bio24 (1mg)        77   òôò÷                 ó                       ó   ó 
  477|DFL33             210   òú                   ó                       ó   ó 
  137|1/Hg,4             24   òú                   ó                       ó   ó 
  309|Hel68             138   òú                   ó                       ó   ó 
  364|GW12/3995         173   òú                   ó                       ó   ó 
  387|Hel59 Fph 5L ud   182   òú                   ó                       ó   ó 
  223|Hel48b/4.5 (2mg)   86   òú                   ó                       ó   ó 
  483|GW10/3246         215   òú                   ó                       ó   ó 
  209|KVCyB16 (2,5mg)    78   òú                   ó                       ó   ó 
  299|Pic005            131   òú                   ó                       ó   ó 
  283|Pic016            119   òú                   ó                       ó   ó 
  400|GW24/1811         189   òú                   ó                       ó   ó 
  126|1/ACF,5            16   òú                   ó                       ó   ó 
  292|Amp,3             127   ò÷                   ó                       ó   ó 
  103|1/HKI136L           4   òûòòòòòòòòòòòø       ó                       ó   ó 
  304|RK339gelb         136   ò÷           ó       ó                       ó   ó 
  229|Bio26 (4mg)        89   òø           ó       ó                       ó   ó 
  268|Hel23             112   òôòø         ó       ó                       ó   ó 
  252|GCy,5             100   ò÷ ùòø       ùòòòòòòò÷                       ó   ó 
  301|MPep,2            134   òòò÷ ó       ó                               ó   ó 
  320|DSQ2S             146   òø   ó       ó                               ó   ó 
  487|GW3/1542          217   òú   ó       ó                               ó   ó 
  203|Bio23 (6mg)        74   òú   ùòòòòòòò÷                               ó   ó 
  237|Hel8(1)(3.)(1mg)   90   òú   ó                                       ó   ó 
  276|Hel13             115   òú   ó                                       ó   ó 
  212|Bio29 (3mg)        79   òú   ó                                       ó   ó 
  226|ACF,8-5 (1mg)      88   òôòø ó                                       ó   ó 
  317|Alkane std.       143   òú ùò÷                                       ó   ó 
  289|RK339 rot         125   ò÷ ó                                         ó   ó 
  310|GW90a             139   òòò÷                                         ó   ó 
  13|1//0024             19   òø                                           ó   ó 
  95|1//0025            246   òú                                           ó   ó 
  32|Bio205             145   òú                                           ó   ó 
  335|Hel51b,V1         154   òôòø                                         ó   ó 
  91|1/Amp,2            242   ò÷ ó                                         ó   ó 
  22|Hel38               84   òø ùòòòø                                     ó   ó 
  345|Schuk 15          162   òú ó   ó                                     ó   ó 
  341|1/AMP3 ud         159   òôò÷   ó                                     ó   ó 
  349|Bio232            165   òú     ó                                     ó   ó 
  14|1/Hel30             26   ò÷     ó                                     ó   ó 
  92|1/Hel19            243   òø     ó                                     ó   ó 
  94|1/Hel26            245   òú     ó                                     ó   ó 
  10|1/Hel35              1   òú     ó                                     ó   ó 
  84|1/Lox155ab         235   òú     ó                                     ó   ó 
  87|1/Hel14            238   òú     ó                                     ó   ó 
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Dendogram 8.12  Continued. 
 
 
  78|1/Hel18            232   òú     ó                                     ó   ó 
  79|1/Hel32            233   òú     ó                                     ó   ó 
  76|1/Hel41            230   òú     ó                                     ó   ó 
  77|1/107aa            231   òú     ó                                     ó   ó 
  70|1/Hel29            228   òú     ó                                     ó   ó 
  74|1/Hel25            229   òú     ó                                     ó   ó 
  42|Pic018             191   òú     ùòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷   ó 
  7|1/Hel27             227   òú     ó                                         ó 
  366|Hel23             175   òú     ó                                         ó 
  377|Öl GW62/1540      179   òú     ó                                         ó 
  356|MCy,4             169   òú     ó                                         ó 
  361|Bio210            171   òú     ó                                         ó 
  75|1/Hel23             69   òú     ó                                         ó 
  2|1/Hel12              70   òú     ó                                         ó 
  157|1/GW73b            36   òú     ó                                         ó 
  18|1/Hel33             46   òú     ó                                         ó 
  15|1/Hel28             32   òú     ó                                         ó 
  152|1//0019            33   òú     ó                                         ó 
  136|1/Hel24            23   òú     ó                                         ó 
  138|1/Hel38            25   òú     ó                                         ó 
  111|1/107ba            10   òú     ó                                         ó 
  124|1/Hel135bb         15   òú     ó                                         ó 
  105|1/Hel31             6   òôòòòø ó                                         ó 
  107|1/Hel37             8   òú   ùò÷                                         ó 
  9|1//0005             240   ò÷   ó                                           ó 
  101|1/H135ba            2   òòòòò÷                                           ó 
  380|Öl GW10/1828      181   òø                                               ó 
  442|B6007             198   òú                                               ó 
  115|HKI135L            55   òú                                               ó 
  37|Bio209             177   òú                                               ó 
  378|Öl Bio215         180   òôòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòú 
  33|Bio214             151   òú                                               ó 
  240|G410               94   òú                                               ó 
  30|Bio213             132   ò÷                                               ó 
  527|GW27/3236         254   òòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòòò÷ 
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